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Outline of the thesis 
The present thesis reports the works performed at (i) Rosário Oliveira’s lab at IBB - Institute for 
Biotechnology and Bioengineering, Centre of Biological Engineering, Universidade do Minho, 
Braga, Portugal, (ii) Manuel Coimbra’s lab at Departamento de Química, Universidade de Aveiro, 
Aveiro, Portugal, (iii) José Lopez-Ribot’s lab at Department of Biology and South Texas Center for 
Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, Texas, USA, 
and (iv) Fernando Rodrigues’s lab at Life and Health Sciences Research Institute (ICVS), School 
of Health Sciences, Universidade do Minho, Braga, Portugal, to complete my Ph.D. work plan.  
This thesis is organized into five chapters. The first chapter briefly reviews relevant aspects of 
Candida species biology and summarizes the state-of-the-art knowledge on Candida species 
extracellular molecules, other than proteins. Chapters 2 and 3 report the studies performed on 
the analysis of compounds released by Candida species into the extracellular medium and on the 
elucidation of the interactions of these molecules with virulence traits of Candida species. The 
research strategy consisted of selecting extracellular DNA (Chapter 2) and a set of alcohol 
compounds (Chapter 3), based on previous investigations on the fungal field. The fourth chapter 
focuses on the evaluation of Candida species in a clinical setting. Finally, general conclusions are 
presented in Chapter 5, unifying the published and submitted data and suggesting clues for 
future work.  
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Abstract 
Over the last years fungi have emerged as a major cause of human disease. Candida albicans is 
the most common cause of opportunistic mycoses, albeit Non-Candida albicans Candida (NCAC) 
species, namely Candida dubliniensis, Candida glabrata, Candida krusei, Candida parapsilosis, 
and Candida tropicalis, are emerging as pathogens. Candida species factors that might influence 
the pathogenesis of infection include the ability to: undergo a reversible conversion between yeast 
and filaments (only for C. albicans and C. dubliniensis), form biofilms, and secrete proteins and 
chemicals, such as E,E-farnesol (farnesol), into the extracellular medium. This work aimed to 
bring insights into Candida species world, following two main routes: first, the analyses of 
compounds released by Candida species into the extracellular medium focusing on extracellular 
DNA (eDNA) and alcohol compounds, and second, the identification of Candida species in clinical 
samples.  
Concerning eDNA, here we show that it is a component of C. albicans biofilm extracellular matrix 
(ECM). In addition, based on the degradation of eDNA by deoxyribonuclease (DNase) and 
addition of exogenous DNA at different stages of biofilm development, it was possible to define 
that eDNA contributes to the maintenance and stability of C. albicans mature biofilms. 
Furthermore, the study of the impact of the combined use of DNase and antifungals against C. 
albicans biofilms revealed that DNase increases the effectiveness of the antifungal agents 
amphotericin B and caspofungin. Our results present evidence that eDNA is a key element of the 
ECM in C. albicans, contributing to biofilm integrity and antifungal resistance. 
With respect to extracellular alcohols, the results presented herein show that C. albicans 
extracellular alcohol farnesol impairs C. glabrata, C. krusei, and C. tropicalis planktonic growth by 
interfering with cell viability and/or cell cycle, depending on the species. In addition, headspace-
solid-phase microextraction and gas chromatography-mass spectrometry were used for profiling 
Candida extracellular alcohols. Those procedures allowed the identification and quantification of 
isoamyl alcohol, 2-phenylethanol (phenylethanol), 1-dodecanol, E-nerolidol (nerolidol), and 
farnesol in C. albicans and C. dubliniensis planktonic and biofilm cells supernatants. With the 
exception of nerolidol, these compounds were also identified in C. parapsilosis and C. tropicalis 
planktonic supernatants. Based on the quantifications performed in this work, the effect of the 
exogenous addition of commercial formulations of the alcohols was tested in vitro and in vivo. 
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In vitro, physiological levels of these alcohols were capable of inhibiting C. albicans and C. 
dubliniensis yeast to filament conversion, under filamentation inducing conditions, when used 
alone or in combination (simulating a 96-h culture supernatant). Furthermore, the evaluation of 
the impact of the individual addition of the extracellular alcohols against Candida species biofilm 
cells mitochondrial activity and biofilm biomass showed that these compounds differentially affect 
biofilm development. Of note, physiological levels of isoamyl alcohol, phenylethanol, and nerolidol 
interfered with C. parapsilosis and C. tropicalis biofilm development. In vivo, using the well 
established murine model of hematogenously disseminated candidiasis, it was shown that a 
solution simulating the composition of alcohols present in a C. albicans culture supernatant is 
able to increase mice survival, decreasing fungal burden, and filamentation in the kidney. Overall, 
these results show that extracellular compounds produced by Candida species regulate their 
virulence traits. 
Finally, we evaluated the oral Candida carriage in patients attending a dental clinic in Braga, 
Portugal. This study showed that although C. albicans is the Candida species most frequently 
isolated from the oral cavity in this population, NCAC species also contribute to the fungal 
burden. Notably, the majority of these NCAC species was co-isolated with C. albicans, evidencing 
the complex control of Candida species diversity and distribution in a natural environment. 
Taken together, these studies represent a very important contribution to our understanding of the 
composition of the extracellular milieu of Candida species and its relationship with the regulation 
of Candida biology, and open the possibility of the development of new treatment and/ or 
diagnostic strategies to combat candidiasis. 
ABSTRACT 
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Resumo 
Ao longo dos últimos anos os fungos têm emergido como uma das principais causas de doenças 
humanas. Candida albicans constitui a principal causa de micoses oportunistas, embora outras 
espécies de Candida não albicans (CNA), como Candida dubliniensis, Candida glabrata, Candida 
krusei, Candida parapsilosis e Candida tropicalis estejam a emergir como patogénicos. São 
vários os factores que podem influenciar a patogénese, nomeadamente, a capacidade de 
transitar reversivelmente entre as formas de levedura e filamento (especificamente C. albicans e 
C. dubliniensis), a capacidade de formar biofilme e ainda a de libertar proteínas e outras classes 
de compostos, como o E,E-farnesol (farnesol), no meio extracelular. Esta tese teve como 
objectivo principal o estudo do universo das espécies de Candida seguindo, nesse sentido, duas 
linhas de investigação. Primeiro, efectuando a avaliação dos compostos libertados por espécies 
de Candida para o meio extracelular, especificamente DNA extracelular (DNAe) e compostos 
alcoólicos. Segundo, procedendo à identificação de espécies de Candida em amostras clínicas. 
Relativamente aos estudos que visaram o DNAe, os nossos resultados mostraram que este é um 
componente da matriz extracelular de biofilmes formados por C. albicans. Adicionalmente, com 
base na degradação do DNAe pela enzima desoxiribonuclease e na adição de DNA exógeno em 
diferentes fases de desenvolvimento do biofilme, foi possível estabelecer que o DNAe contribui 
para a manutenção e estabilidade de biofilmes maduros de C. albicans. Complementarmente, o 
estudo do efeito da combinação da desoxiribonuclease com agentes antifúngicos em biofilmes 
de C. albicans revelou que a desoxiribonuclease aumenta a eficácia dos agentes antifúngicos 
anfotericina B e caspofungina. Os nossos resultados evidenciam que o DNAe é um elemento 
chave da matriz extracelular de biofilmes de C. albicans que contribui para a sua integridade e 
resistência a agentes antifúngicos. 
Em relação aos álcoois extracelulares, os resultados apresentados nesta tese revelaram que o 
farnesol, álcool extracelular produzido por C. albicans, afecta negativamente o crescimento de 
células planctónicas de C. glabrata, C. krusei e C. tropicalis, por interferir com a viabilidade e/ou 
ciclo celular, dependendo da espécie em estudo. Adicionalmente, a técnica de microextracção 
em fase sólida, em modo de espaço de cabeça acoplada a cromatografia de gás-espectrometria 
de massa foi utilizada para determinar o perfil dos álcoois extracelulares de espécies de 
Candida. Esta análise permitiu a identificação e quantificação dos álcoois: álcool isoamílico,  
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2-feniletanol (feniletanol), 1-dodecanol, E-nerolidol (nerolidol) e farnesol em sobrenadantes 
obtidos de culturas de C. albicans e C. dubliniensis na forma planctónica e em biofilme. Estes 
compostos, à excepção do nerolidol, foram também identificados em culturas planctónicas de C. 
parapsilosis e C. tropicalis. De seguida, tendo por base as quantificações dos compostos 
determinadas no decurso deste trabalho, foram efectuados ensaios no sentido de avaliar o efeito 
destes compostos in vitro e in vivo. Por um lado, nos ensaios in vitro, verificou-se que 
concentrações fisiológicas destes compostos inibem a transição morfológica de levedura para 
filamento de C. albicans e C. dubliniensis, sob condições que promovem a filamentação. Este 
efeito foi observado quando os álcoois foram adicionados ao meio de cultura individualmente ou 
em combinação, simulando um sobrenadante de 96 h. De seguida, a avaliação do efeito da 
adição de álcoois extracelulares na actividade mitocondrial e biomassa de biofilmes de espécies 
de Candida mostrou que estes compostos interferem com o desenvolvimento do biofilme. De 
notar que observámos que concentrações fisiológicas de álcool isoamílico, de feniletanol e 
nerolidol regulam a formação de biofilme de C. parapsilosis e C. tropicalis. Por outro lado, para 
os ensaios in vivo foi utilizado um modelo de murino de candidiase já estabelecido e 
caracterizado. Os resultados revelaram que a administração intraperitoneal de uma solução 
mimetizando um sobrenadante de C. albicans relativamente à sua composição em álcoois, 
conduz a um aumento da sobrevivência dos ratinhos, acompanhado pela diminuição da carga 
fúngica e da filamentação a nível renal. De uma forma geral, estes resultados mostram que 
moléculas extracelulares produzidas por espécies de Candida são capazes de regular os seus 
factores de virulência. 
Finalmente, avaliámos a colonização oral por espécies de Candida numa população de pacientes 
de uma clínica dentária em Braga, Portugal. Este estudo mostrou que nesta população, embora 
C. albicans tenha sido a espécie de Candida mais frequente, as espécies CNA também 
contribuem para a carga fúngica na cavidade oral. De notar que a maioria das CNA foi co-isolada 
com C. albicans, evidenciando a complexidade do controlo da diversidade e distribuição de 
espécies de Candida num ambiente natural. 
Em conclusão, os resultados apresentados nesta tese contribuem significativamente para a 
elucidação da composição do meio extracelular de espécies de Candida e da sua relação com a 
regulação da biologia das próprias espécies de Candida, abrindo novas perspectivas no sentido 
de desenvolver novos tratamentos e/ou terapias de diagnóstico para combater a candidiase. 
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GENERAL INTRODUCTION 
Starting in the early 1980s, fungal diseases began to constitute a major public health problem. 
The observed increase in opportunistic fungal infections has parallel with the expansion in 
populations with metabolic and immunosuppressive diseases, and mucosal or cutaneous barrier 
disruption, as a consequence of the advances in medical practices [1, 2]. Overall, Candida 
species are now recognized as major agents of opportunistic fungal infections worldwide. 
Although for many years Candida infections were synonymous of disease caused by Candida 
albicans, the recent surveillance studies indicate that Non-Candida albicans Candida (NCAC) 
species, particularly, Candida dubliniensis, Candida glabrata, Candida krusei, Candida 
parapsilosis, and Candida tropicalis are emerging as pathogens [1, 3, 4]. This species 
distribution shift has been attributed to NCAC species intrinsic or acquired resistance to 
antifungal agents, namely fluconazole [3]. The recognition of Candida infections as a life-
threatening problem associated with high mortality rates and costs, due to increased length of 
patients hospitalization, antifungals acquisition, ineffective treatment, and antifungals side effects 
[5], probably are responsible for the increasing interest in the study of Candida and candidiasis.  
While fundamental researchers focus on Candida species biology, clinicians are concerned 
with the invasive form of the disease [6]. In fact, Candida species make part of the commensal 
flora of healthy individuals [7], as stated by Professor Carol Kumamoto, “C. albicans has an 
identity crisis; it thinks it’s a part of the human body” (reported in [8]). However, when the host 
immune system is impaired for example by immunosuppressive treatments, or the competing 
flora is altered by antibiotics or hormonal therapies, Candida species can overwhelm the 
protective host defense mechanisms and become pathogenic, thus causing disease. The 
spectrum of clinical manifestations ranges from skin and mucous membrane lesions, such as the 
observed in the oral cavity, to life-threatening invasive infections, arising from bloodstream 
invasion and hematogenously spread of the Candida species [9]. To fulfill the clinicians’ 
demands of new diagnostic tools, efficient treatments for invasive candidiasis [10], and to direct 
the research into the patients needs, it is important to establish a strict cooperation between 
fundamental researchers and clinicians for the understanding of (i) the distribution and 
epidemiology of Candida species in specific niches, and (ii) Candida biology, including the fungal 
specific attributes and strategies associated with pathogenesis, ie, Candida virulence factors.  
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Although fungal virulence is thought to be multifactorial, over the years some virulence 
factors have been highlighted in Candida species (reviewed in [11-16]), with special focus on C. 
albicans. The fact that for many years NCAC species were considered benign for the human host 
may have diverted researchers from studying these species, delaying the development of 
molecular tools and animal models. Actually, to define the genes responsible for virulence it is 
essential to show that the null mutants have attenuated virulence and that the addition of the 
gene back to the mutant restores the virulence [17]. Thus, to date, the research on NCAC 
species virulence factors seems to be driven by the evaluation of factors shared by C. albicans 
and NCAC species, and not on the investigation of factors that distinguish them. 
 
CANDIDA SPECIES MORPHOGENESIS 
From the observation that during infection C. albicans grows in both yeast and filamentous form 
(Fig.1.1 A) emerged one of the branches of Candida biology – morphogenesis -. Not only in vivo, 
but also in vitro C. albicans can undergo a reversible conversion from yeast (Fig.1.1 B) to hyphae 
(Fig.1.1 D), passing through an intermediate form, the pseudohyphae (Fig.1.1 C) [18]. Notably, 
among NCAC species, the ability to grow in yeast and hyphae forms is only shared by C. 
dubliniensis [15]. In fact, although all the NCAC species are able to form yeast, and the majority 
can form pseudohyphae, only C. dubliniensis can form true hyphae [19]. However, C. 
dubliniensis seems to have less ability to filament in vitro and in vitro [20]. 
The C. albicans morphological transition from yeast to hyphae depends on the 
environmental conditions in which C. albicans is growing. Several environmental factors such as 
serum, N-acetylglucosamine, neutral pH, starvation, temperature above 35°C, cell density 
 
 
Fig.1.1. Common growth forms of C. albicans. Microscopy analysis of (A) histopathological analysis of a kidney from 
a mouse infected with C. albicans, exhibiting both yeast (y) and filamentous (f) forms, and in vitro cultured cells under 
experimental conditions that promote (B) yeast, pseudohyphae (B), and hyphae (C) forms growth. 
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below 106 cells/ml have been described as effectors of the conversion from yeast to hyphae 
through different signaling pathways (reviewed in [21, 22]). Of note, two additional forms adopted 
by C. albicans, the opaque and chlamydospores forms, whose function has not been deeply 
investigated [23], can also be regulated by environmental factors [24, 25].  
The association between C. albicans morphogenesis and virulence arises from several 
lines of evidences suggesting that yeast and hyphae forms are required for the pathogenecity, 
being proposed that while yeast cells are more suitable for dissemination, hyphae may be 
essential for infection, colonization, and biofilm structure (reviewed in [26, 27]). However, it is not 
clear whether morphogenesis, per se, is a virulence factor, or it is its co-regulation with other 
virulence traits that promotes pathogenecity [28]. 
 
CANDIDA SPECIES BIOFILM FORMING ABILITY 
The analysis of the predisposing factors underlying NCAC species infections [29] indicates that 
among other factors, the C. glabrata and C. parapsilosis candidaemia correlates with intravenous 
catheters and prosthetic heart valves, respectively [29]. This suggests that the ability of NCAC 
species to adhere to a biomaterial represents the first stage of the infection process. In fact, as 
reviewed by Ramage et al. [30], virtually all implanted devices can be colonized by endogenous 
and/or exogenous Candida species, constituting this the first of four steps that end in the 
formation of (mature) biofilms (Fig.1.2). In a genetically controlled process, the cell adhesion and  
 
 
Fig.1.2. Schematic diagram of C. albicans biofilm life cycle. The four main phases of biofilm development, (A) early, 
(B) intermediate, (C) maturation, and (D) dispersion are indicated as well as the key processes occurring at each 
phase, according to Chandra et al. [31] and Uppuluri et al. [32]. ECM means extracellular matrix. 
Chapter 1 General introduction 
 
30 
colonization (Fig.1.2 A, early phase) is followed by cell division and proliferation with formation of 
microcolonies and emergence of self produced extracellular material, the extracellular matrix 
(ECM) (Fig.1.2 B, intermediate phase). In the maturation phase, there is an increase in the 
amount of ECM produced that encases the microcolonies into a structured microbial community 
(Fig.1.2 C, maturation phase) [31, 33]. In addition, it was recently shown that the dispersion of 
cells from the biofilm occurs through all the stages of the life cycle, although in higher proportion 
during the intermediate phase of growth [32]. Of note, not only biomedical devices can be 
colonized by Candida species, but also host surfaces, such as the oral cavity [34]. 
Overall, three major problems can be anticipated concerning Candida biofilms and its 
contribution to disease. First, the possibility of impairment of the medical device function, thus 
leading to its removal. Second, the biofilm eradication, since the cells within the biofilms display 
increased tolerance/resistance to antifungal agents in comparison with free-living, planktonic, 
cells. Third, the possibility of the development of disseminated disease and of the colonization of 
additional sites, from cells derived from biofilm dispersion (reviewed in [30, 33, 35]). Thus, the 
ability to adhere and ultimately form biofilms has been increasingly referred to as a potential 
Candida virulence factor [12, 14, 16, 36, 37].  
Despite their recognized clinical relevance, research in Candida species biofilms is still in 
its infancy. It should be noted that although the majority of our understanding on biofilms has 
been gained from studies in C. albicans, this knowledge cannot be transposed to NCAC species 
biofilms or even to strains of the same species. In fact, some studies show that biofilm forming 
ability and biofilm features, such as morphology and ECM composition may be strain dependent 
[38, 39]. In addition, few studies have addressed the polimicrobial nature of biofilms, that are 
found in a clinical setting. For example, a clinical study showed the co-isolation of Candida 
species in eight patients, from a cohort of 54 individuals infected with human immunodeficiency 
virus [40]. Evidences from in vitro data, show that C. albicans has growth competitive advantages 
over Candida dubliniensis, being more evident in planktonic than in biofilm growing conditions 
[41]. An additional study has reported that C. albicans and other Candida species may interact in 
order to control biofilm growth, even though this is strictly dependent on the Candida species that 
dominates the biofilm [42]. The mechanisms that regulate the diversity and distribution of 
Candida species within biofilms are still not understood. However, similarly to what is observed 
for fungi-bacteria interactions [43] it cannot be discarded that extracellular molecules contribute, 
at least in part, to these inter-species interactions. 
General introduction Chapter 1 
 
31 
CANDIDA SPECIES EXTRACELLULAR MOLECULES 
Together with the cell wall, secreted molecules may constitute an efficient means by which 
Candida cells can sense and interact with surrounding environment, and ultimately constitute 
virulence attributes. The set of protein secreted by Candida species is well documented, namely 
lipases, phospholipases and secreted aspartic proteinases (reviewed in [11-16, 44]). However, 
Candida cells may secrete into the extracellular milieu other molecules, including nutrients, 
metabolic by-products, and signaling molecules [45] that may contribute to fungal pathogenecity. 
In fact, in the last years, other extracellular molecules, besides proteins, are emerging in the 
literature as potential regulators of Candida biology. Table 1.1 aims to summarize Candida 
species extracellular molecules that have been reported to regulate fungal and/or host functions. 
However, it must be noted that some of these compounds may be found in literature with 
different names, due to the non-uniformity of the nomenclature used.  
All the molecules described in Table 1.1 have been identified in Candida species culture 
planktonic supernatants. Only DNA [46] has been isolated from the biofilm ECM, prostaglandins 
[47], and tyrosol [48], have been identified in the supernatant of biofilm growing cells. In 
addition, the majority of the studies summarized in Table 1.1, focus on one single molecule. This 
limitation may result from the extraction and concentration methods applied and not from the 
analytical method, specifically gas chromatography-mass spectrometry, applied for example for 
the analysis of farnesol [49], and high performance liquid chromatography, used for the analysis 
of tyrosol [48]. 
Notably, a large group of these metabolites share an alcohol functional group, namely, E,E-
farnesol (farnesol), isoamyl alcohol, E-nerolidol (nerolidol), 2-phenylethanol (phenylethanol), 
tryptophol, and tyrosol (Table 1.1). Although the biosynthetic pathways have not been 
characterized in Candida species, they have been assigned based on indirect evidences using 
inhibitors of specific pathways (e.g., [50]) or by analogy with biosynthetic pathways in 
Saccharomyces cerevisiae (e.g., [51]). Thus, based on their biosynthetic precursors they are 
classified as: aromatic (phenylethanol, tryptophol, and tyrosol) and aliphatic (isoamyl alcohol) 
alcohols, sesquiterpenoids (farnesol, farnesoic acid, and nerolidol), and lipids (prostaglandins and 
3(R)-hydroxy-tetradecaenoic). Curiously, the main biosynthetic precursors of these molecules: 
amino acids, mevalonate, and fatty acids, together with shikimate and acetate are considered the 
“building blocks” of the secondary metabolites [52].   
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Table 1-1: Summary of molecules secreted by Candida species into the extracellular milieu 
Extracellular 
molecule 
Candida species Biosynthetic precursor (Candida species) Regulated function 
DNA C. albicans, C. 
tropicalis, C. 
parapsilosis [46, 53] 
n.k. (C. albicans), ‡Biofilm [54] ,host 
immunomodulator [55-57] 
Farnesoic acid C. albicans [58] ‡Mevalonate (farnesyl 
diphosphate) [59] 
(C. albicans) Filamentation [58] 
E,E-Farnesol C. albicans [49], C. 
dubliniensis, C. 
parapsilosis, C. 
tropicalis, C. glabrata, 
C. krusei, C. kefyr, C. 
guilliermondii [60] 
‡Mevalonate (farnesyl 
diphosphate) [50, 61] 
(C. albicans) Biofilm [62], chlamydospores 
formation [25], cross-kingdom 
communication (reviewed in [43, 63]), 
filamentation [49], †growth [64], host 
immunomodulator [65-68], mating [24], 
oxidative stress resistance [69] 
(C. dubliniensis) antifungal resistance, 
biofilm [70], filamentation, †growth [70, 
71] 
(C. parapsilosis, C. glabrata, C. krusei, C. 
tropicalis) †Biofilm [72-74], growth [72, 73] 
3(R)-Hydroxy-
tetradecaenoic 
acid 
C. albicans [75] ‡Fatty acids 
(arachidonic acid) 
[75] 
(C. albicans) Biofilm, filamentation [75] 
Isoamyl alcohol C. krusei [76] ‡Amino acids 
(leucine) [77] 
(C. albicans) Filamentation [78] 
E-Nerolidol C. krusei [76] ‡Mevalonate (farnesyl 
diphosphate) [79] 
(C. albicans) Filamentation [49] 
2-Phenylethanol C. albicans [80, 81], 
C. krusei [76] 
‡Amino acids 
(phenylalanine) [51] 
(C. albicans) Biofilm [81], †filamentation 
[81, 82], growth [80] 
Prostaglandins C. albicans [47, 83] ‡Fatty acids 
(arachidonic acid) 
[84] 
(C. albicans) Filamentation [83] 
Tryptophol C. albicans [80, 81], 
C. dubliniensis [85] 
‡Amino acids 
(tryptophan) [51] 
(C. albicans) †Biofilm [81]; †filamentation 
[81, 82], growth [80] 
Tyrosol C. albicans [48, 86], 
C. glabrata, C. 
parapsilosis, C. 
tropicalis [87] 
‡Amino acids 
(tyrosine) [51] 
(C. albicans) †Biofilm [48, 81], 
filamentation, growth [86], protection 
against phagocytic killing [87] 
n.k., not known; †, ambiguous effect, based on different reported information; ‡, presumptive pathway   
General introduction Chapter 1 
 
33 
Remarkably, the research on extracellular compounds has been centered in C. albicans 
(Table 1.1), with only few studies focusing on NCAC species [e.g. [73, 74, 76]]. Furthermore, the 
insights into Candida species extracellular molecules (Table 1.1) arose from studies evaluating 
one/two reference strains of each Candida species, with the use of mutant strains being 
restricted to C. albicans studies [46, 47, 51, 57, 67, 68, 88]. Of note, from these mutant strains 
only one defective in the production of the extracellular molecules has been generated, 
specifically the C. albicans dpp3∆/dpp3∆ mutant strain, defective in one of the two genes that 
converts farnesyl pyrophosphate to farnesol [68]. 
Additionally, Table 1.1 shows the particular interest in the elucidation of the role of these 
molecules in the in vitro regulation of planktonic cells filamentation and growth, and biofilm 
development. In general, the strategy followed by the several researchers consisted on the 
evaluation of the effect of the exogenous addition of such compounds in order to infer the effect 
on the specific function evaluated. The ambiguous effect reported for the action of some 
compounds (e.g., tyrosol in C. albicans biofilm [48, 81]) may be related to the use of different 
strains and growth conditions, such as medium or compound concentration. Furthermore, it is 
observed an attempt to elucidate the immunomodulatory role of these molecules, specifically 
observed for farnesol and DNA (Table 1.1), evidencing the need to evaluate the in vivo effect of 
the compounds to establish a possible relationship with pathogenesis.  
Finally, it is clear from the data reported in Table 1.1 that farnesol is by far the most 
extensively studied molecule (recently reviewed by Langford et al. [89]). This is probably due to 
the fact that it was the first quorum sensing molecule described in an eukaryote [49]. Quorum 
sensing was originally identified in bacteria as a mechanism of cells to respond to changes in cell 
population density. Cells produce, release, detect, and respond to threshold levels of 
autoinducers molecules in order to coordinate virulence factors expression [90]. As a quorum 
sensing molecule, farnesol accumulates in the extracellular medium during growth and regulates 
C. albicans filamentation upon a threshold level [49]. However, a farnesol specific receptor has 
not been identified yet, and this is a requirement that needs to be fulfilled for it to be considered 
a quorum sensing molecule [91]. In addition, farnesol has been shown to modulate the host 
immune system in a manner that is advantageous for C. albicans, being suggested to act as a 
virulence factor in this Candida species [65, 65, 67].  
 
Chapter 1 General introduction 
 
34 
Overall, there is an increasing awareness that Candida species release other molecules 
than proteins, into the extracellular medium, that may regulate their species biology, and the 
ones presented in Table 1.1 may represent only the “tip of the iceberg”. Thus, this work aimed to 
bring insights into Candida species world, following two main routes: first, the analysis of 
compounds released by Candida species into the extracellular medium focusing on extracellular 
DNA (Chapter 2) and alcohol compounds (Chapter 3), and to elucidate the interactions of the 
identified molecules with virulence traits of Candida species, and second, the identification of 
Candida species in a clinical context (Chapter 4).  
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ABSTRACT 
DNA has been described as a structural component of the extracellular matrix (ECM) in bacterial 
biofilms. In Candida albicans there is a scarce knowledge concerning the contribution of extracellular 
DNA (eDNA) to biofilm ECM and overall structure. This work examined the presence and quantified the 
amount of eDNA in C. albicans biofilm ECM and the effect of deoxyribonuclease I (DNase) treatment and 
the addition of exogenous DNA on C. albicans biofilm development as indicators of a role for eDNA in 
biofilm development. We were able to detect the accumulation of eDNA in biofilm ECM extracted from C. 
albicans biofilms formed under conditions of flow, although the quantity of eDNA detected differed 
according to growth conditions, in particular with regards to the medium used to grow the biofilms. 
Experiments with C. albicans biofilms formed statically using a microtiter plate model indicated that 
DNase treatment (> 0.03 mg/ml) decreases biofilm biomas, and, conversely addition of exogenous DNA 
(>160 ng/ml) increases biofilm biomass, at later time points of biofilm development. We present 
evidence for the role of eDNA in C. albicans biofilm structure and formation, consistent with eDNA being 
a key element of the ECM in mature C. albicans biofilms and playing a predominant role in biofilm 
structural integrity and maintenance.   
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INTRODUCTION 
Biofilms are structurally complex microconsortia of surface adhering cells embedded within a 
extracellular matrix (ECM) composed of substances produced and secreted by cells or derived 
from cell lysis [1]. The ECM contributes to the architectural preservation of biofilms by the 
maintenance of stable cell–cell and cell–surface interactions, and acts as a protective barrier 
[2]. Although polysaccharides and proteins are the more extensively studied substances of 
biofilms ECM, other molecules such as lipids and nucleic acids play a crucial role on ECM 
functions [1]. In fact, extracellular DNA (eDNA) has been identified in the surrounding milieu as 
part of the ECM of biofilms formed by both Gram-negative species such as Pseudomonas 
aeruginosa [3] and Gram-positive bacteria such as Bacillus cereus [4]. The proposed 
mechanisms implicated in eDNA release include: (i) cell lysis, (ii) quorum sensing, and (iii) 
excretion from DNA containing vesicles [3]. Bacterial biofilms eDNA characterization revealed 
that it comprises fragments of high molecular weight (around 30 Kb) [5] that differ from 
genomic DNA, as indicated by the different profiles exhibited upon restriction endonuclease 
treatments or randomly amplified polymorphic DNA analysis [6, 7]. Evidence for a role of eDNA 
as a structural component of bacterial biofilms ECM arose from studies showing that eDNA is 
required at the initial stages of biofilm formation [8, 9]. Additionally, independent studies 
evaluating exogenous DNA and DNase effect on biofilm cells antimicrobial susceptibility [5, 10] 
showed an association between eDNA and biofilms increased antibiotic resistance. 
Despite the intensive research in the bacterial field, the investigation focusing on eDNA in 
fungal biofilms is scarce.  
C. albicans is a polymorphic fungus that causes opportunistic infections in humans and 
its ability to form biofilms is well characterized [11]. C. albicans ECM abundance was recently 
shown to be regulated positively by the glucoamylases Gca1 and Gca2 and by the alcohol 
dehydrogenase Adh5, and negatively by the alcohol dehydrogenases Csh1 and Ifd6 [12]. C. 
albicans ECM consists predominantly of carbohydrates but also contains proteins, hexosamine, 
uronic acid, and phosphorus [13]. Consistent with the presence of phosporous, circumstantial 
evidences points to the presence of eDNA in ECM. Specifically, mature biofilms treatment with 
50 µg/ml of deoxyribonuclease I (DNase) resulted in 30% decrease of biofilm biomass, similarly 
to the observed for proteinase K treatments [13]. More recently, eDNA was extracted from C. 
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albicans 72 h biofilm ECM within micrograms per gram of biofilm wet weight [14]. Additionally, 
it has been demonstrated that the presence of eDNA is a common feature of biofilms formed by 
other Candida species [14].  
However, further studies are required to extend the knowledge on the contribution of 
eDNA to C. albicans biofilms structure and matrix composition. Here we examined the presence 
of DNA in C. albicans biofilm ECM and the effect of DNase and the addition of exogenous C. 
albicans DNA on biofilm formation. 
 
MATERIAL AND METHODS 
Strain and culture conditions 
The C. albicans wild type strain SC5314 was used in this study. Cells were stored at -70°C in 
20% glycerol stocks and propagated by streaking a loopfull of cells onto Sabouraud dextrose 
agar medium (BD, Franklin Lakes, NJ, USA) supplemented with 100 mg/l ampicillin (Fisher 
Bioreagents, Fair Lawn, NJ, USA) and incubating at 30°C for 24 h. These stocks were stored at 
4°C for no longer than two weeks. For all experiments, batches (30 ml in 125 ml flasks) of 
yeast extract-peptone-dextrose (YPD) medium [1% (w/v) yeast extract, 2% (w/v) peptone, 2% 
(w/v) glucose] (US Biological, Swampscott, MA) were inoculated with freshly grown yeast cells 
in an orbital shaker at 30°C for 24 h. Cells were harvested by centrifugation and washed in 
sterile saline. Cells were counted with a haemocytometer and dilutions were made to prepare 
standardized cell suspensions (1 × 106 cells/ml) in the appropriate pre-warmed growth 
medium (see below). Confirmation of the number and viability of cells was determined by 
plating serial dilutions on Sabouraud dextrose agar. Colony forming units (CFU) were counted 
after 24-h incubation at 30°C. 
 
eDNA estimation in C. albicans biofilm ECM 
Biofilm formation under conditions of flow 
Three different influent media were used (i) Roswell Park Memorial Institute 1640 (RPMI) 
medium supplemented with L-glutamine (Mediatech Inc., Herdon, VA, USA), sodium 
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bicarbonate [0.2% (w/v)], and buffered with 0.165 M 3-[N-morpholino] propanesulfonic acid) 
(Research Products International Corp., Mount Prospect, IL, USA), final pH 7, (ii) YPD and (iii) 
yeast nitrogen base (YNB) (Fluka, St. Louis, MO, USA) supplemented with glucose [0.9% (w/v)] 
at final pH 7. The culture media used in the flow system were diluted in order to promote 
biofilm formation. Specifically, the chemically defined media RPMI and YNB were diluted 1:1 
whereas the rich medium YPD was diluted 1:10. The media were supplemented with ampicillin 
100 mg/l. Culturing conditions and apparatus were established as previously described [15]. 
Briefly, silicone elastomer (SE) strips (1 × 9 cm2) (Cardiovascular Instrument Corp. Silicone 
sheets, Wakefield, MA) were washed twice with ultrapure water, sterilized by autoclaving and 
pretreated overnight at 30°C with foetal calf serum (Sigma, St. Louis, MO, USA). C. albicans 
standardized cell suspensions (13 ml) were prepared using the same growth medium as the 
influent (1 × concentrated) and incubated with the SE at 37°C, 130 rpm for 90 min. After the 
adhesion period, the SE were transferred to the flow system and influent medium was set up at 
an initial flow rate of 0.75 ml/min [15]. Biofilms were formed at 37°C for 48 h. For subsequent 
analysis, two SE with biofilm were pooled together. Two independent experiments were 
performed for each growth medium condition. 
Planktonic cultures (50 ml of standardized cell suspension per 125 ml flask; 1 × 
concentrated YPD, RPMI or YNB) were grown at 37°C and 130 rpm for 48 h to validate the 
isolation of biofilm ECM (see below). 
 
Isolation of biofilm ECM 
ECM was isolated as previously described [16] with slight modifications. Briefly, after formation 
the biofilms were transferred to polypropylene conical tubes (BD), resuspended in 10 ml of 
ultrapure sterile water and vortexed for 1 min. Next, biofilm cells were sonicated in an ultrasonic 
bath for 45 min, followed by a vortexing step of 2 min and centrifuged (2000 rpm; 20 min). The 
supernatant fraction was recovered and filtered through 0.2 µm acrodisc syringe filters with 
Supor Membrane (Pall Life Sciences, Ann Arbor, MI, USA) that are low protein and nucleic acids 
binding membranes. Planktonic cultures were processed in parallel with biofilms during ECM 
extraction and aliquots were taken before and after the sonication step. The confirmation of 
planktonic cultures viability was performed by CFU counts in Sabouraud dextrose agar medium. 
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ECM analyses 
The DNA of the ECM fraction was extracted with an equal volume of 
phenol:chlorophorm:isoamyl alcohol (25:24:1, v/v) (Invitrogen, Carlsbad, CA, USA) and then 
precipitated with isopropanol (1:1; v/v). After centrifugation, the pellet was rinsed with 70% 
ethanol and air dried. The pellet was dissolved in 20 µl of Tris–EDTA (TE) buffer [10 mM Tris-
HCl (pH 7.5), 1 mM EDTA].  
DNA was quantified using the Quant-iTTM ds BR Assay kit (Molecular Probes, Invitrogen) 
according to the suppliers’ instructions. This assay allows an accurate determination of DNA 
between 100 ng/ml and 1000 ng/ml. A λ DNA standard 45.7 µg/ml was prepared in TE buffer 
from a commercially available standard solution (Promega, Madison, WI, USA) and run in 
parallel with samples in each assay. Additionally, a blank (TE only) was included in each assay. 
Samples were read in the QuibitTM fluorometer (Molecular Probes, Invitrogen) and a new 
calibration was run for each assay. A minimum of one DNA measurement was performed for 
biofilm samples. 
The protein content of the ECM fraction was estimated using the EZQ® Protein 
Quantification kit (Molecular Probes, Invitrogen). Standards for the assay were prepared in 
nanopure water (Biorad, Hercules, CA, USA) with ovalbumin supplied with the kit. Standard 
concentrations range was between 0 and 0.25 mg/ml in order to include sample 
concentrations. Fotodyne UV 300 transiluminator (Fisher) was used for UV measurements. 
Standard curves were generated for mean UV intensity vs ovalbumin concentration. All 
measurements were made with three replicates. 
 
Effect of DNase and exogenous DNA treatment on C. albicans biofilm formation 
Deoxyribonuclease I (DNase) from bovine pancreas (Sigma) stock solutions were prepared 
before each experiment in saline supplemented with 5 mM of MgCl2 (Merck, VWR, West 
Chester, PA, USA). The range of concentrations chosen was based on previously described 
titration data for bacterial species [17]. Working solutions of DNase in two-fold increments 
ranging from 0.02 to 2 mg/ml were prepared in RPMI medium.  
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C. albicans genomic DNA, to be added as exogenous DNA for C. albicans cells treatment, 
was extracted with the MasterPureTM Yeast DNA Purification kit (Epicentre Biotechnologies, 
Madison, WI, USA) according to the suppliers’ instructions. C. albicans DNA purity and 
concentration were estimated by measuring the A260 and A280 (Eppendorf Biophotometer, 
Eppendorf, USA). It has been previously described that in C. albicans stationary phase 
planktonic cultures eDNA levels are higher than 0.1 ng/ml [18]. In this sense, physiological and 
supraphysiological concentrations ranging from 10 to 2,560 to ng/ml, with two-fold increments, 
were chosen for this assay. Dilutions of the genomic DNA stock solution were prepared in RPMI 
medium. 
For control experiments, DNase was heat inactivated at 95°C for 10 min, and 
Ribonuclease (RNase) (Sigma) stock solutions were prepared in TE buffer.  
  
DNase treatment and exogenous DNA addition at different stages of biofilm formation 
Standardized cell suspensions (100 µl) were inoculated into polystyrene, flat-bottomed, 96-well 
microtitre plates (Corning Inc., Corning, NY, USA) and incubated for 0, 1, 2 and 24 h at 37°C 
under static conditions. At 0-h (preincubation), DNase was added to the standardized 
suspension. At 1-, 2- and 24-h of incubation the medium was removed and adhered cells 
washed two times with sterile phosphate buffered saline (PBS) (10 mM phosphate buffer, 2.7 
mM potassium chloride, 137 mM sodium chloride, pH 7.4) (Sigma). DNase working solutions 
were then added to C. albicans cells. The plates were incubated at 37°C for additional 24 h. 
The same procedure was performed for the addition of exogenous DNA to C. albicans cells. 
Positive controls for biofilm formation included RPMI only and RPMI plus 5 mM of MgCl2 for 
DNase experiments. Negative background control for subsequent analysis consisted of RPMI 
medium only. Four independent assays with three to eight replicates for each condition were 
performed. The effect of DNase treatment and exogenous DNA treatments was examined in 
terms of biofilm biomass changes using the crystal violet assay (see below). 
As controls for DNase enzymatic activity, RNase and heat inactivated DNase were added 
at 24 h as described above. This experiment was performed once with eight replicates.  
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The effect of DNase and/ or exogenous DNA on C. albicans viability and filamentation 
was examined in planktonic cultures and on preformed biofilms. For planktonic cultures, 5 ml of 
the standardized cell suspension plus (i) 5 mM of MgCl2, (ii) 2 mg/ml DNase, and (iii) 2,560 
ng/ml of exogenous DNA were incubated at 37°C, 130 rpm for 2 h. Viability was examined by 
CFU counts in Sabouraud dextrose agar medium. Filamentation was monitored by light 
microscopy using an inverted microscope (Westover Scientific, Mill Creek, WA, USA). These 
experiments were performed twice. The highest concentrations of DNase and exogenous DNA 
used in these experiments did not have an effect on C. albicans planktonic cells viability and 
filamentation. For preformed biofilms, DNase ranging from 2 to 0.02 mg/ml was added to 24-h 
mature biofilms as described above and incubated for an additional 24 h. Next, cells were 
removed with a micropipette tip, re-suspended in saline solution and CFU analysis carried out. 
Light microscopy examination of biofilms was performed in parallel. All the treatments were 
compared with the untreated (RPMI and RPMI plus 5 mM MgCl2) controls. 
 
Examination of the effect of DNase treatment and exogenous DNA on biofilm formation 
The effect of DNase and exogenous DNA on C. albicans biofilm biomass was estimated using 
the crystal violet assay. Briefly, the medium was removed and biofilms washed twice with PBS. 
Then, biofilms were stained with 50 µl of crystal violet 3 g/l [0.3% (w/v) crystal violet (Sigma), 
5% (v/v) isopropanol, 5% (v/v) methanol, 90% (v/v) water] for 5 min. Afterwards, each well was 
washed twice with PBS, air dried and destained with 100 µl of ethanol 100%. Next, 75 µl of the 
destaining solution was transferred to a new microtiter plate, and the A550 was measured 
(Benchmark Microplate Reader, Bio-Rad, Hercules, CA, USA). Samples exhibiting very intense 
color, yielding “offscale” absorbance values, were diluted before performing a second 
absorbance reading. 
 
Statistical analyses 
The association between the C. albicans 48-h biofilm ECM eDNA/protein content in the different 
experimental conditions was analysed using the chi-square test [19]. A statistical confidence 
interval of 95% was established. The comparison between (i) log CFU/ml before and after 
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sonication and (ii) each biofilm treatment and control condition was performed by two-tailed 
unpaired t-test (confidence interval 95%) using GraphPad Prism, version 5.00 software for 
Windows (GraphPad Software, San Diego, CA, USA). Differences were considered significant at 
P< 0.05.  
 
RESULTS 
Presence of eDNA on C. albicans biofilm ECM 
Three different media were tested for their ability to promote the accumulation of eDNA in the 
ECM of 48-h C. albicans biofilms developed under flow conditions. 
In the extraction of ECM it was mandatory to ensure that there was no leak of cellular 
DNA during sample processing. To validate the ECM extraction process 48 h planktonic cultures 
were handled in parallel with biofilm samples. Before and after samples processing, aliquots 
were collected and CFU analysis carried out. Difference between means log CFU/ml before and 
after sonication were of: 0.00 (P= 1.00) for RPMI, -0.07 (P= 0.39) for YPD, and 0.00 (P= 1.00) 
for YNB. 
As shown in Table 2.1-1, irrespective of which medium was used, eDNA was detected at 
measurable levels in ECM of C. albicans biofilms. Under the conditions used in this assay, the 
highest levels of eDNA in ECM were observed for biofilms formed using RPMI medium (3,045.4 
± 227.3 ng eDNA/mg of protein). These levels were 9-fold higher than those observed in the  
 
Table 2.1-1. C. albicans 48-h biofilm ECM eDNA and protein content. DNA was extracted and further quantified. 
Protein content was directly assayed from the samples. Data presented represents mean ± mean deviation 
a obtained from biofilms developed under flow conditions, corresponding to 18 cm2 of area; b used at 1:1 dilution; c used at YPD 
1:10 dilution 
Influent Medium eDNAa Proteina eDNA/ protein 
 (ng) (mg) (ng/mg) 
RPMIb 1518 ± 822 0.48 ± 0.2 3m045.4 ± 227.3 
YPDc 180 ± 160 0.42 ± 0.1 339.6 ± 265.6 
YNBb 1.8 ± 1.6 0.10 ±0.1 13.0 ± 8.8 
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Table 2.1-2. Results of the statistical analysis (P values) of C. albicans 48-h biofilm 
ECM quantification (ng eDNA/ mg of protein) obtained from the different 
experimental conditions 
 
 
 
 
ECM of biofilms grown in YPD (Table 2.1-1; P< 0.01, Table 2.1-2). Both the absolute quantities 
of eDNA and the ratio of eDNA/protein were lowest in the ECM from YNB-grown biofilms when 
compared to biofilms grown in RPMI and YPD (Tables 2.1-1 and 2.1-2). 
This data shows that eDNA is a component of C. albicans biofilm matrix and suggests 
that its accumulation in the ECM is affected by culture conditions. 
 
Effect of DNase treatment on C. albicans biofilm formation 
In order to examine the possible role of eDNA on C. albicans biofilm development, in a first set 
of experiments DNase was added to cells at different times (0, 1, 2 and 24 h) in the wells of 
microtiter plates and biofilm formation allowed to proceed for an additional 24 h (Fig. 2.1-1). 
The results of these experiments, assessed by a colorimetric assay for biofilm biomass showed 
that DNase did not exhibit major effects on C. albicans adherent cells at early time points during 
biofilm development (Fig.2.1-1). DNase was also used to treat preformed biofilms (24 h) to 
determine whether different concentrations of this enzyme could affect the formed biofilms. As 
shown in Fig.2.1-1, DNase showed a general inhibitory effect on C. albicans preformed biofilms. 
This was reflected by lower crystal violet readings at DNase concentrations higher than 0.03 
mg/ml. For example, biofilms treated for 24 h with 0.13 mg/ml DNase showed a reduction of 
40% in A550 readings when compared with the control (P= 0.03). Furthermore, preformed 
biofilms treatment with RNase and heat inactivated DNase at the same concentrations used for 
DNase did not display a decrease in biofilm biomass (data not shown), demonstrating that 
DNase activity is required for the observed effect. 
Additionally, it should be noted that the microscopic examination of biofilms before 
washing suggested that the DNase treated biofilms (Fig.2.1-2 I-b) resembled the control 
Influent Media  P value 
RPMI vs YPD  < 0.01 
YPD vs YNB < 0.01 
YNB vs RPMI  < 0.01 
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Fig.2.1-1. Effect of DNase treatment on C. albicans biofilm formation. Different DNase concentrations (0, 0.02, 
0.03, 0.06, 0.13, 0.25, 0.50, 1.00 and 2.00 mg/ml) were added to C. albicans cells at different times (0, 1, 2 and 
24 h) of incubation in the wells of microtiter plates and incubated at 37°C under static conditions. The extent of 
biofilm formation was estimated by the crystal violet assay. Presented values are mean A550 ± standard error of mean 
(SEM) of four independent experiments with three to eight replicates. Statistically significant differences (compared to 
biofilms formed in the absence of DNase) are indicated with an asterisk. (*, P < 0.05). 
 
biofilms (Fig.2.1-2 I-a). However, during the biofilm processing for the determination of biofilm 
biomass, the DNase treated biofilms did detach from the microtiter plate surface (Fig.2.1-2 II-d), 
resulting in decreased A550, in contrast to non-treated biofilms (Fig.2.1-2 II-c). Accordingly, the 
assessment of cell viability of pre-washed biofilms did not reveal a detrimental effect of DNase 
on biofilm cells viability (compared with the control). For example, for 24 h treatment with 0.13 
mg/ml DNase the log CFU/well was 6.1 vs 6.5 for control biofilms. 
This suggests that the observed effect induced by DNase treatment is not due to changes 
in biofilm cells growth or filamentation, but rather due to a direct effect on the biofilm ECM 
which is important for biofilm integrity and maintenance. 
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Fig.2.1-2. Example of microscopy evaluation of the effect of DNase treatment on 24 
h C. albicans biofilm formation. Microphotographs of cells in wells before (I) and after 
(II) aspiration of medium and subsequent washings with PBS for biofilms treated with 0 
mg/ml (a and c) and 0.13 mg/ml of DNase (b and d). The bar in the picture 
represents 200 µm. 
 
Effect of addition exogenous DNA on C. albicans biofilm formation 
To further substantiate the effect of eDNA as a structural component of biofilms, exogenous 
DNA was added to C. albicans cells. As shown in Fig.2.1-3, the addition of exogenous DNA to C. 
albicans adhered cell populations did not affect further biofilm development. In contrast, 
addition of exogenous DNA, at concentrations higher than 160 ng/ml to mature biofilms led to 
increases in biofilm biomass , as indicated by the differences in A550 readings compared with 
control biofilms (grown in the absence of exogenous DNA) (Fig.2.1-3). As an example, under the 
exposure to 320 ng/ml of exogenous DNA, biofilm biomass increased up to 63% in comparison 
with untreated biofilms (P= 0.03). 
These experiments indicate that eDNA may contribute to the maintenance and stability of 
C. albicans mature biofilms, but is not required for the early stages of biofilms establishment. 
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Fig.2.1-3. Effect of addition of exogenous DNA on C. albicans biofilm formation. Different exogenous DNA 
concentrations (0, 20, 40, 80, 160, 320, 640, 1280, and 2,560 ng/ml) were added to C. albicans cells at different 
times (0, 1, 2, and 24 h) of incubation in the wells of microtiter plates and incubated at 37°C under static conditions. 
The extent of biofilm formation was estimated by the crystal violet assay. Presented values are mean A550 ± SEM of 
four independent experiments with three to eight replicates. Statistically significant differences (compared to biofilms 
formed in the absence of exogenous DNA) are indicated with an asterisk. (*, P < 0.05). 
 
DISCUSSION 
In recent years there has been an increasing interest in the natural sources and target effects of 
the nucleic acids found outside the cells in several biological systems [20]. However, the study 
of eDNA in C. albicans biofilms has not been the subject of extensive research. Here, a series of 
experiments were designed to specifically address the contribution of eDNA to C. albicans 
biofilms ECM. 
For this, we first determined the eDNA content from the ECM of 48-h biofilms using three 
different culture media, to ensure that eDNA is a component of ECM under different 
environmental growth conditions. Biofilms were developed in a flow model due to the predicted 
higher amounts of exopolymeric material that could be obtained when compared to biofilms 
developed under static conditions [15, 21]. Regardless of the growth medium used, eDNA was 
found to be a component of C. albicans ECM in all conditions used (Tables 2.1-1 and 2.1-2). In 
this study, it was noticed that the amount of eDNA varied considerably with the growth medium 
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used, with RPMI favouring the accumulation of eDNA in the ECM of C. albicans biofilms (Table 
2.1-1). As the DNA content in the effluent medium was not determined it cannot be discarded 
that biofilm cells grown in YPD released more eDNA compared with RPMI but the ECM amount/ 
composition of RPMI biofilms promotes the accumulation of DNA. It should be noted that the 
association between ECM eDNA/protein content and growth medium was observed for biofilms 
formed in flow model. 
The release of eDNA into the extracellular medium is not biofilm cells specific. It has 
been previously reported the release of DNA into the supernatant of C. albicans planktonic cells 
grown in RPMI and Hanks balanced salt solution [18]. The highest levels of eDNA attained in 
the stationary phase of growth have been suggested to result from cell death due to the nutrient 
depletion and toxic metabolites accumulation [18]. We also determined the amount of free DNA 
in the supernatant of 48-h grown C. albicans planktonic cultures and observed the following 
hierarchy of eDNA accumulation relative to the amount of protein: YPD > RPMI > YNB 
(unpublished data).  
In bacteria, it was proposed that quorum sensing is one of the mechanisms that 
contributes to increased release of eDNA into the environment [22]. Recently, the eDNA content 
of C. albicans chk1/chk1 ECM was determined [14], which is a mutant strain known to be 
nonresponsive to the C. albicans quorum sensing molecule farnesol [23]. The ECM of the 
mutant strain contained only slightly lower eDNA and protein levels/ biofilm wet weight in 
comparison with the wild-type strain [14], suggesting that DNA release by C. albicans biofilm 
cells may not be a controlled step linked to cell-cell communication through farnesol. 
Regardless the factors that promote eDNA accumulation it was important to address the 
role of this ECM component in C. albicans biofilms. Circumstantial evidences have shown that 
DNA may play a structural role in C. albicans 48-h biofilms [13]. In this sense, we evaluated the 
impact of eDNA removal by DNase (Fig.2.1-1), and addition of exogenous DNA (Fig.2.1-3) at 
different stages of C. albicans biofilm formation. For the determination of the effect of these 
treatments on biofilms, a rapid and robust method, such as the 96-well plate model [24] that 
allows testing of multiple parameters in the same experiment was preferred. Furthermore, RPMI 
medium was the choice medium for the following experiments because it provides an optimal 
pH for DNase activity. Results from these series of experiments demonstrate that eDNA is an 
important component of C. albicans mature biofilms contributing to its maintenance and 
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stability, but is not required for the establishment of biofilms or during the very early phases of 
biofilm development (Fig.2.1-1 and 2.1-3).  
Although it has not been determined how biofilms grown in 96-well plates compare to 
those developed under flow conditions the conjugation of the data obtained from the two 
models is consistent with eDNA being a key element of the ECM in mature C. albicans biofilms 
and playing a predominant role in biofilm structural integrity and maintenance. However, we 
note that eDNA role in Candida biofilms may be species/strain dependent since a previous 
study reported that C. tropicalis biofilm biomass is not affected by 50 µg/ml DNase treatment 
[13]. Data presented in this work also points to a differential role of eDNA among C. albicans 
and bacterial biofilms. In fact, for several bacterial species eDNA is required for the initial 
attachment as well as for subsequent early phases of biofilm formation, but only for some 
species DNA was found to be an important structural component of mature biofilms [8, 9].  
In the last years several lines of evidence suggested that in vivo eDNA has a functional 
activity in the regulation of host immune response. On one hand, it was demonstrated that the 
administration of C. albicans DNA to mice at specific time points prior to infection promoted 
mice survival [25, 26]. On the other hand, it was demonstrated that after C. albicans infection 
of nonneutropenic rabbits fungal eDNA was detected in the plasma within the first 24 h and 
increased over the course of disease [18]. This eDNA may be available for interaction with Toll-
like receptor 9 (TLR9), an intracellular fungal DNA receptor, as evidenced by studies showing C. 
albicans eDNA activation of bone marrow-derived myeloid dendritic cells through the TLR9/ 
Myeloid differentiation factor 88 signalling pathway [27], and the increased survival of TLR9 
deficient mice upon challenge with C. albicans hyphae [28]. We can hypothesize that eDNA 
present on C. albicans biofilms may contribute to the modulation of host immune response. 
Overall, this work reveals novel aspects of the role of eDNA on C. albicans biofilms, and 
properties of biofilm ECM that contribute to a better understanding of C. albicans biofilm 
lifestyle.  
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ABSTRACT 
Cells within Candida albicans biofilms display decreased susceptibility to most clinically used antifungal 
agents. We recently demonstrated that extracellular DNA plays an important role in biofilm integrity, as a 
component of the biofilm matrix. The main objective of this work was to gain insight into the contribution 
of extracellular DNA to C. albicans biofilms antifungal susceptibility by the investigation of the impact of 
the combined use of deoxyribonuclease I (DNase) and antifungals to treat biofilms. Here we report the 
improved in vitro efficacy of DNase in combination with amphotericin B and caspofungin, but not 
fluconazole, against C. albicans biofilms. This work suggests that agents that target processes affecting 
the biofilm structural integrity may have potential use as a therapeutic adjuvant in the treatment of 
biofilm-associated candidiasis. 
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INTRODUCTION 
Candida albicans is an opportunistic fungal organism that is present as part of the normal 
microbiota of healthy individuals. However, when the host immune system is impaired or the 
competing bacterial microbiota is altered, C. albicans can overwhelm the host defences and 
gain access to the bloodstream, invading tissues, or contaminating medical devices, causing life 
threatening infections [1]. These infections are often associated with the formation of biofilms, 
and one of the major concerns with disease management is the fact that C. albicans biofilm 
cells display reduced susceptibility against azoles and polyenes in comparison to planktonic 
cells. This intrinsic property of biofilms is likely to be multifactorial and has been associated with 
factors such as cells physiological state, activation of drug efflux pumps, and a protective effect 
of the extracellular matrix (ECM) [2]. Recently our group showed that extracellular DNA (eDNA) 
is a critical component of the C. albicans biofilm ECM that contributes to biofilm structural 
integrity [3].  
In order to gain further insight into the contribution of eDNA to C. albicans biofilms 
antifungal susceptibility, in the present study we have investigated the impact of the combined 
use of deoxyribonuclease I (DNase) (which degrades eDNA) and antifungals to treat C. albicans 
biofilms.  
 
MATERIAL AND METHODS 
Chemicals 
A polyene (amphotericin B), echinocandin (caspofungin), and azole (fluconazole) were chosen 
for their different mechanisms of action. Drug solutions were prepared according to the Clinical 
and Laboratory Standards Institute recommendations, and the range of concentrations were as 
follows: amphotericin B (Sigma, St. Louis, MO), 0.06 to 16 mg/l; caspofungin (Merck, NJ, 
USA), 0.008 to 2 mg/l, and fluconazole (Pfizer, CT, USA), 4 to 1,024 mg/l. DNase I from 
bovine pancreas (Sigma) stock solutions were prepared in saline supplemented with 5 mM of 
MgCl2 (Merck, PA, USA). The enzyme, which retains exonuclease activity in nutrient media for 
24 h [4], was used at 0.13 mg/ml, concentration previously shown to decrease C. albicans 
biofilm biomass [3].  
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Biofilm formation and antifungal susceptibility assay 
C. albicans SC5314 biofilms were formed in 96-well microtiter plates as previously described, 
using Roswell Park Memorial Institute 1640 (RPMI) medium (Mediatech Inc., Herdon, VA, USA) 
buffered with 3-[N-morpholino] propanesulfonic acid (Research Products International Corp 
Mount Prospect, IL, USA) to pH 7 [5]. Biofilms (24-h) were washed with phosphate buffered 
saline (PBS) (10 mM phosphate buffer, 2.7 mM potassium chloride, 137 mM sodium chloride, 
pH 7.4) (Sigma) and challenged with RPMI containing the different concentrations of antifungals 
alone or in combination with DNase. Control biofilms were challenged with RPMI, RPMI MgCl2, 
and RPMI DNase. Following 24-h incubation at 37°C, biofilm cells were washed with PBS and 
mitochondrial activity estimated by the 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-
[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) reduction assay [5]. Sessile minimum 
inhibitory concentrations (SMIC) were determined at 50% (SMIC50) and 80% (SMIC80) 
decrease in absorbance at 490 nm, in comparison with the corresponding control biofilms 
challenged with RPMI for antifungals tested alone or challenged with RPMI DNase for 
antifungals tested in combination with DNase.  
 
Reproducibility and statistical analyses 
All the experiments were repeated on three separated occasions with eight replicates each. 
Statistical analyses were performed using GraphPad statistical software (GraphPad Software, 
San Diego, CA, USA). The normality of the data was examined using D'Agostino and Pearson 
omnibus normality test. To determine if the DNase improves the in vitro efficacy of antifungal 
drugs against C. albicans biofilms, the percentage of colorimetric readings for XTT reduction 
assays were analysed using two-way ANOVA followed by Bonferroni post-hoc tests. Statistical 
significance was defined as P< 0.05. 
 
RESULTS AND DISCUSSION 
Consistent with previous investigations [6, 7], results revealed that the amphotericin B SMIC80 
(1 mg/l) (Fig.2.2-1 a) is within the resistance range of this drug (> 1 mg/l). However, addition 
of DNase to amphotericin B resulted in SMIC50 (0.06 mg/l) and SMIC80 (0.25 mg/l) values  
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Fig.2.2-1. Activity of amphotericin B (a), caspofungin (b), and fluconazole (c) 
against C. albicans SC5314 24-h biofilms used alone (white bars) or in combination 
with DNase (black bars). Data is presented as mean ± standard error of mean (SEM) 
of the percentage of colorimetric readings for XTT reduction assays (% of XTT 
colorimetric readings), as compared with drug-free controls. DNase at 0.13 mg/ml was 
added together with serial dilutions of antifungal agents. SMIC are indicated. 
 
that were two dilutions lower than when this polyene agent was used alone (Fig.2.2-1 a). 
Accordingly, between the amphotericin range of 0.06 and 0.25 mg/l the % of XTT colorimetric 
readings were significantly lower when the antifungal drug was used in combination with DNase 
than when used alone. Importantly, the SMIC50 values in the presence of DNase (Fig.2.2-1 a) 
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were below the planktonic minimal inhibitory concentration (typically 0.25 mg/l) [6], and the 
SMIC80 values for amphotericin B plus DNase (Fig.2.2-1 a) were below the resistance range for 
this antifungal agent.  
 
As reported before [8-10], C. albicans biofilm cells were susceptible to caspofungin, with 
the SMIC80 value (1 mg/l, Fig.2.2-1 b) within the susceptible range (≤ 2 mg/l). Our results 
indicate that, similarly to amphotericin B, the in vitro activity of caspofungin against C. albicans 
biofilms was increased when used in combination with DNase (Fig.2.2-1 b). In fact, SMIC50 
and SMIC80 values for caspofungin plus DNase were three dilutions (0.13 mg/l) and two 
dilutions (0.25 mg/l) lower, respectively, when compared with biofilms exposed to this 
antifungal alone (Fig.2.2-1 b). Therefore, biofilm cells treated with DNase and caspofungin 
ranging from 0.13 to 0.5 mg/l exhibited lower % of XTT readings in comparison with those 
treated with caspofungin only (P< 0.05). Of note, trailing growth with caspofungin is usually 
observed [11], and this was not abolished with the addition of DNase (Fig. 2.2-1 b). However, to 
confirm the trailing growth effect, higher caspofungin concentrations should be evaluated. 
 
It is well established in the field that cells within biofilms are intrinsically less susceptible 
to azole derivatives [6, 9, 10]. Our results for C. albicans biofilm cells reduced susceptibility to 
fluconazole (Fig.2.2-1 c) show that both SMIC80 and SMIC50 values are higher than 1,024 
mg/l. Contrary to the observed for the other drugs tested, the susceptibility of biofilm cells 
against fluconazole was not changed by the addition of DNase (Fig.2.2-1 c). Even though, other 
azole drugs need to be tested.  
 
Several literature reports have shown that eDNA contributes to bacterial biofilms 
increased susceptibility to some antibiotics [12, 13], sodium dodecyl sulfate [14], antiseptics, 
and disinfectants agents [15]. It has been suggested that this effect may be due to eDNA 
induction of genes involved in the modification of lipopolysaccharides [13] and/or poor 
penetration of drugs within biofilms [12]. However, this is probably not a biofilm specific trait, as 
there is some controversy on the effect of DNase on the antimicrobial susceptibility of bacterial 
planktonic cells [4, 16]. In addition exogenous DNA was shown to promote its increase [13]. We 
observed that DNase increases C. albicans planktonic cells susceptibility to amphotericin B (by 
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one dilution) and caspofungin (by three dilutions), but not to fluconazole, in comparison with 
cells challenged only with the drugs (data not shown). In contrast, in C. albicans biofilm and 
planktonic cultures treated with DNA (320 ng/ml) and antifungals the drug susceptibility was 
not affected, when compared to antifungals tested alone (data not shown). Overall, these results 
suggest that eDNA, as a component of biofilm ECM, may not impede antifungals diffusion 
through biofilms, in accordance with previous reports  showing that C. albicans biofilm ECM do 
not impair antifungals penetration [17]. Nevertheless, products of the enzymatic digestion of 
eDNA or DNase might interact with cell component(s) facilitating the action of antifungal agents. 
In fact, Nett et al. [18] have shown shown that ECM β-glucans are involved in biofilm antifungal 
resistance by hampering the access of the drugs access to their targets inside the cells. 
 
In conclusion, our results show that C. albicans biofilm cells susceptibility to amphotericin 
B and caspofungin is enhanced by the addition of DNase. Although the mechanism(s) and in 
vivo efficacy of this effect needs to be further explored, this work suggests that agents that 
target processes affecting the biofilm structural integrity may have potential use as a therapeutic 
adjuvants in the treatment of biofilm-associated candidiasis, at least as part of devices 
antifungal lock therapy. 
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ABSTRACT 
Non-Candida albicans Candida (NCAC) species are emerging as significant pathogens. The present study 
aimed to investigate the effect of E,E-farnesol (farnesol) (Candida albicans signaling molecule) in 
Candida glabrata, Candida krusei, and Candida tropicalis planktonic cells. Stationary cultures challenged 
with several farnesol concentrations (5 to 150 µM) were monitored in terms of morphology, cell growth, 
viability, and cell cycle progression. Farnesol did not induce morphological changes in the assayed NCAC 
species. Additionally, changes in NCAC species growth were observed: (i) farnesol (100 and 150 µM) 
compromised C. glabrata growth, which was not associated with changes in cell survival, although S-
G2/M cell cycle phase transition was delayed; (ii) farnesol (50, 100, and 150 µM) delayed C. krusei 
growth without compromising cell viability, but delaying G0/G1 cell cycle phase; (iii) farnesol 100 and 
150 µM delayed C. tropicalis growth, that was associated with a decrease in cell viability and G0/G1 
phase cell cycle phase delay. The present findings suggest that farnesol impairs NCAC species but the 
mode of action of this molecule is species dependent.  
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INTRODUCTION 
Candida albicans is the predominant etiological agent of candidiasis, although Non-C. albicans 
Candida (NCAC) species are emerging as significant pathogens [1]. NCAC species tend to be 
less susceptible to the commonly used antifungals than C. albicans, and are frequently 
associated with host diminished defenses and implanted devices [2]. As C. albicans has been 
for many years the focus of investigators’, the research on NCAC species has relied on clinical 
laboratory studies, hampering the knowledge on the biology of these species.  
 
E,E-Farnesol (farnesol) is a molecule produced by C. albicans, which depending on the 
experimental conditions used, can regulate yeast morphogenesis [3], biofilm formation [4], or 
act as an apoptotic effector [5]. Additionally, for other yeast and fungi such as Saccharomyces 
cerevisiae [6], Aspergillus nidulans [7], Candida dubliniensis [8], and Candida parapsilosis [9] 
farnesol has been described as a growth inhibitor or cell death effector. In C. albicans, farnesol 
mediated cell death correlated with mitochondrial degradation, reactive oxygen species 
accumulation, and caspases activation [5]. In C. parapsilosis, farnesol induced growth delay 
was associated with changes in lipid metabolism, ribosome biogenesis, and amino acid 
biosynthesis gene expression [9]. In C. dubliniensis, farnesol promoted cell death that was 
associated with cell membrane disruption [8]. However, these distinct mechanisms induced by 
farnesol cannot be associated with a species specific effect due to the different experimental 
conditions used in the independent studies. 
To date, the effect of farnesol in other NCAC species has not been reported, thus, the 
objective of this work was to evaluate the effect of this molecule in Candida glabrata, Candida 
krusei, and Candida tropicalis cells in terms of morphology, growth, viability, and cell cycle 
progression. 
 
MATERIAL AND METHODS 
Strains and culture conditions 
C. glabrata ATCC 2001, C. krusei ATCC 6258, and C. tropicalis ATCC 750 were used in this 
study. C. parapsilosis ATCC 22019 growth was already described to be regulated by farnesol 
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[9], thus, this strain was used as a control. Candida species cells were propagated onto 
Sabouraud dextrose agar medium (Liofilchem) and incubated at 37°C for 24 h. Batches of 
Sabouraud dextrose broth (Liofilchem) (20 ml in 50 ml flasks) were inoculated with freshly 
grown Candida cells, and incubated at 37°C, 130 rpm, for 24 h. After that, cells were pelleted, 
washed with water, and enumerated in a hematocytometer. Before use in further experiments, 
1 × 106 cells/ml standardized suspensions (20 ml in 125 ml flasks) were prepared in Roswell 
Park Memorial Institute 1640 (RPMI) (Sigma), supplemented with sodium bicarbonate 
(Pronolab) 2.0 g/l, and buffered with 3-[N-morpholino] propanesulfonic acid (Sigma) (0.165 M) 
to pH 7.0.  
 
Chemicals 
Farnesol (Sigma) stock solutions were freshly prepared in methanol before each experiment. 
The pure compound was stored according to the supplier’s specifications. Working solutions of 
farnesol (5, 50, 100, and 150 µM) were prepared in RPMI medium. Controls included methanol 
(vehicle) and octylphenol ethylene oxide condensate (Triton X-100; Sigma) at the maximum 
concentration used in the farnesol experiments: 0.07% (v/v) and 150 µM respectively. 
 
Morphology assessment 
To evaluate the effect of farnesol on Candida morphology, standardized cells suspensions were 
grown at 37°C, 130 rpm in RPMI medium containing farnesol from 0 to 150 µM or vehicle, for 
2 h. Afterwards, samples (1 ml) were collected, washed with water, and fixed with 70% ethanol 
(v/v) at 4°C. After 24 h, cells were pelleted, ressuspended in water, and observed by light 
microscopy. Experiments were performed on three separate occasions. 
 
Growth assessment 
To study the effect of farnesol on Candida growth, standardized cells suspensions were grown 
at 37°C, 130 rpm in RPMI medium containing the indicated farnesol concentrations (0 to 150 
µM). Appropriated controls were included in each assay. Growth was monitored at 0, 2, 4, 6, 8, 
and 24 h. First, absorbance at 640 nm (A640) (Bio-Tek Synergy HT, Izasa) was determined. 
Second, the total cell number was determined after counting cells in a haemocytometer. The 
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percentage of growth inhibition was calculated as described by Rossignol et al. [9]: [1- 
(∆farnesol/∆vehicle)] × 100, where ∆ is the difference between the number of cells at a specific 
time point after addition of farnesol and that at the time of addition. Experiments were 
performed in duplicate, with at least three independent replicates.  
At selected time points, samples exhibiting a decrease in growth and the corresponding 
controls (farnesol 0 µM and vehicle) were used for viability assessments and DNA content 
analysis (see below). 
 
Viability assessment 
To evaluate the effect of farnesol on Candida viability, at time 0 h and 2 h of farnesol exposure, 
cells from selected cultures were pelleted and washed with water. First, colony forming ability 
was determined by plating appropriate dilutions on Sabouraud dextrose agar. After 48 h of 
incubation at 37°C, colony forming units (CFU) were counted. The percentage of survival was 
calculated as [(CFU at time 2 h/ CFU at time 0 h) × 100]. Second, cell membrane integrity was 
assessed after staining with 0.4% trypan blue (Sigma) [10]. Cell suspensions (100 µl) were 
mixed with an equal volume of dye and incubated at room temperature for three minutes. Cells 
with intact membranes exclude trypan blue and cells that exhibit membrane damages are 
labelled with the dye. The number of cells excluding or not trypan blue was enumerated in a 
haemocytometer. The percentage of trypan blue negative cells was calculated as the [(number 
of trypan negative cells/ number total cells) × 100]. All the assays were performed on three 
separate occasions with two replicates.  
 
DNA content analysis 
To evaluate the effect of farnesol on Candida cell cycle, at selected time points DNA content 
was analysed using SYBR Green I, as previously described [11]. Samples (1 ml) were pelleted 
and fixed overnight with 70% ethanol (v/v) at 4ºC. Cell suspensions were pelleted, washed, and 
resuspended in 50 mM sodium citrate (Sigma) buffer, pH 7.5, to a final cell concentration of 5 
× 106 cells/ml. Cells were subjected to 3 consecutive ultrasound pulses at 40 W for 1 s, with 
an interval of 1 to 2 s between each pulse (Ultrasonic Processor, Cole-Parmer). Then, cell 
suspensions were treated with 125 µg ribonuclease A (Invitrogen) for 60 min at 50ºC, followed 
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by a 0.5 mg proteinase K treatment for 60 min at 50ºC. Cell staining was achieved by overnight 
incubation with 25 × SYBR Green I (Molecular Probes) final concentration, at 4ºC. Before 
analysis by flow cytometry, Triton X-100 to a final concentration of 0.25% (v/v) was added to 
each sample. Analyses were performed on an EPICS XL-MCL (Beckman-Coulter Corporation) 
flow cytometer equipped with an argon-ion laser emitting a 488 nm beam at 15 mW. Offline 
data was analyzed with the Multigraph software included in the system II acquisition software 
for the EPICS XL/XL-MCL version 1.0, and Expo32 ADC software. Two independent sets of cells 
were analysed. 
 
Microscopy analyses 
Light microscopy analyses of cell morphology and cell membrane integrity were carried out on 
an Olympus BX51 microscope fitted with a 40 × objective and equipped with a DP71 camera. 
 
Statistical analyses 
Results are expressed as mean ± standard error of mean (SEM). Statistical analyses were 
performed using GraphPad Prism, version 5.00 software for Windows (GraphPad Software). 
Comparisons between the number cells/ml (farnesol treatment vs control) were performed by 
two-tailed unpaired t-test (confidence interval 95%). Comparisons between the: (i) distributions 
of the percentage of survival, (ii) trypan blue negative cells, and (iii) single cells in farnesol 
treatments vs control were performed by two-tailed Mann-Whitney test (confidence interval 95%). 
Differences were considered significant at P < 0.05.  
 
RESULTS 
Under the conditions used in this study, farnesol 50, 100, and 150 µM delayed growth of C. 
parapsilosis stationary cells transferred to fresh medium, when compared to controls, similarly 
to previously described [9]. For all the experiments performed, no differences were observed 
between farnesol 0 µM and vehicle or Triton X-100 treatments. Therefore, only data from 
vehicle assays are presented.  
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Effect of farnesol in C. glabrata 
C. glabrata morphology analysis (Fig.3.1-1 A) revealed that cells grown in the presence of 
vehicle (Fig.3.1-1 A-I) or farnesol- exemplified for 5 µM (Fig.3.1-1 A-II) and 150 µM farnesol 
(Fig.3.1-1 A-III) - exhibited a yeast form. 
Growth monitoring assays (Fig.3.1-1 B and C) showed that farnesol 5 and 50 µM did not 
affect C. glabrata cell growth vs vehicle. The growth of cells exposed to 100 and 150 µM 
farnesol was indistinguishable from that of controls from 0 to 4 h in terms of cell density 
(Fig.3.1-1 C), although it was lower than that of vehicle at 6 and 8 h when compared to controls 
(Fig.3.1-1 C) (P< 0.05). The maximum reduction in growth was observed at 8 h, specifically, 45 
and 36% for 100 and 150 µM treated cultures, respectively. The cells recovered from the 
farnesol mediated growth arrest, although after 24 h exposure to 150 µM farnesol, cell density 
was lower than that of vehicle (Fig.3.1-1 C) (P< 0.05).  
C. glabrata viability, assessed after farnesol addition (Table 3.1-1) revealed that farnesol 
100 and 150 µM did not affect the ability of cells to form colonies, or cell membrane integrity, 
as indicated by the similar proportions of survival and trypan blue negative cells, respectively 
(Table 3.1-1).  
Consistent with the growth delay profile induced by farnesol (Fig.3.1-1 C), from 0 to 2 h, 
the emergence of cellular buds was not affected by the compound treatment, as indicated by 
the similar percentages of single cells at 2 h for treated and untreated cultures (Fig.3.1-1 D). 
From 6 to 8 h the proportion of single cells for the vehicle treated cells increased (Fig.3.1-1 D), 
suggesting the entry of cells in the late log phase, with a return of cells to G1 phase and bud 
separation. In contrast, in the same time interval, the percentage of single cells in the farnesol 
treated cultures remained unaltered (Fig.3.1-1 D). As a consequence, in farnesol (100 and 150 
µM) treated cells the proportion of single cells at 8 h of growth was lower than that of control 
(P< 0.05). This was confirmed by the lower percentage of cells in the G0/G1 phase of the cell 
cycle at this time point. Specifically, the percentage of cells in G0/G1 population for untreated 
cells was 81% vs 38% for 100 and 150 µM treatments, respectively.  
These data show that farnesol does not affect C. glabrata morphology, but at 
concentrations ≥ 100 µM delays cell growth, increasing the length of S-G2/M cell cycle phases.  
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Fig.3.1-1. Characterization of farnesol (FOH) effect in C. glabrata. Morphology (A) 2 h after vehicle (I), FOH 5 µM 
(II), and FOH 150 µM (III) treatments is exemplified (bar = 20 µm). Growth is expressed as mean ln A640 ± SEM (B) 
and mean ln cells/ml ± SEM (C). Progression through the cell cycle is expressed as mean percentage of single cells ± 
SEM (D). At 0 h, the mean percentage of single cells was 100%. At each time point statistically significant differences 
(farnesol treatment) vs control are indicated with an asterisk (*, P< 0.05). For simplicity statistical significances were 
omitted from the panels B and C.   
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Table 3.1-1 Candida species viability 2 h after farnesol (FOH) exposure  
Candida species Viability  
(mean ± SEM)a 
Vehicle FOH 50 µM FOH 100 µM FOH 150 µM 
C. glabrata % Survival 122.3 ± 4.7 n.d. 107.6 ± 16.3 109 ± 10.6 
 % Trypan blue negative cells 98.5  ± 0.8 n.d. 93 ± 4.1 97.3 ± 1.6 
C. krusei % Survival 81.9 ± 10.4 78 ± 7.5 72.2 ± 7.8 73.6 ± 3 
 % Trypan blue negative cells 98.5 ± 1.1 87.7 ± 4.9 92.3 ± 4.1 76.7 ± 10.3 
C. tropicalis % Survival 127.6 ± 14.1 n.d. 120.5 ± 5.3 84.2 ± 0.7 
 % Trypan blue negative cells 93.5 ± 3.4 n.d. 41.1 ± 9.5 51.9 ± 7.5 
n.d., not determined; aViability assessment was based on % survival, calculated as [(CFU at 2 h/ CFU at 0 h) × 100], and % of 
trypan blue negative cells, calculated as [(number of trypan blue negative cells/ number total cells) × 100] 
 
Effect of farnesol in C. krusei 
C. krusei morphology was evaluated after cells exposure to several farnesol concentrations. The 
pseudohyphal growth exhibited by C. krusei cells in the control conditions (Fig.3.1-2 A-I) was 
maintained upon farnesol treatments ranging from 5 (Fig.3.1-2 A-III) to 150 µM (Fig.3.1-2 A-IV).  
C. krusei cell growth monitoring under the different treatments (Fig.3.1-2 B and C) 
indicated that farnesol 5 µM does not affect cell growth when compared to vehicle (Fig.3.1-2 B 
and C). However, farnesol ≥ 50 µM treatments resulted in a strong growth inhibition (Fig.3.1-2 
B and C), with the maximum inhibition levels (up to 70%) observed at 4 h of growth. The cells 
recovered during the following hours of growth, although 24 h after farnesol (50 to 150 µM) 
addition the cell density of treated cultures was lower than that of controls (Fig.3.1-2 C) (P< 
0.05).  
C. krusei cells viability assessment (Table 3.1-1) showed that farnesol (50 to 150 µM ) 
did not induce major changes on cell viability, as indicated by the similar percentages of survival 
and trypan blue negative cells for treated and untreated cells (P> 0.05).  
The proportion of C. krusei single cells (Fig.3.1-2 D) and cellular DNA content (data not 
shown) were assessed in the presence of farnesol (50 to 150 µM) . The addition of farnesol 50 
µM did not affect cell budding (Fig.3.1-2 D) or G0/G1 cell cycle phase distribution vs vehicle 
(data not shown). However, farnesol at 100 and 150 µM delayed cell division, as indicated by 
the higher percentage of single cells at 4, 6, and 8 h (P < 0.05, vs vehicle) (Fig.3.1-2 D). A 
comparable delay in the G1/S cell cycle phase transition was observed upon 100 and 150 µM  
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Fig.3.1-2. Characterization of farnesol (FOH) effect in C. krusei. Morphology (A) 2 h after vehicle (I), FOH 5 µM (II), 
and FOH 150 µM (III) treatments is exemplified (bar = 20 µm). Growth is expressed as mean ln A640 ± SEM (B) and 
mean ln cells/ml ± SEM (C). Progression through the cell cycle is expressed as mean percentage of single cells ± 
SEM (D). At 0 h, the mean percentage of single cells was 27%. At each time point statistically significant differences 
(farnesol treatment vs control) are indicated with an asterisk (*, P< 0.05). For simplicity statistical significances were 
omitted from the panels B and C.   
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farnesol treatments from 4 to 8 h (data not shown). For example, at 4 h G0/G1 cell population 
was 4% in the vehicle cultures vs 14% and 15% in 100 and 150 µM farnesol treated cultures, 
respectively.  
These data show that farnesol does not regulate C. krusei morphology, but compromises 
cell growth, lengthening the G0/G1 cell cycle phase. 
 
Effect of farnesol in C. tropicalis 
Microscopic analysis of C. tropicalis revealed that the cell morphology observed in vehicle 
(Fig.3.1-3 A-I) cultures did not change upon farnesol 5 µM (Fig.3.1-3 A-II) or 150 µM (Fig.3.1-3 
A-III) treatments.  
C. tropicalis growth analysis did not reveal significant differences between farnesol 5 and 
50 µM treated vs control cultures (Fig. 3.1-3 B and C). In contrast, C. tropicalis cells exposed to 
farnesol 100 and 150 µM displayed reduced growth (Fig.3.1-3 B and C). The maximum 
inhibition levels were observed at 4 h, specifically, 79% and 100% for 100 and 150 µM 
treatments, respectively. Farnesol treated cells recovered during the following hours of growth 
(Fig.3.1-3 B and C) although at 24 h, cell density was lower than that of vehicle for all farnesol 
concentrations tested (Fig.3.1-3 C) (P< 0.05).  
C. tropicalis cell viability revealed that farnesol 150 µM induced a slight reduction in the 
ability of cells to form colonies (vs vehicle) (Table 3.1-1) (P < 0.05). In addition, farnesol 100 
and 150 µM altered cell membrane permeability, as indicated by the lower percentages of 
trypan blue negative cells (vs vehicle) (Table 3.1-1) (P< 0.05).  
Data from cell cycle progression of C. tropicalis treated cells revealed that until 6 h of 
growth, the percentage of single cells in farnesol 100 and 150 µM treated cultures was higher 
than in vehicle (P < 0.05) (Fig.3.1-3 D). This was confirmed by the delay in the G1/S cell cycle 
phase transition (data not shown). For example, at 6 h, the proportion of cells in the G0/G1 
subpopulation was 8% for vehicle cultures vs 34% for 100 and 150 µM farnesol ones.  
These data show that although farnesol does not regulate C. tropicalis morphology, it 
impairs cell growth with an involvement of cell viability and G0/G1 cell cycle progression. 
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Fig.3.1-3. Characterization of farnesol (FOH) effect in C. tropicalis. Morphology (A) 2 h after vehicle (I), FOH 5 µM 
(II), and FOH 150 µM (III) treatments is exemplified (bar = 20 µm). Growth is expressed as mean ln A640 ± SEM (B) 
and mean ln cells/ml ± SEM (C). Progression through the cell cycle is expressed as mean percentage of single cells ± 
SEM (D). At 0 h, the mean percentage of single cells was 49%. At each time point statistically significant differences 
(farnesol treatment vs control) are indicated with an asterisk (*, P< 0.05). For simplicity statistical significances were 
omitted from the panels B and C.   
Farnesol in NCAC species Chapter 3.1 
 
 
83 
DISCUSSION 
The role of farnesol in C. albicans and some NCAC species planktonic [3, 9, 12] and biofilm 
cells [4, 8, 13, 14] has been investigated in the last years. Herein, we aimed to expand previous 
studies and evaluate the effect of farnesol in other NCAC species planktonic cells, selecting for 
that one type strain representing C. glabrata, C. krusei, and C. tropicalis. 
 
This study shows that farnesol does not regulate the morphology of the NCAC species 
evaluated (Fig.3.1-1 A to Fig.3.1-3 A). This suggests that the role of farnesol in morphology 
regulation may be specific of C. albicans [3] and C. dubliniensis [12], probably related to the 
ability of these Candida species to switch between forms in response to environmental factors, 
which is not a known specific trait of other Candida species such as C. glabrata, C. krusei, and 
C. tropicalis [15]. 
 
However, the present results showed that farnesol has a concentration dependent effect 
in NCAC species growth (Fig.3.1-1 B and C to Fig.3.1-3 B and C). At levels considered 
physiological relevant for C. albicans (below 5 µM) [16, 17], farnesol did not affect NCAC 
species growth (Fig.3.1-1 B and C to Fig.3.1-3 B and C). In accordance, the effect of farnesol 
treatment in different cell types [recently reviewed by Langford et al. [18]] show that in general, 
the compound levels that compromise growth are ≥ 5 µM. In fact, at supraphysiological levels 
(≥ 50 µM), farnesol impaired NCAC species growth (Fig.3.1-1 B and C to Fig.3.1-3 B and C). In 
light of the recent controversies [18], it should be noted that under similar experimental 
conditions farnesol up to 150 µM did not affect C. albicans and C. dubliniensis growth [12], but 
at concentrations ≥50 µM impaired C. parapsilosis growth [9]. Particularly, the minimal farnesol 
level required to reduce cell growth differed between the different NCAC species: 50 µM for C. 
krusei (Fig.3.1-2 B and C) and 100 µM for C. glabrata (Fig.3.1-1 B and C) and C. tropicalis 
(Fig.3.1-3 B and C).  
In general, the effects of farnesol on NCAC species levelled off beyond 100 µM (Fig.3.1-1 
B-D to Fig.3.1-3 B-C; Table 3.1-1), suggesting a threshold level for NCAC species farnesol 
susceptibility. Although it can be argued that the effect induced by higher farnesol levels is non-
specific, no differences were observed between farnesol 0 µM and Triton X-100 or methanol 
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treatments (data not shown). In fact, a similar behaviour has been described for farnesol 
treatment of the fungus Penicillium expansum [19] and of tobacco cells [20]. Additionally, 
further inspection of the parameters evaluated reveals that in some cases the effects elicited by 
the different farnesol concentrations are distinct. Specifically, (i); farnesol 50 µM showed a weak 
detrimental effect in C. krusei growth (Fig.3.1-2 B and C) without changes in cell cycle 
progression (Fig.3.1-2 D), in comparison to the higher farnesol levels; (ii) farnesol 150 µM, but 
not 100 µM, induced a reduction in C. glabrata cell number/ml at the end of 24 h (Fig.3.1-1 C); 
and (iii) farnesol 150 µM, but not 100 µM, reduced the ability of C. tropicalis to form colonies 
(Table 3.1-1).  
 
In addition, this study suggests that the effect of farnesol in cell viability is species 
dependent (Table 3.1-1). In contrast to C. glabrata and C. krusei, C. tropicalis farnesol mediated 
growth inhibition (Fig.3.1-3 B and C) reflect, at least in part, loss of cell culturability and/or cell 
membrane damage (Table 3.1-1). Similarly, it has been reported that farnesol slightly reduces 
C. parapsilosis cell viability, which was suggested to be associated with the expression of cell 
aging genes [9]. However, it has been shown that farnesol prevented the normal cell division of 
S. cerevisiae cells for a long period, after which the cells can recover the ability to form colonies 
[21]. So, it cannot be excluded that the changes in C. tropicalis viability (Table 3.1-1) are 
transient. It was also noted that farnesol 100 µM treated C. tropicalis cells exhibited membrane 
changes but retained the ability to form colonies, in contrast to farnesol 150 µM treated cells 
(Table 3.1-1). These results suggest that farnesol at 100 µM increases the permeability/fluidity 
of the membrane, whereas at 150 µM is more cytotoxic, disrupting the cell membrane and thus 
compromising cell viability. Therefore, the assessment of other parameters from which 
membrane damage could be inferred, such as, potassium and adenosine triphosphate leakage, 
membrane potential, and membrane ultrastructure may clarify the impact of farnesol treatment 
on C. tropicalis. 
 
Additionally, the cell cycle progression of farnesol treated cells was species specific (Fig. 
3.1-1 D to Fig. 3.1-3 D). Cell growth and cell cycle are highly coordinated processes. The 
mechanisms that couple these processes include: (i) the dependency of cell cycle progression 
on growth and vice versa, (ii) their simultaneous coordination, and (iii) the independent 
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regulation of both [22]. On one hand, data showed that farnesol 100 and 150 µM triggers a 
delay in C. glabrata S-G2/M cell cycle phase (Fig.3.1-1 D), in accordance with a delay in the log 
growth phase (Fig.3.1-1 B and C). On the other hand, farnesol 100 and 150 µM induced a 
delay in C. krusei (Fig.3.1-2 D) and C. tropicalis (Fig.3.1-3 D) G0/G1 cell cycle phases, in line 
with the prolonged lag phase exhibited by these species (Fig.3.1-2 B and C and Fig.3.1-3 B and 
C) in the presence of farnesol. The fact the C. krusei and C. tropicalis cell size does not seem to 
be affected by farnesol (Fig.3.1-2 A and Fig.3.1-3 A), suggests that for these strains the cell 
cycle delay is a consequence of the growth delay [22]. An additional study has shown that 
farnesol does not induce cell cycle changes in C. parapsilosis exponential growing cells [9]. 
However, as several lines of evidence point to a correlation between the growth phase of the 
inocula and the effects elicited by farnesol [23, 24], the challenge of C. glabrata, C. krusei, and 
C. tropicalis exponentially growing cells with farnesol may clarify if cell cycle changes are 
inocula growth phase or species specific. Additionally, synchronizing the cell cycle of NCAC 
species cells before farnesol treatment, or the use of 5-bromodeoxyuridine [25] may be helpful 
in the determination of cell cycle phase durations and eventually in the discrimination of a 
subpopulation of farnesol tolerant cells. Finally, the determination of the cycle checkpoints 
regulated upon farnesol treatment could clarify how farnesol treated cells coordinate cell growth 
and division, and how that correlates with cell ability to withstand the toxic effects of farnesol 
recovering from a transient cell cycle arrest. 
 
In summary, this study gives new insights into farnesol as a potential regulator of C. 
glabrata, C. krusei, and C. tropicalis physiology. The present work shows that farnesol ≥ 50 µM 
impairs the tested NCAC species cell growth. Although a similar net effect and ability to 
overcome farnesol toxicity was observed, these data suggest that farnesol has distinct effects in 
the different NCAC species.  
 
Update 
Recent work demonstrated that farnesol inhibits C. glabrata, C. krusei, and C. tropicalis 
planktonic cells growth [26]. 
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ABSTRACT 
Morphogenesis control by chemical signaling molecules is beginning to be highlighted in Candida 
biology. The present study focuses on morphogenic compounds produced in situ by Candida albicans 
and Candida dubliniensis during planktonic and biofilm growth that may at least partially substantiate the 
effect promoted by supernatants in morphogenesis. For both species, planktonic vs biofilm supernatants 
were analyzed by headspace-solid-phase microextraction and gas chromatography-mass spectrometry. 
Both planktonic cells and biofilm supernatants of C. albicans and C. dubliniensis contained isoamyl 
alcohol, 2-phenylethanol (phenylethanol), 1-dodecanol, E-nerolidol (nerolidol), and E,E-farnesol (farnesol). 
Alcohol secretion profiles were species, culture mode, and growth time specific. The addition of 
exogenous alcohols to the cultures of both species inhibited the morphological transition from the yeast 
to the filamentous form by up to 50%. The physiological role of these alcohols was put to evidence by 
comparing the effects of 96-h cultured supernatants with Cocktail synthetic mixtures containing isoamyl 
alcohol, phenylethanol, nerolidol, and farnesol at concentrations determined herein. All Cocktail mixtures 
elicited a morphological effect similar to that observed for the corresponding supernatants when used to 
treat C. albicans and C. dubliniensis cultures, except for the effect of the 96-h C. dubliniensis planktonic 
supernatant culture on C. albicans. Overall, these results reveal a group of alcohol extracellular signaling 
molecules that are biologically active with C. albicans and C. dubliniensis morphogenesis.  
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INTRODUCTION 
Candida albicans is a major human pathogen, causing life-threatening disseminated infections. 
Candidiasis epidemiology was recently reviewed [1], emphasizing the increase in invasive 
Candida infections, mainly due to an augment ascribed to Non-Candida albicans Candida 
(NCAC) species. This is supported by the increased use of immunosuppressive therapy and 
broad-spectrum anti-mycotic prophylaxis [1]. In particular, Candida dubliniensis, a NCAC 
species, colonizes mostly the adult population carrying immunodeficiency virus, causing oral 
lesions and bloodstream infections [2]. 
Some mechanisms have been implicated in C. albicans and C. dubliniensis 
pathogenicity, namely the morphological switch from the yeast to filamentous form. In this 
sense, one of the key issues in C. albicans and C. dubliniensis is the elucidation of the 
mechanisms involved in morphogenesis control. 
Some environmental factors have been reported as determinants of morphological 
regulation, particularly in C. albicans. For instance, hyphal inducing conditions include stimuli 
such as increase in temperature, pH, serum, nutrient starvation, and cell density [3]. In 
particular, at high cell densities, C. albicans grows in the yeast form, while at low densities 
filamentation is observed [4]. Cell density regulation is a key process not only in the planktonic 
mode of growth, but also in biofilms, that are found in many medical devices and constitute a 
clinically relevant issue [5]. In biofilms, this process may allow overpopulation and nutrient load 
control, as well as filamentation regulation, important players in sessile development [6]. The 
morphologic switch mediated by auto-regulatory metabolites produced by C. albicans cells has 
been investigated. Namely, 2-phenylethanol (phenylethanol), tryptophol [7, 8], and farnesoic 
acid [9] were pointed out to control cellular germination. Moreover, Hornby et al. [4] showed 
that C. albicans produces E,E-farnesol (farnesol) that, when accumulated at a threshold level, 
inhibits the mycelial growth in a cell density trend. Subsequent studies demonstrated that this 
molecule, produced in situ by planktonic C. albicans cultures, also prevents biofilm formation 
[10]. The increasing knowledge on cell-cell communication molecules highlighted tyrosol as a 
quorum sensing signal in C. albicans [11]. Regarding morphological control, tyrosol accelerates 
C. albicans germ tube formation in inducing conditions, but does not elicit this effect in non-
inducing conditions. Although it is produced by planktonic and biofilm cells [12], its effect on 
biofilm formation is not clear yet [8, 12]. 
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Nowadays, it is known that among Candida species farnesol effects are not restricted to 
C. albicans. Specifically, farnesol prevents yeast to pseudohyphae transition in C. dubliniensis 
[13], and has no effect on Candida parapsilosis morphology [14] although it reduces biofilm 
formation in both NCAC species [15, 16]. 
In this study, the main goal was to gain insights into C. albicans and C. dubliniensis 
morphogenesis control through signaling molecules released into the environment.  
 
MATERIAL AND METHODS 
Chemicals 
Standard alcohols were all obtained from Sigma. Stock solutions were prepared in methanol 
(except for isoamyl alcohol), and then used at the following concentrations: isoamyl alcohol, 46 
mM, 23 mM and 46 µM; phenylethanol, 500 µM and 5 µM; 1-dodecanol (dodecanol), 200 µM, 
2 µM and 2 nM; E-nerolidol (nerolidol) and farnesol, 1.5 µM and 1.5 nM. Cocktail mixtures 
mimicking supernatant fractions from 96-h cultures contained isoamyl alcohol, phenylethanol, 
nerolidol, and farnesol at the following concentrations: 94 µM, 70 µM, 3.2 nM, 18 nM and 48 
µM, 87 µM, 9.5 nM, 5.3 nM (for C. albicans planktonic and biofilm forms, respectively); 77 µM, 
61 µM, 1.5 nM, 2.0 nM and 53 µM, 93 µM, 5.3 nM, 1.5 nM (for C. dubliniensis planktonic and 
biofilm forms, respectively).  
 
Strains and culture conditions 
Two Candida species were used in this study: C. albicans CECT 1472 (Colección Española de 
Cultivos Tipo, Spain) and C. dubliniensis CBS 7987 (Centraalbureau voor Schimmelcultures, 
Germany). Prior to each experiment, both Candida species were maintained at 37°C in 
Sabouraud dextrose agar. After that, cells were grown in Sabouraud dextrose broth at 37°C for 
24 h on a mechanical shaker at 130 rpm. Subsequently, cells were washed twice with ultrapure 
water and counted in a hematocytometer. Standardized cell suspensions were prepared at a 
cell density of 1 × 106 cells/ml except if otherwise stated, in 1× Roswell Park Memorial Institute 
1640 (RPMI) medium (Sigma) buffered with 3-[N-morpholino] propanesulfonic acid (Sigma) 
(final concentration 0.165 M; pH 7.0). 
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Preparation of culture supernatants 
For planktonic supernatant preparation, 120 ml of standardized cell suspensions were 
inoculated in 300 ml flasks and incubated at 37°C, 130 rpm. At every 24 h of incubation the 
culture medium was partially renewed (30 ml). At the selected times, supernatant fractions 
were filter sterilized (0.22 µm) and stored at 4°C.  
For biofilm supernatant, standardized cells suspensions (4 ml) were inoculated into six 
well plates and incubated at 37°C, 130 rpm. After 3 h non-adherent microoganisms were 
removed and fresh medium was added to allow biofilm formation from 24 to 96 h at 37°C and 
130 rpm. After every 24 h of incubation, broth was partly renewed (1 ml). Before storage the 
supernatant fractions were prepared as above. 
 
Biomass dry weight measurements 
At the end of incubation periods, 1 ml of either planktonic or ressupended biofilm cells was 
filtered through pre-weighted filters (0.45 µm) and washed three times with ultrapure sterilized 
water. Filters were dried at 60°C until constant weight and cell dry weight was determined. This 
was repeated at least four times. 
 
Planktonic and biofilm cells characterization 
Planktonic cultures were prepared as described above and, at selected times, cellular 
morphology was observed directly by light microscopy. 
Biofilms were formed by seeding 2 ml of the standardized cell suspension in 24 well 
plates and incubating for 3 h at 37°C, 130 rpm. Then, non-adherent cells were aspirated and 
fresh medium was added. Plates were incubated at 37°C, 130 rpm. At the selected time 
points, biofilms were washed three times with ultrapure sterile water. Samples were alcohol 
dehydrated (70% ethanol for 10 min, 95% ethanol for 10 min, and 100% ethanol for 20 min), 
and air dried for 20 min. Samples were kept in a desiccator until the bottoms of the wells were 
cut and coated with gold. Biofilm examination was performed on a Leo scanning electron 
microscope. 
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Supernatant alcohols analyses 
Supernatant alcohols were extracted using headspace-solid-phase microextraction (HS-SPME) 
and analysed by gas chromatography-mass spectrometry (GC-MS). The SPME holder for manual 
sampling and fibre used were purchased from Supelco (Aldrich, Bellefonte, PA). The SPME 
device included a fused silica fibre, partially cross-linked carbowax-divinylbenzene (CW/DVB) 
with 65 µm film thickness, containing a liquid polymer and solid particles [17]. The CW/DVB 
coating fibre is recommended for small and polar molecules (molecular weight between 40 and 
275), such as the compounds under study. The SPME fibre was conditioned at 250°C for 30 
min in the GC injector port, according to the manufacturer’s recommendations. For headspace 
sampling, 20 ml of each supernatant fractions was introduced into a 60 ml glass vial. The vial 
was capped with a polytetrafluoroethylene septum and an aluminium cap (Chromacol Ltd, 
Herts, UK) after the addition of 4 g of NaCl and a 20 × 5 mm stirring bar (200 rpm), and was 
placed in a thermostat bath adjusted to 40 ± 0.1ºC for 15 min to transfer the compounds from 
the sample to the headspace. Following this step, the SPME fibre was manually inserted into 
the sample vial headspace for 45 min and then introduced into the GC injection port at 250°C 
and kept for 5 min for alcohol thermal desorption. The GC-MS parameters were established 
according to Coelho et al. [18]. The injection port was lined with a 0.75 mm ID splitless glass 
liner. The desorbed volatile compounds were separated in a GC-MS Agilent Technologies 6890 
N Network gas chromatograph, equipped with a 30 m × 0.32 mm ID, 0.25 µm film thickness 
DB-FFAP model fused silica capillary column (J&W Scientific Inc., Folsom, CA, USA), connected 
to an Agilent 5973 quadrupole mass selective detector. Splitless injection mode was used (5 
min). The oven temperature was programmed from 35 to 220ºC at 2ºC/min, and the transfer 
line was heated at 250ºC. Helium carrier gas had a flow of 1.7 ml/min. The mass spectrometer 
was operated in the electron impact mode at 70 eV scanning the range 33-300 m/z in a 1-s 
cycle, in a full scan acquisition mode. The identification of Candida metabolites was achieved 
comparing the GC retention times and mass spectra, with those of the pure standard 
compounds. All mass spectra were also compared with the data system library (Wiley 275). A 
comparable analysis was done with growth medium and no interfering substances were found 
into or near the retention times of those compounds. The quantification was performed by 
preparation of RPMI solutions containing pure standards in the same conditions of the samples. 
For each compound, appropriate concentration ranges were chosen in order to include sample 
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concentrations. Standard curves were generated for GC-MS peak areas versus concentration of 
each compound (R2>0.98), with quantification relying above quantification limits. All 
measurements were made with, at least, two replicates, each replicate representing the analysis 
of one different aliquot (20 ml) of each supernatant fraction. This approach allows the GC peak 
area data to be used as an indirect approach to estimate the relative content of each volatile 
compound. Blanks, corresponding to the analysis of the coating fibre not subjected to any 
extraction procedure, were run between sets of three analyses. Alcohols analyses in planktonic 
and biofilm supernatant fractions were carried out in duplicate for each sample within results 
agreeing with ≤ 15%. 
 
Filamentation and growth assays 
Standardized cell suspensions were prepared in 2 × RPMI and diluted (1:1) with either C. 
albicans or C. dubliniensis supernatant prepared as described above. Cultures were incubated 
for 12 h at 37°C, 130 rpm. A control of RPMI without culture supernatant was used.  
Standardized cell suspensions were prepared in RPMI with the specific compounds at 
specified concentrations or in Cocktail mixtures mimicking supernatant fractions from 96 h 
culture. All the suspensions were incubated for 12 h, at 37°C, 130 rpm. For each experiment 
an equal volume of solvent was used as an appropriate control, as well as culture medium 
without the specific compound. Cell morphology was evaluated according to Henriques et al. 
[13]. All experiments were repeated at least three times with duplicate samples and 10 fields 
per slide were examined (at least 150 cells). Morphological analyses of methanol treated and 
untreated controls agreed in more than 97%. Assays regarding supernatant effect were 
standardized against cell dry weight.  
To investigate the effect of isoamyl alcohol, phenylethanol, dodecanol, nerolidol, and 
farnesol on Candida cell growth, batches of cultures were grown for 12 h at 37°C, 130 rpm in 
the presence or absence of these alcohols as well as appropriate methanol controls, and 
absorbance was measured at 620 nm, and compared to that of controls. Cell growth monitoring 
was performed in three independent assays. No growth inhibition was detected in methanol 
treated controls. 
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Statistical analyses 
Statistical analyses was performed using the GraphPad Prism Software version 5.00 for 
Windows. Normality of data distribution was tested by the Kolmogorov–Smirnov method. Two 
tailed paired t-test method was used to determine differences between: (i) means of optical 
densities of C. albicans and C. dubliniensis cultures grown in RPMI medium and RPMI plus 
tested alcohols, (ii) means of the effect of 96 h supernatant vs the corresponding Cocktail 
mixture on both Candida species filamentation inhibition, and (iii) means of RPMI grown cells vs 
methanol controls, in growth and filamentation assays. Statistical significance of groups’ means 
regarding (i) cultures cell dry weight, (ii) the effect of culture supernatants, and (iii) that of 
synthetic alcohols vs supernatants in Candida species morphology were evaluated using a one-
way ANOVA. Subsequent comparisons were performed using Tukey’s post-hoc test. Two-way 
ANOVA was used to test for eventual interactions between: (i) cultures cell dry weight, and (ii) 
the effect of culture supernatants in cells morphology and Candida species. 
 
RESULTS 
Characterization of planktonic and biofilm cells 
The morphology of C. albicans and C. dubliniensis planktonic cells, which produced the 
supernatant, was monitored by light microscopy in 24-, 48-, 72-, and 96-h cultures (data not 
shown). Most of C. albicans, at 24 h, comprised cells in the hyphae form, while from 48- and 
72- h an increase in yeast and pseudohyphae was found. Concerning C. dubliniensis, 24 h 
cultures presented a prevalence of pseudohyphae but from 48 to 96 h an increase in yeast 
forms was observed. 
Scanning electron microscopy observation of C. albicans biofilms showed cells in the 
filamentous form, and some yeast cells, despite biofilm age (Fig.3.2-1 I). C. dubliniensis 24 and 
48 h biofilms comprised pseudohyphae and yeast forms (Fig.3.2-1 II-A and II-B). However, 72 h 
biofilms were composed mostly of yeast cells and pseudohyphae were rarely observed (Fig.3.2-
1 I-C). Additionally, 96-h C. dubliniensis biofilms (Fig.3.2-1 IID) contained again a 
heterogeneous mixture of yeast and pseudohyphae forms.  
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Fig.3.2-1. Scanning electron microscopy of C. albicans (I) and C. dubliniensis (II) 
biofilms grown over 24 h (A), 48 h (B), 72 h (C), and 96 h (D). Bar, 20.0 µm. 
 
Effect of planktonic and biofilm culture supernatants on C. albicans and C. dubliniensis 
filamentation 
One of the aims of this work was to assess the effect of C. albicans and C. dubliniensis 
planktonic and biofilm supernatant on inter and intra species morphological transition. It should 
be noted that for each assay the percentage of inhibition reveals the relation between the 
percentage of hyphae inhibition, in C. albicans, and the percentage of pseudohyphae inhibition, 
in C. dubliniensis. Also the averages of biomass dry weight from C. albicans planktonic cells 
were significantly higher than biofilm ones, except at 24 h. An opposite relation was observed 
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for C. dubliniensis cultures. Comparing both species cell dry weight no statistical differences 
were detected, except for 24 h biofilms. 
C. albicans supernatants displayed an inhibitory activity regarding morphological 
transition from yeast to filamentous form, on both species (Fig.3.2-2 I). For C. albicans cells 
treated with its own planktonic supernatant (Fig.3.2-2 I-A) percentages of inhibition of hyphae 
formation significantly increased from 48 to 96 h. The evaluation of the effect of the same 
supernatants in C. dubliniensis (Fig.3.2-2 I-B) showed the highest inhibition of pseudohyphae 
formation for the 96 h fraction (P<0.001). C. albicans biofilm supernatant, markedly increased 
the percentage of inhibition with increasing culture time in both Candida species (Fig.3.2-2 I-A 
and I-B). 
Furthermore, the use of C. dubliniensis supernatant, from either planktonic or biofilm  
 
Fig.3.2-2. Effect of time on C. albicans supernatants (I) and C. dubliniensis supernatants (II) from planktonic and 
biofilm cultures on the morphology of 12-h planktonic growth of C. albicans (A) and C. dubliniensis (B). 
Filamentation was assessed as the number of hyphae in C. albicans and number of pseudohyphae in C. dubliniensis 
per 10 slides counted in duplicate samples. Control cells were incubated in RPMI medium, representing >90% of 
hyphae plus 2% of pseudohyphae for C. albicans and >60% of pseudohyphae for C. dubliniensis. The percentages of 
inhibition in the three independent assays were determined as a mean percentage of reduction (vs control), as a 
function of mg of dry weight ± standard deviation (SD).  
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cells, also prevented the yeast to filamentous form transition not only in C. albicans but in C. 
dubliniensis as well (Fig.3.2.2 II). Regarding planktonic supernatant effect in the morphological 
transition of C. albicans (Fig.3.2-2 II-A) and C. dubliniensis (Fig.3.2-2 II-B) cells, the highest 
effect was observed for the 24 h fraction (P<0.001). Additionally, the 24 h biofilm supernatant 
of C. dubliniensis had significantly lower effect, in both Candida species (Fig.3.2-2 II).  
Both C. albicans (Fig.3.2-2 I) and C. dubliniensis (Fig.3.2-2 II) biofilm spent media from 
older biofilms (72 and 96 h) were significantly more effective, in the reduction of filamentation 
than their planktonic equivalents in both species. 
Overall, the present results show that supernatant composition may be dependent on 
Candida species, differing not only due to the mode of growth, but also along time. 
 
Characterization of planktonic and biofilm supernatant composition 
Supernatant samples were analysed by HS-SPME GC-MS. Comparison of retention times, and 
mass spectra with library, and chemically synthesized standards ascertained five of the peaks 
as isoamyl alcohol, phenylethanol, dodecanol, nerolidol, and farnesol (data not shown). The 
results expressed as a function of cell dry weight (Table 3.2-1) reveal that these compounds are 
continuously excreted by planktonic and biofilm cells. 
Regarding the amounts of isoamyl alcohol in C. albicans planktonic supernatants, they 
were very similar (Table 3.2-1). However, 24 h biofilms released less isoamyl alcohol than older 
ones. For C. dubliniensis planktonic cells (Table 3.2-1) the highest amount of isoamyl alcohol 
was observed for 24 cultures, while in biofilms supernatant isoamyl alcohol concentration 
slightly increased with maturation. 
Considering phenylethanol release by C. albicans planktonic and biofilm cells (Table 3.2-
1), this aromatic alcohol increased into supernatant medium, during the transition from 24 to 
96h of growth time. In contrast, C. dubliniensis biofilm and planktonic cells exhibited different 
secretion alcohol patterns (Table 3.2-1). Indeed, culture media from 96 h biofilms contained 
higher phenylethanol levels than the ones obtained from 24 h biofilms, in contrast to an 
approximately constant level of phenylethanol production exhibited by planktonic cultures 
supernatant. 
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Nerolidol amounts in C. albicans planktonic supernatants (Table 3.2-1) were 
approximately constant from 48 to 96 h. However, in C. albicans biofilm supernatants, the 
concentration of this sesquiterpenoid continuously raised along with biofilm development, 
levelling off at 72 h. C. dubliniensis displayed a different nerolidol excretion profile according to 
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the growth mode (Table 3.2-1). In fact, planktonic cells that excreted higher levels of this alcohol 
belong to the 48-h population. In biofilms, the highest amounts of nerolidol were detected in 
samples recovered at more than 48 h of growth. Concerning farnesol excretion by C. albicans, a 
similar profile was observed for both planktonic and sessile cells (Table 3.2-1), attaining the 
highest level at 96 h of growth. In the case of C. dubliniensis, farnesol reached the maximum 
experimental concentration in 48 h supernatant fractions. 
Regarding dodecanol, it was detected in all supernatant samples from both Candida 
species at concentrations lower than 2.79 nM (data not shown). 
 
Effect of secreted alcohols on C. albicans and C. dubliniensis filamentation and growth 
The addition of 46 mM of isoamyl alcohol to both Candida species growth medium inhibited cell 
growth (Table 3.2-2). However, for 46 µM and 23 mM of this compound filamentation was 
inhibited. The increase of the isoamyl alcohol concentration significantly repressed filamentation 
on both Candida species (Table 3.2-2). 
In the present study two phenylethanol concentrations were assayed, 5 and 500 µM, and 
no arrest of cell growth was observed for both concentrations. At 5 µM a reduction in hyphae 
formation was observed for C. albicans, 71.4 ± 15.8%, with 72.9± 17.0% pseudohyphae 
inhibition for C. dubliniensis. 
Additionally, dodecanol was assayed at 2 nM, 2 µM, and 200 µM. C. albicans revealed 
no growth inhibition at any of the assayed concentrations. In contrast, 200 µM dodecanol 
reduced C. dubliniensis cell growth in more than 90% (Table 3.2-2). However, dodecanol elicits 
morphogenic inhibition in both Candida species even at a concentration of 2 nM. 
In the present situation, 1.5 nM or 1.5 µM of nerolidol promoted a reduction in both 
Candida species filamentation (Table 3.2-2) without growth inhibition. It may be stressed that 
for both Candida species no significant differences were observed concerning the effect 
triggered by nerolidol at 1.5 nM and 1.5 µM. 
Herein, 1.5 µM farnesol control was included and the percentages of inhibition obtained 
were similar to those previously described [13]. Additionally, 1.5 nM farnesol was noticed to 
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Table 3.2-2. Effect of secreted alcohols on the growth and filamentation inhibition of planktonic C. albicans and 
C. dubliniensisa 
Compound Concentration C. albicans C. dubliniensis 
 
 
% growth 
inhibition 
% hyphae  
inhibition 
% growth 
inhibition 
% pseudohyphae 
inhibition 
Isoamyl alcohol 46 mM 77.7 ± 1.4 NA 89.2 ± 0.5 NA 
 23 mM - 95.8 ± 3.0 - 92.4 ± 2.1 
 46 µM - 68.4 ± 12.3 - 70.7 ± 15.6 
Phenylethanol 500 µM - 95.3 ± 1.23 - 91.5 ± 10.7 
 5 µM - 71.4 ± 15.7 - 72.9 ± 17.0 
Dodecanol 200 µM - 98.7 ± 7.9 93.3 ± 0.8 NA 
 2 µM - 69.9 ± 16.8 - 74.5 ± 9.6 
 2 nM - 57.8 ± 14.3 - 54.1 ± 12.1 
Nerolidol 1.5 µM - 64.8 ± 4.7 - 64.6 ± 7.8 
 1.5 nM - 51.1 ± 9.3 - 68.3 ± 5.0 
Farnesol 1.5 µM - 67.5 ± 10.1 - 74.1 ± 17.8 
 1.5 nM - 63.5 ± 10.8 - 57.8 ± 4.8 
aPercentage of growth inhibition was determined as a reduction of optical density at 620 nm of three independent assays 
compared to that of controls. Mean optical densities for the controls were 0.51 for C. albicans and 0.57 for C. dubliniensis. 
Filamentation was assessed as the number of hyphae in C. albicans and the number of pseudohyphae in C. dubliniensis per 10 
slides, counted in duplicate samples. Control cells were incubated in RPMI medium, presenting >90% of hyphae plus 2% of 
pseudohyphae for C. albicans and >60% of pseudohyphae for C. dubliniensis. Percentages of inhibition in the three independent 
assays were determined as mean percentages of reduction (vs control) ± SD. NA, not applicable. 
 
inhibit cellular germination in both Candida species (Table 3.2-2). Similarly to nerolidol, a 
decrease in farnesol concentration, from 1.5 µM to 1.5 nM, did not result in a significant 
reduction in filamentation inhibition for C. dubliniensis. 
On the whole, the results show that these compounds also present in supernatant 
fractions (Table 3.2-1), regulate yeast cell morphology not resulting in significant growth 
constraints.  
 
Effect of Cocktail solutions simulating planktonic and biofilm culture supernatants on C. 
albicans and C. dubliniensis filamentation 
Considering all the conditions assayed (Fig.3.2-3 I and II), no significant differences were 
encountered between the effect of supernatant and Cocktail mixtures on Candida filamentation 
inhibition, except for C. dubliniensis planktonic supernatant on C. albicans (Fig.3.2-3 I, condition 
3) (P=0.02).  
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Fig.3.2-3. Effect of 96-h supernatants and corresponding Cocktail mixtures on the morphology of 12-h planktonic 
cells of C. albicans (I) and C. dubliniensis (II). Condition 1, C. albicans planktonic supernatant; 2, C. albicans biofilm 
supernatant; 3, C. dubliniensis planktonic supernatant, and 4, C. dubliniensis biofilm supernatant. Filamentation was 
assessed as the number of hyphae in C. albicans and number of pseudohyphae in C. dubliniensis per 10 slides 
counted in duplicate samples. Control cells were incubated in RPMI medium, representing >90% of hyphae plus 2% of 
pseudohyphae for C. albicans and >60% of pseudohyphae for C. dubliniensis. The percentages of inhibition in the 
three independent assays were determined as the means of percentage of reduction (vs control) ± standard 
deviations. 
 
DISCUSSION 
Within the predominant human pathogenic fungi are the well recognized C. albicans and the 
emerging C. dubliniensis. Both Candida species are phenotypically very similar and a unifying 
feature is that both are polymorphic, undergoing interconversion into filamentous and yeast 
forms. However, C. dubliniensis appears to have less ability to cause disease and to ascertain 
this issue “will enhance our understanding of candidal pathogenesis in general” [2]. 
Results show that the addition of supernatant medium from planktonic and biofilm 
cultures prevents filamentation of planktonic cells of the same species (Fig.3.2-2 I-A and II-B). 
Besides, similar results were observed crossing supernatant fractions between species (Fig.3.2-
2 I-B and II-A). These data are in accordance with previous reports [16], showing inter- and 
intra-species effect of C. albicans and C. dubliniensis supernatant, although using different 
strains.  
Isoamyl alcohol, phenylethanol, dodecanol, nerolidol, and farnesol were detected in 
supernatant of planktonic and biofilm forms of both Candida species by HS-SPME GC-MS. 
Different studies have reported the effect of these alcohols in filamentation of Saccharomyces 
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cerevisiae and C. albicans [4, 8, 19-21]. Previous reports also showed that C. albicans yeast 
cells secret tyrosol and tryptophol at concentrations within micromolar levels [8, 12]. However, 
those compounds were not detected in the present study. Failure to detect tyrosol and 
tryptophol may have been due to the SPME experimental conditions used and/or the high 
solubility of these compounds in water.  
Farnesol concentrations determined in the supernatants (Table 3.2-1) were lower than 
11.08 nM. Hornby and Nickerson [22] reported that six out of seven C. albicans reference 
strains and clinical isolates produce farnesol at hundreds nanomolar. The exception was the 
reference strain C. albicans ATCC 10231, for which, farnesol, if present, was below the limit of 
detection of the method used (22.5 nmol/g of cell dry weight). However, using HS-SPME/GC-
MS, the limit of detection obtained for farnesol was 0.01 nM (data not shown). Therefore, it 
seems likely that C. albicans ATCC 10231 could produce farnesol within the levels observed for 
C. albicans CECT 1472 and C. dubliniensis CBS 7987, used herein. 
A time based comparison of supernatant composition (Table 3.2-1) highlights the 
differential excretion patterns of these alcohols, as previously inferred from supernatant effect in 
Candida species planktonic morphology assays reported in Fig. 3.2-2.  
 
Concerning C. dubliniensis, neither of the compounds quantified (Table 3.2-1) supports 
the high effect triggered by its 24 h planktonic supernatant in the inhibition of self-filamentation 
(Fig.3.2-2 B). Probably, other molecules, not identified in this analysis, may contribute to the 
observed result. 
Moreover, from 48 h onwards the alcohols concentration in C. albicans supernatant 
(planktonic and biofilm) are higher than in C. dubliniensis ones (Table 3.2-1). These results 
suggest that during the ongoing of growth, C. dubliniensis can be overcome by C. albicans, 
which corroborates one of the hypotheses postulated by Sullivan et al. [2], whereby C. albicans 
would be more “robust” than C. dubliniensis. In fact, previous reports concerning C. albicans 
and C. dubliniensis fit these results. Reports of in vitro studies showed that C. albicans has 
growth competitive advantages over C. dubliniensis, more evident at 96 h for planktonic than in 
biofilm growing conditions [23]. Results presented in Fig.3.2-3 may support this behavior since 
it can be inferred that C. dubliniensis secretes into the environment substances that specifically 
regulate C. albicans morphogenesis. Conversely, in vivo studies [24] showed that whe 
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inoculated togheter, although the viability of both species was similar in the initial days, C. 
dubliniensis was not detectable at days 8 and 10, post-infection. 
Other competitive interactions described in literature show that phenylethanol selectively 
inhibits certain Gram positive and Gram negative bacteria [25], which could provide growth 
advantages to C. albicans and C. dubliniensis. 
Another important aspect to be retained is that a distinct biofilm vs planktonic alcohol 
secretion pattern was found, which is consistent with microbiological regulation of a 
multicellular behavior that includes protection from environment, nutrient availability and 
metabolic cooperation. Results from Table 3.2-1 reveal that supernatants from biofilm cells at 
the latest growth states contain more phenylethanol and nerolidol than the planktonic ones. 
Interestingly, a similar relation has been described for prostaglandins [26] and tyrosol secretion 
by C. albicans [12]. However, this behavior was not observed for isoamyl alcohol and farnesol. 
This may at least, in part, explain the higher percentage of inhibition of filamentation induced by 
biofilm supernatant, in contrast to the planktonic ones (Fig.3.2-2). 
 
Regarding C. albicans, an earlier report described that a mixture of nerolidol isomers was 
two times less active than farnesol [4]. However, the results obtained in this work show that 
both nerolidol and farnesol have an equivalent activity on cell morphology (Table 3.2-2). 
Herein, 5 µM of phenylethanol and 2 nM of dodecanol inhibited (> 50%) both Candida 
species morphological transition from yeast to filamentous form (Table 3.2-2). Other authors 
described morphological changes only at higher concentrations, 500 µM for phenylethanol [8] 
and 10 µM for dodecanol [21]. These discrepancies may be due to the distinct design of 
filamentation assays, although different strain sensitivity to these alcohols may not be excluded. 
Furthermore, isoamyl alcohol should be put in parallel with phenylethanol and tryptophol, 
as inhibitors of C. albicans and C. dubliniensis filamentous growth but stimulate S. cerevisiae 
filamentation [8, 27]. This differential response may be supported by the fact that S. cerevisae 
response to isoamyl alcohol involves the phosphorylation of Cdc28 at tyrosine 19 by Swe1 [28], 
a protein not involved in C. albicans filamentation [29]. 
Data in Table 2 show that these alcohols elicit a morphogenic inhibition at physiological 
concentrations in both Candida species. When 96-h supernatant from both species were 
mimicked in isoamyl alcohol, phenylethanol, nerolidol, and farnesol composition, similar 
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percentages of inhibition were achieved (Fig.3.2-3). These results suggest that the major 
morphogenic compounds produced in situ by C. albicans and C. dubliniensis into the 
extracellular medium have been identified. The exception was the mixture that mimicked C. 
dubliniensis planktonic supernatant, which elicited a lower morphological response in C. 
albicans than the supernatant (Fig.3.2-3 I, condition 3), suggesting that C. dubliniensis may 
release non-identified compound(s) that specifically control C. albicans morphogenesis. 
Chen and Fink [8] suggested that in S. cerevisae phenylethanol and tryptophol might 
have some synergic effect regarding invasive growth. However, the effect triggered by the 
specific mixtures of alcohols (Fig.3.2-3) is slightly lower than the expected from the percentages 
of inhibition obtained for each single compound (Table 3.2-2). These observations suggest two 
hypotheses: a competition phenomenon or a saturation process. 
Furthermore, it should be stressed that these studies were performed in vitro. 
Environmental conditions might influence the properties of microorganisms and in the 
laboratory it is difficult to mimic natural conditions and their heterogeneous parameters [30, 
31]. In an attempt to approximate experimental conditions to the natural environment, RPMI 
medium was used. This may in part simulate human host conditions, however, the amino acid 
composition of this growth medium might determine the molecules detected (Table 3.2-1), 
namely isoamyl alcohol and phenylethanol. In addition, cell culture supernatants medium was 
partially replaced every 24 h, and in fact, in the environment, partial nutrient replacement may 
occur. Nevertheless, metabolites detected at each time point assayed (Table 3.2-1) may also 
account to additional metabolism, but this experimental parameter was maintained along all 
culture times. However, in vivo, the effect and excretion patterns may certainly differ. Some 
authors noted that farnesol concentrations needed to block germination in C. albicans [32] and 
C. dubliniensis [13] in serum are different from the observed in RPMI. So, in vivo, the 
effectiveness of these alcohols in the control of morphogenesis may be distinct. Moreover, 
farnesol is not produced under anoxia [33], which is important for some tissue invasion. Thus, it 
is reasonable to ask if the regulation of synthesis and/or secretion of the other alcohols 
identified within this study could be different in vivo. 
In summary, several lines of evidence provide new insights in C. albicans and C. 
dubliniensis metabolites, as well as their role in morphogenesis control. Specifically, isoamyl 
alcohol, phenylethanol, nerolidol, and farnesol were identified in the extracellular medium of 
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planktonic and biofilm cells. Besides, these alcohols were shown to inhibit the morphological 
transition in these Candida species, in a similar degree, at physiological concentrations. Despite 
cell morphology, signalling molecules were secreted at different profiles depending on Candida 
species, stage, and mode of growth (planktonic and biofilm). Overall, this represents a 
breakthrough in morphogenesis control in both Candida species and also inter and intra species 
interactions may now be better understood. 
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ABSTRACT 
Cell-cell signaling alcohol molecules were recently identified in Candida albicans and Candida 
dubliniensis supernatants. To date, it is not known whether these molecules are produced by other 
Candida species and their role in biofilm formation is not fully clarified. Herein, Candida parapsilosis and 
Candida tropicalis extracellular alcohols production by planktonic cultures was analyzed by headspace-
solid-phase microextraction and gas chromatography-mass spectrometry. Both Candida species 
extracellular media contained E,E-farnesol (farnesol), 1-dodecanol (dodecanol), 2-phenylethanol 
(phenylethanol), and isoamyl alcohol but not E-nerolidol (nerolidol), as produced by C. albicans and C. 
dubliniensis. Moreover, the ability of these compounds to regulate C. albicans, C. dubliniensis, C. 
parapsilosis, and C. tropicalis sessile cells was assessed by adding the alcohols after 3 h of adhesion 
and 48 h of biofilm formation. After 24 h, biofilms were analyzed in terms of cellular mitochondrial 
activity and total biomass. Farnesol affected C. albicans and C. dubliniensis. Nerolidol and dodecanol 
elicited C. parapsilosis and C. tropicalis changes in further biofilm development. C. tropicalis was 
affected by phenylethanol and isoamyl alcohol triggered changes in C. albicans, C. dubliniensis, and C. 
tropicalis sessile cells. The results demonstrate that almost all of these alcohols are produced by these 
Candida species and also evidence the complexity of biofilm formation.  
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INTRODUCTION 
Candida albicans is the predominant etiological agent of candidiasis, nevertheless, Non-C. 
albicans Candida (NCAC) species have been emerging as significant pathogens [1]. Specifically, 
Candida dubliniensis has been associated with oral candidiasis infections in human 
immunodeficiency virus infected and acquired immunodeficiency syndrome populations [2]. 
Candida parapsilosis and Candida tropicalis are pathogens found in association with 
candidemia, and are frequently isolated from implanted devices [3, 4].  
The success of Candida species as pathogens is attributed to survival strategies such as 
their ability to form biofilms. In fact, biofilms may initiate or prolong infections by providing a 
source of cells that can colonize local and new sites, and be recalcitrant to antifungal therapy 
and host immune defenses [3]. C. albicans biofilm formation is modulated by the extracellular 
alcohol E,E-farnesol (farnesol) [5]. However, other extracellular alcohols have been identified in 
C. albicans and C. dubliniensis supernatants namely E-nerolidol (nerolidol), 1-dodecanol 
(dodecanol), 2-phenylethanol (phenylethanol), and isoamyl alcohol. These molecules were 
shown to inhibit C. albicans and C. dubliniensis yeast to filament formation in filamentation 
inducing conditions [6], but the production and role of these molecules in other Candida 
species has been poorly studied.  
This work aimed at investigating the production of extracellular alcohols by C. parapsilosis 
and C. tropicalis, and to evaluate the effect of the addition of such alcohols’ commercial 
formulations on C. albicans, C. dubliniensis, C. parapsilosis, and C. tropicalis biofilm 
development. 
 
MATERIAL AND METHODS 
Chemicals 
Farnesol (purity ≥95%), phenylethanol (purity ≥99%), and isoamyl alcohol (purity ≥99%) were 
obtained from Sigma Aldrich, and nerolidol (purity ≥85%) and dodecanol (purity ≥99.5%) were 
obtained from Fluka. Pure compounds were stored according to suppliers’ instructions.  
Isoamyl alcohol working solutions were prepared by direct dilution in growth medium. All 
the other alcohols stock solutions were prepared in methanol (VWR) and appropriated dilutions 
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made in growth medium. Stock solutions were prepared freshly before each experiment and 
appropriated controls were performed in order to ensure compounds stability through the 
course of the experiments. 
Farnesol was already described to regulate biofilm formation of C. albicans [5], C. 
parapsilosis [7], and C. dubliniensis [8]. In this sense, 150 µM farnesol was used as a control in 
this study. The selected concentrations of all the other alcohols were based on previously 
reported physiological and supraphysiological concentrations in C. albicans and C. dubliniensis 
[6]. Specifically, they were used at final concentrations of: 1.5 × 10-3, 1.5, and 150 µM for 
nerolidol; 2 × 10-3 and 2 µM for dodecanol; 5 and 500 µM for phenylethanol, 46 × 10-3 and 23 
mM for isoamyl alcohol. 
 
Strains 
In this study the following Candida type strains were used: C. albicans CECT 1472, C. 
dubliniensis CBS 7987, C. parapsilosis ATCC 22019, and C. tropicalis ATCC 750.  
 
Growth conditions 
Candida species were stored at -80°C and propagated by streaking a loopfull of cells onto 
Sabouraud dextrose agar medium (Liofilchem) and incubating at 37°C for 24 h. These stocks 
were stored at 4°C for no longer than two weeks.  
For all experiments, batches of Sabouraud dextrose broth (Liofilchem) (20 ml in 50 ml 
flasks) were inoculated with freshly grown Candida cells, and incubated at 37°C with agitation 
(130 rpm). After 24 h of growth the cells were harvested by centrifugation, washed twice with 
ultrapure sterile water, and enumerated in a hematocytometer. Before use in further 
experiments, 1 × 106 cells/ml standardized cell suspensions were prepared in Roswell Park 
Memorial Institute 1640 (RPMI) (Sigma), and buffered with 3-[N-morpholino] propanesulfonic 
acid (Sigma) (0.165 M) to pH 7.0. 
 
Preparation of supernatant samples 
C. parapsilosis and C. tropicalis culture supernatants were prepared by inoculation of 120 ml of 
a standardized cell suspension in 300 ml flasks, and incubated at 37°C with shaking at 130 
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rpm for 24 h. Cell free fractions were recovered by centrifugation and filter sterilized (0.22 µm 
pore size). 
Culture biomass dry weight measurements were performed by filtration of 1 ml of culture 
through pre-weighed filters (0.45 µm) and washed three times with ultrapure sterilized water. 
Filters were dried at 60°C until constant weight and cell dry weight was determined.  
 
Supernatant alcohol analysis 
Supernatant alcohol composition was evaluated by headspace-solid-phase microextraction (HS-
SPME) using a carbowax/divinylbenzene-coated fibre combined with gas chromatography-mass 
spectrometry (GC-MS) as described by Martins et al. [6]. In order to increase the sensitivity of 
the methodology, the samples were analysed in selective ion monitoring acquisition mode: 
farnesol (m/z 69, 107 and 161), nerolidol (m/z 69, 93 and 107), dodecanol (m/z 69, 83 and 
111), phenylethanol (m/z 91 and 122), and isoamyl alcohol (m/z 55 and 77). These alcohols 
were identified by comparing GC retention times and mass spectra with those of pure standard 
compounds. A control analysis was performed with RPMI medium, and no interfering 
substances were found in the retention times of those compounds. The GC peak area data were 
used to: (i) compare alcohols’ relative abundance in different Candida species (determining the 
peak areas in both species); (ii) estimate the compound level in the sample (comparing the GC 
peak area of each alcohol in the sample with that of one standard with a known concentration). 
 
Biofilm formation on the surface of wells of microtiter plates 
For the determination of the effect of alcohols on subsequent biofilm development, a rapid and 
robust method, the 96-well plate model [9] that allows testing of multiple parameters in the 
same experiment, was used. Due to the volatile nature of these alcohols and to avoid possible 
cross contaminations, each compound was assayed individually in a single microtitre plate. 
Candida biofilms were formed on commercially available polystyrene, flat-bottomed, 96-
well microtitre plates (Orange Scientific). Standardized cell suspensions (200 µl) were seeded 
into the wells, and the plates were incubated at 37°C and 130 rpm. After 3 h, the medium was 
aspirated, and the wells were washed twice with ultrapure sterile water to remove non-adherent 
cells. 
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For the study of alcohols’ effect on subsequent biofilm formation of adhered cells, each 
alcohol diluted in RPMI medium (200 µl) was added to the adhered yeast cells. The plates were 
incubated at 37°C (130 rpm) for additional 24 h.  
To evaluate alcohols’ effect on further development of preformed biofilms, RPMI medium 
was added to adhered cells, and was renewed after 24 h of growth. At 48 h of incubation, the 
medium was removed, and the wells were washed as described above. Two hundred microlitres 
of fresh medium containing each alcohol at the desired concentrations were added to each well, 
and the plates were incubated for further 24 h.  
Positive controls for biofilm formation consisted of unchallenged biofilms. Negative 
background controls for subsequent analysis consisted of non-seeded wells filled with RPMI 
medium. Solvent interferences were discarded including methanol controls. All wells contained 
at most 0.07% (v/v) of methanol. An agreement of more than 90% in biofilm parameters 
evaluated (see below) was observed for methanol treated and untreated sessile cells. 
For each experiment, at the end of the incubation time, the wells were washed two times 
with ultrapure sterile water, and the biofilm development was estimated as described below. 
 
Colony-forming units of cells in biofilms 
In the assays performed, each alcohol was tested at the same concentrations in all Candida 
species, but the number of cells within biofilms may vary with Candida species. To estimate the 
number of colony forming units (CFU) of sessile cells before alcohol challenge, cells were 
scraped, after the washing procedure, and re-suspended in ultrapure sterile water in four steps: 
3 × 100 µl plus 200 µl, in a total of 500 µl. Suspensions containing the biofilm cells were 
vortexed for 2 min. Viable counts were obtained by serial dilution in ultrapure sterile water, and 
plating on Sabouraud dextrose agar medium. After 24 h of incubation at 37°C, CFU were 
enumerated. The efficacy of biomass removal was assessed by crystal violet staining (see 
below) performed in each well.  
 
Assessment of biofilm cells mitochondrial activity 
Biofilm cells mitochondrial activity was determined through the quantification of the reduction of 
[2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide] (XTT) [10]. Briefly, 200 
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µl of 100 µg/µl XTT (Sigma) and 10 µg/µl phenazine methosulphate (PMS; Sigma) were added 
to each well, containing washed biofilms. Then, the plates were incubated in the dark at 37°C 
and 130 rpm for 3 h. After that, cells were allowed to settle, and 150 µl of the supernatant was 
transferred to a new 96-well plate. Formazan salt formation was measured by absorbance 
reading at 490 nm (A490) (Bio-Tek Synergy HT, Izasa). Controls were performed to check for 
interferences between XTT and the alcohols assayed, and no changes were detected in A490 
readings. Samples exhibiting very intense color, yielding “offscale” absorbance values, were 
diluted as necessary before performing a second absorbance reading. 
 
Assessment of biofilm total biomass (crystal violet assay) 
Biofilm biomass was quantified using the crystal violet assay [11]. Briefly, after the washing 
procedure, air dried biofilms were fixed with 200 µl of 99% (v/v) methanol for 15 min. After 
methanol removal, the plates were left to air dry. Then, the biofilm within the wells was stained 
with 200 µl of crystal violet (VWR) diluted to 1% (v/v) during 5 min. Afterwards, each well was 
washed twice with ultrapure sterile water, air dried and destained with 200 µl of 33% (v/v) 
acetic acid (VWR). The resulting solution was transferred to a new microtiter plate, and the 
absorbance was measured at 570 nm (A570). Samples exhibiting very intense color, yielding 
“offscale” absorbance values, were diluted as necessary before performing a second 
absorbance reading. 
 
Reproducibility and statistical analyses 
Biomass dry weight measurements were performed three times. Supernatant alcohol analysis 
was made with two replicates, with an agreement of results within ≤ 15%. CFUs were 
determined from four independent experiments with two technical replicates. Biofilm cells 
mitochondrial activity and biomass determinations were performed in sets of eight replicates, on 
at least three separate occasions.  
Statistical analyses were performed using GraphPad Prism, version 5.00 software for 
Windows. Data normality was tested by the Kolmogorov-Smirnov method. The distribution of 
culture cell dry weight measurements was performed by Mann-Whitney test. The CFU of 
biofilms subjected to alcohols treatment were compared by Kruskal-Wallis, with a Dunn's post 
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test. Comparison between biofilm biomass and mitochondrial activity means of treated with 
untreated samples was performed by two-tailed unpaired t-test (confidence interval 95%). When 
the two sample standard deviations were not equal, Welch’s correction to Student’s t-test was 
used.  
 
RESULTS 
Qualitative evaluation of extracellular alcohols in C. parapsilosis and C. tropicalis 
supernatants  
Candida species planktonic cultures biomass dry weight determined at the end of 24 h were not 
statistically different (median biomass dry weight of C. parapsilosis was 3.5 mg ml, and of C. 
tropicalis 3 mg/ml, P= 0.18). Cell free supernatants were analyzed by HS-SPME/GC-MS and 
the obtained alcohols profile is summarized in Table 3.3-1. Nerolidol was not detected in culture 
supernatants of both species. Farnesol and dodecanol were identified in both culture 
supernatants, and their concentration was below nanomolar (Table 3.3-1). The comparison of 
phenylethanol and isoamyl alcohol GC peak intensity in the two Candida species samples 
indicates that these compounds levels are approximately 20 × and 100 × higher in C. tropicalis, 
respectively, and for this Candida species their concentration is in the micromolar range (Table 
3.3-1). 
  
 
Table 3.3-1 Alcohols composition of C. parapsilosis and C. tropicalis supernatants- alcohols and the corresponding 
GC peak area (×10−5) determined in samples and standards are shown- 
Compound Mean GC peak area (× 10-5)a 
 Standard (concentration)  C. parapsilosis C. tropicalis 
Farnesol 99 (12 nM) 2.8 1.5 
Nerolidol 6 (4 nM) n.d. n.d. 
Dodecanol 5.4 (0.06 nM) 3.9 10.9 
Phenylethanol 710 (21 µM)  25.9 558.2 
Isoamyl alcohol 390 (182 µM) 5.1 523.7 
n.d., not detected; a,with an agreement of results within ≤ 15% 
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Effect of the addition of synthetic alcohols in C. albicans, C. dubliniensis, C. parapsilosis and 
C. tropicalis biofilm development 
The effect of farnesol, nerolidol, dodecanol, phenylethanol, and isoamyl alcohol on Candida 
species was individually evaluated on biofilm development of adhered cells (Fig.3.3-1) and 
mature biofilms (Fig.3.3-2).  
The analysis of the number of culturable sessile cells at 3 h and 48 h revealed that: (i) C. 
tropicalis adhered cell population was higher than that of C. albicans (median log CFU of 5.2 vs 
3.4, respectively, P< 0.05), and (ii) C. dubliniensis mature biofilms contained more culturable 
cells than those of C. parapsilosis (mean log CFU of 6.7 vs 5.8, respectively, P< 0.05). 
 
Farnesol 
Farnesol was used as a control for C. albicans, C. dubliniensis and C. parapsilosis. Results 
show that 150 µM farnesol only reduced C. albicans biofilm biomass by 50% (Fig.3.3-1 A-II), 
and C. dubliniensis mitochondrial activity by 38% (Fig.3.3-1 A-I) plus biofilm biomass by 64% 
(Fig.3.3-1 A-II) when added to the adhered cell population. This alcohol did not affect C. 
parapsilosis biofilm cells (Fig.3.3-1 A and Fig.3.3-2 A). These data is in accordance to previous 
reports [5, 7, 8]. Additionally, farnesol was tested on C. tropicalis sessile cells and no changes 
were detected on adhered cells (Fig.3.3-1 A) and mature biofilms (Fig.3.3-2 A) development. 
 
Nerolidol 
Nerolidol was assayed at three concentrations (1.5 ×10-3, 1.5, and 150 µM) (Fig.3.3-1 B and 
Fig.3.3-2 B) and showed anti-biofilm activity against C. parapsilosis and C. tropicalis sessile 
cells. 
C. parapsilosis adhered cells treatment with 1.5 ×10-3 and 1.5 µM nerolidol resulted in a 
reduction of mitochondrial activity ≥ 25% (P< 0.05) (Fig.3.3-1 B-I), whereas mitochondrial 
activity of mature biofilm cells was significantly decreased independently of the concentration 
tested (Fig. 3.3-2 B-I).   
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Fig.3.3-1. Effect of alcohols on Candida species adhered cells subsequent biofilm development. Biofilm 
mitochondrial activity, assayed by XTT reduction, (A490) (I) and biofilm biomass, assayed by crystal violet staining 
(A570) (II) were estimated 24 h after exposure to: farnesol (A) [0 (□) and 150 µM (■)], nerolidol (B) [0 (□), 1.5 × 10
-3 
(■), 1.5 (■), and 150 µM (■)], dodecanol (C) [0 (□), 2 × 10-3 (■), and 2 µM (■)], phenylethanol (D) [0 (□), 5 (■), 
and 500 µM(■)], and isoamyl alcohol (E) [0 (□), 46 × 10–3 (■), and 23 mM (■)]. *, P < 0.05, **, P < 0.01, ***, P < 
0.001 for treated biofilms compared with untreated controls (unpaired t-test). 
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Fig.3.3-2. Effect of alcohols on Candida species mature biofilms subsequent biofilm development. Biofilm 
mitochondrial activity, assayed by XTT reduction, (A490) (I) and biofilm biomass, assayed by crystal violet staining 
(A570) (II) were estimated 24 h after exposure to: farnesol (A) [0 (□) and 150 µM (■)], nerolidol (B) [0 (□), 1.5 × 10
-3 
(■), 1.5 (■), and 150 µM (■)], dodecanol (C) [0 (□), 2 × 10-3 (■), and 2 µM (■)], phenylethanol (D) [0 (□), 5 (■), 
and 500 µM(■)], and isoamyl alcohol (E) [0 (□), 46 × 10–3 (■), and 23 mM (■)].*, P < 0.05, **, P < 0.01 for 
treated biofilms compared with untreated controls (unpaired t-test). 
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Biofilm formation by adhered C. tropicalis cells population was hampered by nerolidol. In 
fact, there was a statistically significant decrease in biofilm cells mitochondrial activity (Fig.3.3-1 
B-I) and biofilm biomass (Fig.3.3-1 B-II) induced by nerolidol. In contrast, the addition of 
nerolidol (1.5 ×10-3 to 150 µM) to mature biofilms induced a reduction in mitochondrial activity 
during further development (P< 0.05) (Fig.3.3-2 B-I) but did not affect biofilm biomass (Fig.3.3-
2 B-II). 
 
Dodecanol 
The effect of dodecanol was tested at concentrations of 2 × 10-3 and 2 µM (Fig.3.3-1 C and 
Fig.3.3-2 C). This compound elicited a pro-biofilm activity in C. parapsilosis but an anti-biofilm 
activity in C. tropicalis sessile cells. 
Biofilm biomass of adhered C. parapsilosis cells was increased by 46% after the 24-h 
treatment with the highest alcohol concentration (P= 0.04) (Fig.3.3-1 C-II). Fig.3.3-2C shows 
that dodecanol (2 µM) concomitantly increased C. parapsilosis mature biofilm cells 
mitochondrial activity (P= 0.004) (Fig.3.3-2 C-I), and biofilm biomass (P= 0.02) (Fig.3.3-2 C-II) 
by more than 90% during the subsequent development. 
C. tropicalis adherent cells 24-h treatment with 2 × 10-3 µM dodecanol resulted in a 
significant decrease in mitochondrial activity (33%) (Fig.3.3-1 C-I), without changes in biofilm 
biomass (Fig.3.3-1 C-II).  
 
Phenylethanol 
Phenylethanol at concentrations of 5 and 500 µM (Fig.3.3-1 D and Fig.3.3-2 D) showed anti-
biofilm activity against C. tropicalis sessile cells. Specifically, the mitochondrial activity of C. 
tropicalis adhered cells (Fig.3.3-1 D-I) (but not mature biofilms, Fig.3.3-2 D-I) was significantly 
reduced in a dose dependent trend upon 24-h exposure to phenylethanol, with a 20% decrease 
for the highest concentration tested. 
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Isoamyl alcohol 
Isoamyl alcohol concentrations of 46 × 10-3 and 23 mM used herein (Fig.3.3-1 E and Fig.3.3-2 
E) elicited anti-biofilm activity against C. albicans and C. dubliniensis, and a heterogenous 
activity against C. tropicalis at early stages of development.  
C. albicans adhered cells treatment with isoamyl alcohol 23 mM resulted in a 26% 
reduction of biofilm biomass (P= 0.02) during the subsequent development (Fig.3.3-1 E-II). 
Biofilm formation by the adhered C. dubliniensis cells population was significantly 
reduced by 23 mM isoamyl alcohol in terms of mitochondrial activity (Fig.3.3-1 E-I) and biofilm 
biomass (Fig.3.3-1 E-II). 
The 24-h challenge of C. tropicalis adhered cells with isoamyl alcohol (46 × 10-3 and 23 
mM) induced a significant decrease in cellular mitochondrial activity (Fig.3.3-1 E-I). 
Unexpectedly, upon challenge with the highest isoamyl alcohol concentration assayed, biofilm 
biomass increased 30% (P= 0.04) (Fig.3.3-1 E-II). 
 
DISCUSSION 
Microbial supernatant media contain a variety of products that comprehend final fermentation 
products, temporarily released metabolites, secondary metabolites, and proteins [12]. In 
Candida field, a cohort of secreted alcohol molecules has been sparsely identified in culture 
supernatants, namely, farnesol [13], tyrosol [14], nerolidol, dodecanol, phenylethanol, and 
isoamyl alcohol [6]. In this study it was shown that C. parapsilosis and C. tropicalis secrete 
farnesol, dodecanol, phenylethanol, and isoamyl alcohol but not nerolidol, into the extracellular 
medium (Table 3.3-1). This suggests that, in general, the release of alcohols into the 
extracellular medium is a common trait of Candida species. However, farnesol and dodecanol 
concentration range in C. parapsilosis and C. tropicalis supernatant (below nanomolar) (Table 
3.3-1) was lower than that previously described for C. albicans and C. dubliniensis (nanomolar) 
[6]. In contrast, the phenylethanol and isoamyl alcohol concentration range detected in C. 
tropicalis supernatant (within micromolar) (Table 3.3-1) was similar to that earlier described for 
C. albicans and C. dubliniensis [6]. Thus, although it cannot be excluded that the supernatant 
alcohol profiling may be dependent on experimental conditions [15], and strains used, data on 
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Table 3.3-1 suggests a heterogeneity in terms of the amounts of alcohols production among 
Candida species. 
 
It has been suggested that the majority of the molecules secreted by microorganisms 
modulate physiological functions, although the observed effects are not always derived from a 
quorum sensing circuit but many times resultant from processes of compound metabolisation 
or detoxification [16]. This work examined the effect of the addition of commercial formulations 
of extracellular alcohols in Candida species biofilm formation (Fig.3.3-1 and Fig.3.3-2), as 
indicators of a role for secreted alcohols in biofilm development. In an attempt to ascertain the 
physiological relevance of the alcohols, this study was generally focused on the evaluation of the 
effect of physiological and slightly higher concentrations of secreted alcohols [6]. 
The alcohols treatment induced different types of effects, in terms of mitochondrial activity and 
biofilm biomass changes, for the specific strains evaluated. First, a ‘dose-response’ effect, 
which assumes that, as the dose of the effector increases, also does the biological response 
caused [17] as suggested by dodecanol (Fig.3.3-1 C-II, C. parapsilosis; Fig.3.3-2 C-I and C-II, C. 
parapsilosis), phenylethanol (Fig.3.3-1 D-I, C. tropicalis), and isoamyl alcohol (Fig.3.3-1 E-I, C. 
dubliniensis; Fig.3.3-1 E-II, C. albicans, C. dubliniensis, and C. tropicalis). Second, alcohols that 
induced the highest effect at the lower concentrations tested, which resembles the paradoxical 
effect [18]. An example shown herein include the biofilm development changes induced by 
dodecanol (Fig.3.3-1 C-I, C. tropicalis). Third, alcohols that triggered a similar quantitative effect 
despite the concentration used, as observed for nerolidol (Fig.3.3-1 B-II, C. tropicalis; Fig.3.3-1 
B-I and Fig.3.3-2 B-I, C. parapsilosis and C. tropicalis), and isoamyl alcohol (Fig.3.3-1 E-I, C. 
tropicalis). Fourth, alcohols that induced a simultaneous change in mitochondrial cells activity 
and in biofilm biomass. Although only observed at alcohol supraphysiological concentrations, 
examples include: nerolidol (Fig.3.3-1 B, C. tropicalis), dodecanol (Fig.3.3-2 C, C. parapsilosis), 
isoamyl alcohol (Fig.3.3-1 E, C. dubliniensis), and farnesol (Fig.3.3-1 A, C. dubliniensis).  
Overall, the alcohols assayed showed a moderate anti-biofilm activity, except dodecanol 
in C. parapsilosis (Fig.3.3-1 C-II and Fig.3.3-2 C), and isoamyl alcohol in C. tropicalis (Fig.3.3-1 
E-II), that induced a pro-biofilm activity. However, it cannot be ruled out that these molecules 
elicit other effects in biofilms such as changes in morphology [19] or biofilm matrix [20]. The 
effects elicited by these alcohols did not appear to be compound specific, but rather dependent 
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on the biofilm development stage (Fig.3.3-1 and Fig.3.3-2). Specifically, although all the 
alcohols induced changes in further biofilm formation when added to adhered cells population 
(Fig.3.3-1), only nerolidol (Fig.3.3-2 B-I, C. parapsilosis and C. tropicalis) and dodecanol 
(Fig.3.3-2 C-I and C-II, C. parapsilosis) had influence on mature biofilms development. 
 
During the last years the recognition of polymicrobial cultures has been increasing [21]. 
However, Candida species interactions within mixed species biofilms has been scarcely studied 
[22-24]. The production of diffusible alcohol molecules probably offers a strategy for 
communication between Candida species. As noted, nerolidol was not detected in C. tropicalis 
and C. parapsilosis supernatants (Table 3.3-1). Interestingly, this compound, even at C. 
albicans and C. dubliniensis physiologically relevant concentrations (nanomolar levels) elicited 
an anti-biofilm activity against these specific strains of C. parapsilosis and C. tropicalis at early 
(Fig.3.3-1 B) and late (Fig.3.3-2 B) stages of development. This suggests a competitive 
advantage for Candida species that are nerolidol producers, such as C. albicans and C. 
dubliniensis [6]. Additionally, it was also noticed that the levels of isoamyl alcohol and 
phenylethanol in C. tropicalis supernatants are higher than the observed for C. parapsilosis 
(Table 3.3-1). The exposure to these compounds did not affect C. parapsilosis biofilm but 
induced a decrease in C. tropicalis adhered cells mitochondrial activity at physiologically 
relevant levels (5 µM for phenylethanol and 43 × 10-3 mM for isoamyl alcohol). This suggests 
that these compounds have an antagonist effect in C. tropicalis biofilm development. However, 
further insights can be achieved by a time course characterization of alcohols production, to 
evaluate possible growth stage specificity, and by determining the profile of alcohols secretion 
by biofilm cells. Overall, additional studies to clarify the role of these molecules might include a 
much higher number of strains of each species, the recognition of compound specific receptors, 
and evaluation of transcriptional induced changes [12], the use of mutants that do not respond 
to the molecules and that respond to the molecules but do not increase the molecules 
production in response to the extracellular stimulus.  
 
In conclusion, this study proved the extracellular secretion of farnesol, dodecanol, 
phenylethanol, and isoamyl alcohol by C. parapsilosis and C. tropicalis (as determined by HS-
SPME GC-MS), and contributed to shed more light into cell-cell signaling molecules in Candida 
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species. Moreover, it was shown that physiological levels of these secreted alcohols play an 
effect in C. parapsilosis and C. tropicalis biofilm development, evidencing the complexity of 
biofilm formation regulation. 
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ABSTRACT 
Candida albicans supernatants contain a mixture of autoregulatory alcohols. In vitro, when added 
individually or in combination, these alcohols inhibit the yeast to filamentous form conversion. Here we 
evaluate the in vivo effect of the exogenous administration of a Cocktail solution simulating the 
composition of alcohols present in a C. albicans culture supernatant (1 ml; 94 µM isoamyl alcohol, 70 
µM 2-phenylethanol, 3.2 nM E-nerolidol and 18 nM E,E-farnesol) using the well established murine 
model of hematogenously disseminated candidiasis. Mice injected intraperitoneally with the Cocktail 
solution demonstrated increased survival and decreased organ fungal burden compared to control mice 
(injected with Vehicle only). Histological observations suggest that the Cocktail, to some extent, has an 
inhibitory effect on cell proliferation and filamentation within the tissues. These findings suggest that the 
exogenous administration of C. albicans autoregulatory alcohols displays a protective effect during 
disseminated candidiasis. This information could be harnessed to develop new strategies to combat 
deep-seated candidiasis.  
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INTRODUCTION 
Candida albicans is a normal commensal microorganism able to colonize both biotic and abiotic 
surfaces inside the host. However, it can take advantage of a human host’s weakened defenses 
and cause life threatening infections [1]. This suggests that C. albicans has a high level of 
plasticity to sense and adapt to host’s environmental conditions and associated microbiota [2]. 
Among the fungal factors, that might influence the pathogenesis of infection are chemical 
substances secreted biologically. Indirect evidence indicated that the treatment of rats oral 
epithelium with C. albicans 5 h supernatants increased cells mitotic indices [3]. In the last years 
a special attention has been given to E,E-farnesol (farnesol), a C. albicans autoregulatory 
alcohol. This alcohol is secreted and detected by C. albicans as a sensor of population density 
[4]. In vitro assays, carried out in culture flasks [4] and on several cell lines [5, 6], showed that 
farnesol regulates C. albicans filamentation. In vivo, the effect of the exogenous administration 
of farnesol was suggested to be dependent on the disease model. Specifically, this alcohol 
increases C. albicans virulence in the hematogenously disseminated candidiasis model, 
although it does not seem to regulate C. albicans morphology within the organs [7]. In 
contrast,farnesol has a local protective effect against oral candidiasis, which is associated with 
regulation of filamentation [8].  
 
In addition, our group recently demonstrated that culture supernatants of C. albicans 
contain a mixture of autoregulatory alcohols that, besides farnesol, include isoamyl alcohol, 2-
phenylethanol (phenylethanol), 1-dodecanol, and E-nerolidol (nerolidol) [9]. Moreover, in vitro, 
these molecules were capable of inhibiting C. albicans filamentation when used alone or in 
combination (simulating a 96-h culture supernatant) [9]. Thus, the aim of this study was to 
investigate the in vivo effect of the identified autoregulatory alcohols, through the exogenous 
administration of a solution simulating a C. albicans 96-h culture supernatant, in a murine 
model of hematogenously disseminated candidiasis. 
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MATERIAL AND METHODS 
Chemicals 
Isoamyl alcohol (Sigma), phenylethanol (Fluka), nerolidol (Fluka), and farnesol (Sigma) 
standards purity ranged from 85 to 99%. Pure compounds were stored according to suppliers’ 
instructions. Stock solutions were prepared freshly in 5% (v/v) of ethanol in sterile pyrogen-free 
saline (Vehicle) before each experiment. In order to ensure compounds stability through the 
course of the experiments, appropriate in vitro C. albicans filamentation assays were performed 
concomitantly, following the methodology previously reported by our group [9]. The solution 
simulating C. albicans 96-h planktonic culture supernatant was composed of 94 µM isoamyl 
alcohol, 70 µM phenylethanol, 3.2 nM nerolidol, and 18 nM farnesol [9]. This solution will be 
referred to as “Cocktail”. 
 
Strain and culture conditions 
C. albicans CAF2-1 strain [10] was used for these studies. Cultures were grown overnight in 
yeast extract-peptone-dextrose medium (US Biological) at 30°C. Cells were harvested by 
centrifugation and washed three times in sterile saline. After determination of cell number by 
haemocytometer counts, appropriate dilutions were made to prepare a suspension containing 
1.5 × 106 cells/ml. Confirmation of the number and viability of cells was performed by plating 
serial dilutions on Sabouraud dextrose agar medium supplemented with 100 mg/l ampicillin.  
 
Animal experiments 
All animal experimentation was conducted following the National Institutes of Health guidelines 
for housing and care of laboratory animals and performed in accordance with Institutional 
regulations after pertinent review and approval by the Institutional Animal Care and Use 
Committee at The University of Texas at San Antonio. Disseminated candidiasis was induced in 
imunocompetent BALB/c female mice (6 to 8 week old) by lateral vein injections of 0.2 ml 
suspensions containing 3 × 105 colony forming units (CFU) of C. albicans strain CAF2-1. 
Immediately after infection mice were administered intraperitoneally (i.p.) with one time 
injection of 1 ml of the Vehicle (control group), or the Cocktail solution (experimental group). 
Total amounts of each autoregulatory alcohol per mouse were of 8 µg of isoamyl alcohol and 
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phenylethanol, 0.7 ng of nerolidol, and 4 ng of farnesol. In one set of experiments mice (eight 
per group) were monitored for survival, and in a second set of experiments animals (twelve per 
group) were sacrificed at pre-set times, 1-, 2-, and 3-days post-infection (four animals per group 
at each time point). At the time of death or sacrifice organs were removed for quantitative 
determination of fungal burdens. Briefly, the organs were recovered, weighted and 
homogenized, and appropriated dilutions were performed and plated onto Sabouraud agar 
medium for the determination of CFU counts. Under the conditions used in this study, the 
detection limits were of: 193 CFU/g heart, 103 CFU/g lung, 164 CFU/g spleen, 61 CFU/ 
gliver, 53 CFU/ g brain, and 146 CFU/g kidney. For statistical analysis, negative cultures were 
ascribed one half log10 lower than these limits.  
Since the kidney represents the major target of infection in this model, one kidney per 
animal was processed for histology. Briefly, samples were fixed in 10% buffered formalin and 
stored at 4°C, embedded in paraffin, sectioned, and stained with Grocott- Gomori 
methenamine-silver [11] prior to microscopy evaluation. 
 
Statistical analyses 
Survival data and differences between groups were determined by the Kaplan-Meier log rank 
test. Organs CFU counts were standardized per gram of tissue, and statistically significant 
differences of the logarithmic values between groups were determined by the Mann-Whitney 
test. The GraphPad Prism, version 5.00 software for Windows was used for statistical analyses. 
 
RESULTS AND DISCUSSION 
C. albicans commensal versus pathogenic lifestyles are intrinsically dependent on a very 
delicate balance between the microbe and its host, whose understanding is important to identify 
potential targets for treatment. In this sense, to gain insights into pathogen-host interactions 
through autoregulatory alcohols, the effect of a solution simulating the autoregulatory alcohols 
content of a C. albicans 96-h culture supernatant [9] was evaluated in vivo. Although several 
non-mammalian models have been studied in the last years, the mouse model of 
hematogenously disseminated candidiasis is a valuable experimental tool for the study of C. 
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albicans pathogenesis, since it reproduces many of the clinical features of the human disease 
[12].  
 
The level of each individual autoregulatory alcohol in the Cocktail solution was below the 
toxic levels for mice. Specifically in mice, the i.p. lethal value for isoamyl alcohol is 232 mg/kg 
[13], the median lethal dose (LD50) value for phenylethanol is 400 g/kg [14], and for farnesol 
is 327 mg/kg [15]. To authors’ knowledge, the i.p. LD50 has not been tested for nerolidol. 
However, the oral LD50 reported for nerolidol -≈ 10 g/kg- [16] is similar to that for farnesol -8.7 
g/kg- [15], suggesting that the dose used here is not toxic. A 5% ethanol saline solution was 
used as a Vehicle to administer the Cocktail solution, corresponding to a total amount of 39 mg 
of ethanol per mouse. This ethanol dose is well below the reported toxicity levels [17, 18].  
 
Exogenous administration of C. albicans autoregulatory alcohols affects the outcome of the 
infection 
The effect of the exogenous administration of the Cocktail was examined in terms of survival 
(Fig.3.4-1). The median survival time of mice within the control group was 6 days (Fig.3.4-1 -  
 
 
Fig.3.4-1. Effect of the administration of Candida albicans autoregulatory alcohols on 
mice survival. Groups of eight BALB/c mice were challenged intravenously with a 
suspension containing 3 × 105 CFU CAF2-1 strain/ mouse and 1 ml i.p. of Vehicle or 
Cocktail. Animals were monitored for their ability to survive infection. Survival data was 
analyzed by the Kaplan-Meier log rank test.  
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Vehicle). This is in general agreement with the expected survival for mice challenged with CAF2-
1 strain only [19-21], evidencing the minor effect of Vehicle on mice survival. In contrast, death 
among mice challenged with C. albicans and 1 ml i.p. of the Cocktail solution occurred between 
days 6 and 15 post-infection (median survival time 9 days) (Fig.3.4-1, Cocktail). On day 6 post- 
infection the survival proportion of mice in the Cocktail group was 87.5% compared to only 
12.5% in the Vehicle group. This indicates that the exogenous administration of the Cocktail 
significantly delays the time of death in comparison with untreated mice (P= 0.005).  
 
Exogenous administration of C. albicans autoregulatory alcohols affects fungal load in deep 
organs  
To evaluate whether the protective role observed for the Cocktail administration on survival 
correlated with the temporal progression of C. albicans infection, the fungal burden was 
determined for multiple organs at different times post-infection. On one hand, it is well 
established that in the hematogenously disseminated candidiasis model, C. albicans cells are 
cleared from the bloodstream within minutes post-infection [20, 22]. On the other hand, the 
autoregulatory alcohols pharmacokinetics is fast, with levels of compounds being undetectable 
in the bloodstream several hours after their administration [7, 13, 15]. Thus, the events 
mediated by the autoregulatory alcohols at early stages of the fungus–host interaction may 
determine the outcome of the disseminated candidiasis. In this sense, pre-set times sacrifices 
were performed 1-, 2-, and 3-days post-infection. 
 
As seen in Table 3.4-1, on day 1 post-infection, C. albicans cells were recovered from all 
the organs analysed, and were similar between groups (P> 0.05). Generally, and consistent with 
prior reports in control animals treated with Vehicle only, fungal burdens decreased from day 1 
to day 3 post-infection for all organs examined, except for brain and kidney, the two main 
targets organs in this model [20, 22]. Similar trends were observed for fungal burdens in heart, 
lung, spleen, and liver in the Cocktail-treated group. However, in  marked contrast with the 
control group where fungal organ burdens were maintained at day 3 post-infection, brain fungal 
burden was decreased in Cocktail-treated animals, and at day 3 post-infection renal fungal 
burdens were significantly lower in the Cocktail-treated animals compared to control mice 
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Table 3.4-1. Effect of the administration of C. albicans autoregulatory alcohols on organs fungal burden. Groups 
of four BALB/c mice were challenged intravenously with a suspension containing 3 × 105 CFU CAF2-1 strain/ mouse 
and 1 ml i.p. of Vehicle and Cocktail. At day 1, 2, or 3 post-infection samples from the heart, lungs, spleen, liver, 
brain, and kidneys were recovered and each organ fungal burden monitored by determining the total CFU per gram of 
tissue. Data represents mean and standard deviation (SD), and the differences between groups were determined by 
the Mann-Whitney test.  
Organ 
Treatment  
mean Log10 CFU/ g of tissue (SD) P value 
Pre-set times  Pre-set times 
 Day 1 Day 2 Day 3 Day 1 vs Day 2 Day 2 vs Day 3 Day 3 vs Day 1 
Heart       
Vehicle 3.6 (0.1) 3.4 (0.005) 3.1 (0.3) 0.12 0.06 0.04 
Cocktail 3.8 (0.1) 3.4 (0.2) 3.3 (0.2) 0.03 0.77 0.03 
Lungs       
Vehicle 3.8 (0.2) 2.2 (0.3) 2 (0.8) 0.03 0.88 0.03 
Cocktail 3.7 (0.1) 2.7 (0.2) 1.8 (0.6) 0.03 0.04 0.03 
Spleen       
Vehicle 5.1 (0.2) 4.9 (0.2) 4.7 (0.2) 0.19 0.11 0.04 
Cocktail 5.2 (0.2) 4.9 (0.1) 4.4 (0.1) 0.08 0.03 0.03 
Liver       
Vehicle 4 (0.06) 3.3 (0.1) 3.2 (0.2) 0.03 0.6 0.03 
Cocktail 3.8 (0.3) 3.2 (0.06) 2.8 (0.3) 0.03 0.03 0.03 
Brain       
Vehicle 3.9 (0.2) 3.5 (0.4) 3.8 (0.4) 0.38 0.56 0.66 
Cocktail 4.1 (0.2) 3.9 (0.2) 3 (0.4) 0.23 0.03 0.03 
Kidney       
Vehicle 5.7 (0.2) 5.2 (0.3) 5.9 (0.4) 0.11 0.08 0.77 
Cocktail 5.6 (0.4) 5.1 (0.8) 5.3 (0.2) 0.31 0.34 0.24 
 
(P<0.05) (Table 3.2-1). These decreased organ fungal burdens in brains and kidneys early after 
infection may explain the slower mortality observed for Cocktail-treated mice. However, we note 
that all animals treated with the mixture of autoregulatory alcohols eventually succumb to 
disseminated candidiasis, probably an indication of the short-time effects associated with a 
single administration of these molecules at the time of infection.  
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Exogenous administration of C. albicans autoregulatory alcohols affects fungal morphology 
and distribution in infected organs 
We performed a histological analysis of kidneys recovered from both Cocktail- and Vehicle-
treated (control) mice. As seen in Fig.3.4-2, this examination revealed the characteristic 
presence of filaments and large cellular aggregates in the kidneys of control mice three days 
post-infection (Fig. 3.4-2, A and B). However, examination of the kidneys recovered from mice 
treated with the mixture of autoregulatory alcohols at the same time point revealed the presence 
of mostly yeast cells with a more scattered distribution throughout the organs (Fig. 3.4-2, C). We 
note that cells displaying a filamentous morphology were detected in tissues from Cocktail-
treated mice at time of death as infection progressed (Fig. 3.4-2, D).  
 
In summary, our results indicate that the exogenous administration of a mixture 
containing C. albicans autoregulatory alcohols mimicking a 96h culture supernatant displays the 
capacity to modify the course and decrease the severity of hematogenously disseminated 
 
 
Fig.3.4-2. Histological analysis of kidneys retrieved from infected mice in the untreated (control) group (panels A 
and B) and the Cocktail-treated group (panels C and D). A, filamentous forms are present in the kidney of an 
untreated mouse 3 days post-infection. B, large aggregates of cells in the kidney of an untreated mouse 3 days post-
infection. C, scattered yeast cells in the kidney of a cocktail-treated mouse sacrificed 3 days after infection. D, 
filamentous cells in the kidney of a Cocktail-treated mouse at time of death (7 days post-infection).  
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candidiasis in vivo: it increases survival, decreases organ fungal burden, and regulates 
morphogenetic conversions and global distribution patterns of fungal cells in infected tissues. 
These observations are consistent with similar results obtained in vitro (Martins et al., 2007), 
but they seem somewhat contradictory to results previously reported for single farnesol 
administration in a similar in vivo model of candidiasis [7]. However, the differences in the 
mouse and C. albicans strains, and inoculum load [20, 23], or in the Vehicle used to deliver the 
alcohol in both studies may partially be responsible for this discrepancy.  
 
Although many questions remain unresolved, particularly whether these autoregulatory 
alcohols are produced in vivo, and to which extent host factors or environments regulate their 
production during infection, overall the data presented here provides additional insight into the 
role of these autoregulatory alcohols in vivo and point towards the possibility of novel 
therapeutic strategies to combat disseminated candidiasis.  
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ABSTRACT 
The ability of the Candida species to colonize surfaces can be considered a risk factor for oral infection. 
The aim of this work was to establish oral Candida carriage in patients attending a dental clinic in Braga, 
Portugal. A total of 97 patients were analysed. Swab samples were collected, and directly cultured in 
CHROMagar Candida. Representative yeasts were identified by polymerase chain reaction. From the 
samples analysed 54.6% (n=53) were Candida positive, and Candida albicans was the most frequently 
isolated species, accounting for 79% of all the species identified. Non-C. albicans Candida (NCAC) 
species recovered included Candida parapsilosis, Candida glabrata, Candida tropicalis, and Candida 
guilliermondii. There was a lack of association between the presence of C. albicans, and NCAC species, 
and age, gender or prostheses wearing in this population. In 17% of the cases (n=9) polymicrobial 
cultures, with two different Candida species, were identified. This study shows a high Candida carriage 
rate among this population, thus pointing to the relevance of an accurate diagnostic approach in 
Candida species identification. 
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INTRODUCTION 
Colonization of the oral cavity by Candida species was defined as the acquisition, and 
maintenance of yeast cells without clinical signs. This process entails Candida species 
acquisition, growth, and removal [1]. 
Within the yeast oral community Candida albicans is the most frequently found (47–75% 
of the yeasts isolated) [2]. However, other yeast species have been increasingly identified, such 
as Non-C. albicans Candida (NCAC) species (Candida glabrata, Candida parapsilosis, Candida 
krusei, Candida tropicalis, Candida dubliniensis, and Candida guilliermondii) Saccharomyces 
cerevisiae, Trichosporon species, and Yarrowia lipolytica [3-6].  
Although the presence of Candida species is not an indication of disease, the ability of 
the yeasts to overcome the host clearance mechanisms and to colonize surfaces can be 
considered a risk factor for oral infection. The balance between Candida colonization, and 
candidiasis rely on the balance between pathogen characteristics (e.g., production of adhesins, 
secreted aspartyl proteinases), and host factors [7]. Host local predisposing conditions 
comprise: (i) reduced saliva secretion, (ii) epithelial changes, and local mucosal diseases, (iii) 
changes in commensal flora, (iv) high carbohydrate diet, and (v) denture wearing. Additionally, 
host systemic factors have also been associated with Candida oral colonization, and include: (i) 
age, (ii) tobacco smoking (iii) endocrine disorders, including diabetes, hypothyroidism, 
hyperparathyroidism, (iv) rheumatic diseases, (v) nutritional deficiencies (iron or folate 
deficiencies), (vi) immunosuppressive conditions, such as chemotherapy, deficiencies of 
humoral or cell-mediated immunity, human immunodeficiency virus infection, and acquired 
immunodeficiency syndrome, and (vii) drugs: broad-spectrum antibiotics, and corticosteroids [2, 
5, 8, 9]. 
To the authors’ knowledge oral Candida carriage prevalence, and aetiology studies were 
not yet performed in the Portuguese population. Thus, the main objective of this study was to 
evaluate oral Candida carriage in patients attending a dental clinic in Braga, Portugal. 
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PATIENTS AND METHODS 
Candida type strains 
For quality control purposes, the following Candida type strains were used in the identification 
procedures of Candida isolates: C. albicans CECT 1472, C. dubliniensis, strain provided by 
Biognostica from United Kingdom National External Quality Assessment Service, C. glabrata 
ATCC 2001, C. guilliermondii ATCC 6260, C. kefyr ATCC 204093, C. krusei ATCC 6258, C. 
parapsilosis ATCC 22019, and C. tropicalis ATCC 750. These strains were maintained on 
Sabouraud dextrose agar. 
 
Patients 
Samples were collected from a total of 97 asymptomatic individuals (77 females, and 20 males) 
attending a dental clinic in Braga, Portugal over a 12-month period (May 2005 to 2006). Each 
of the potential subjects was informed of the aims, and methods of the study, and anticipated 
benefits, and potential risks, according to the World Medical Association Declaration of Helsinki. 
Data on patient age, oral hygiene habits, health status, medications, and prosthesis wearing 
were collected.  
 
Sample collection  
Samples were collected by passing a sterile swab (UNI-TER, MEUS, Padua, Italy) across the oral 
mucosa: tongue, hard palate, and gums, and replaced in its sterile container tube. Samples 
were kept at 4°C, and analysed within 24 h. 
 
Candida species identification 
Medium for the primary isolation 
CHROMagar™ Candida medium (CHROMagar, Paris, France) was prepared according to the 
manufacturer’s instructions. The swab was inoculated into CHROMagar Candida medium 
rotating the swab head on the surface of the medium. The plates were incubated at 37°C for 48 
h. Colony morphology, and colour description were assigned in a standard manner by a single 
investigator. Presumptive species identification was performed according to Odds and Bernaerts 
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[10]. At least one colony exhibiting each colour was streaked into a new CHROMagar Candida 
plate, and then cryopreserved. 
 
Molecular identification 
Yeast DNA was extracted using the QIAamp® DNA Mini Kit (QIAGEN, Lisbon, Portugal) 
according to the manufacturer’s instructions. Genomic DNA content was determined by 
spectrophotometry readings at 260 nm. Aliquots of 10 µl were analysed by electrophoresis in a 
0.8% agarose (Bio-Rad, Lisbon, Portugal) gel in 1 × Tris-borate-EDTA (TBE) buffer (Bio-Rad, 
Lisbon, Portugal), and visualized with a ultraviolet (UV) transilluminator, after ethidium bromide 
(Bio-Rad, Lisbon, Portugal) staining (0.5 mg/ml). 
To assess the Candida speciation, a polymerase chain reaction method (PCR) previously 
described [11] was followed. This method uses primer mixtures of the Candida DNA 
topoisomerase II genes (Table 4-1). In a multiplex PCR strategy it allows the identification of C. 
albicans, C. guilliermondii, and C. parapsilosis using primer set A (Table 4-1) and C. 
dubliniensis, C. krusei, C. kefyr, and C. glabrata using primer set B (Table 4-1). C. tropicalis is 
identified in a third PCR reaction using a single pair of primers (Table 4-1). PCR amplification 
was performed in 25 µl volume consisting of: 1 × PCR buffer (160 mM (NH4)2SO4, 670 mM 
Tris-HCl pH 8.8, 0.1% Tween 20, and 25 mM MgCl2) (Bioron, Porto, Portugal); dNTP mixture 
(200 µM each) (Bioron, Porto, Portugal); primer mixture (300 nM each); 1.25 U Taq DNA 
polymerase (Bioron, Porto, Portugal); 10–100 ng genomic DNA template; the remaining volume 
consisted of sterilized ultrapure water. PCR was carried out in a MyCycler thermal cycler (Bio-
Rad, Lisbon, Portugal) under the following cycling conditions: 35 cycles of 30 s at 94°C, 15 s at 
57°C, and 45 s at 65°C, after a 10-min initial period of DNA denaturation, and enzyme 
activation at 94°C. One blank reaction was performed simultaneously per every 10 tests run by 
replacing the template DNA by sterilized ultrapure water. DNA from type strains was also 
included in each reaction as positive and negative controls. An aliquot of 15 µl of each PCR 
product was analysed by electrophoresis in a 1.2% agarose gel in 1 × TBE buffer. Fragments 
were visualized by ethidium bromide staining (0.5 mg/ml) with a UV transilluminator. The size 
of the amplified DNA fragments was determined by comparison with a 100-bp DNA marker 
(Bioron, Porto, Portugal). All the isolates whose presumptive identification in CHROMagar 
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Table 4-1. Primers sets and species specific primers used in this study (as described by Kanbe et al. [11]) 
Primers 
sets 
Target 
species 
Forward primer sequence (name) Reverse primer sequence (name) Expected PCR 
product size (bp) 
Aa 
C. albicans 5’-TTGAACATCTCCAGTTTCAAAGGT-3’ 
(CABF59) 
5’-AGCTAAATTCATAGCAGAAAGC-3’ 
(CADBR125) 
665 
 
C. 
guilliermondii 
5’-CCCAAAATCACAAAGCTCAAGT-3’ 
(CGLF41) 
5’-TACGACTTGAAGTTGCGAATTG-3’ 
(CGLR61) 
205 
 
C. 
parapsilosis 
5’-GGACAACATGACAAAAGTCGGCA-3’ 
(CPPIIF41) 
5’-TTGTGGTGTAATTCTTGGGAG-3’ 
(CPPIIR69) 
310 
Bb 
C. 
dubliniensis 
5’-AAATGGGTTTGGTGCCAAATTA-3’ 
(CDBF28) 
5’-GTTGGCATTGGCAATAGCTCTA-3’ 
(CDBR110) 
816 
 
C. krusei 5’-GAGCCACGGTAAAGAATACACA-3’ 
(CKSF35) 
5’-TTTAAAGTGACCCGGATACC-3’ 
(CKSR57) 
227 
 
C. kefyr 5’-CTTCCAAAGGTCAGAAGTATGTCC-3’ 
(CKFF35) 
5’-CTTCAAACGGTCTGAAACCT-3’ 
(CKFR85) 
532 
 
C. glabrata 5’-CCCAAAAATGGCCGTAAGTATG-3’ 
(CGBF35) 
5’-ATAGTCGCTACTAATATCACACC-3’ 
(CGBR103) 
674 
Cc 
C. tropicalis 5’-CTGGGAAATTATATAAGCAAGTT-3’ 
(CTPIIF36) 
5’-TCAATGTACAATTATGACCGAGTT-
3’ (CTPIIR121) 
860 
In the original report [11] primers sets had the designation of aPsI, bPsII, and cPsIII  
 
Candida did not correspond to the molecular identification were re-tested by two independent 
researchers in a blind assay. 
 
Statistical analysis 
CHROMagar Candida medium sensitivity was calculated as: [# true positives × 100 / (# true 
positives + # false negatives)], and specificity as: [# true negatives × 100 / (# true negatives +  
# false positives)]. Statistical analysis was performed using GraphPad Prism, version 5.00 
software for Windows. Data was analysed using two-tailed chi-square test or Fischer test to 
measure association between Candida species distribution within groups. A statistical 
confidence interval of 95% was established.  
 
RESULTS 
Candida species identification 
Presumptive identification of yeasts clinical isolates was based on their colour on CHROMagar 
Candida medium. Samples were processed in parallel with C. albicans, C. krusei, and C. 
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tropicalis type strains that presented the expected colours on CHROMagar Candida medium: 
green, pink, and blue, respectively.  
For each culture, representative isolates were identified by PCR using Candida specific 
primers pairs for the genomic sequences of DNA topoisomerase II gene [11]. Reference strains 
DNA was included in each assay as control. DNA of C. albicans (Fig.4-1 A, lane 1), C. 
guilliermondii (Fig.4-1 A, lane 3), and C. parapsilosis (Fig.4-1 A, lane 4) were amplified using 
primer set A (Table 4-1). Primer set B (Table 4-1) allowed the identification of C. glabrata (Fig.4-
1 1B, lane 2), C. dubliniensis, C. krusei, and C. kefyr reference strains (data not shown). Finally, 
the set of primers C (Table 4-1) allowed the identification of C. tropicalis reference strain  
 
 
Fig.4-1. Candida species-specific amplification of DNA topoisomerase II fragments. Genomic DNA 
was amplified using different sets of species-specific primers (from A to C), in accordance with Table 1. 
Lanes: M,100-bp DNA marker and their molecular size in bp is indicated in the left margin; 1. C. 
albicans CECT 1472; 2. C. glabrata ATCC 2001; 3. C. guilliermondii ATCC 6260; 4. C. parapsilosis 
ATCC 22019; 5. C. tropicalis ATCC 750; 6–10. example of clinical isolates of each species; 11. blank. 
C. dubliniensis, C. krusei ATCC6258, and C. kefyr ATCC 204093 identification was omitted for 
simplicity. Arrows on the right indicate molecular weight of the amplified products. 
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(Fig.4-1 1C, lane 5). For all Candida species the amplicon size obtained (Fig.4-1) was as 
expected (Table 4-1). Clinical isolates identification was based on the comparison of the size of 
the amplified DNA products (assessed by the DNA ladder), with the respective type strain PCR 
product. Fig.4-1 shows an example of the identification of an isolate of C. albicans (lane 6), C. 
glabrata (lane 7), C. guilliermondii (lane 8), C. parapsilosis (lane 9) and C. tropicalis (lane 10). 
CHROMagar Candida phenotypic characteristics of the Candida species identified by PCR 
are specified in Table 4-2. As expected, C. glabrata, and C. parapsilosis did not present a 
distinguishable colour in this medium. Using PCR as a standard method, and considering the 
CHROMagar Candida identifying colours claimed by the manufacturer, CHROMagar Candida 
sensitivity, and specificity for C. albicans were found to be 97.9%, and 83.3%, respectively. For 
C. tropicalis CHROMagar Candida sensitivity was 66.7%, and specificity 100%.  
 
Candida species carriage 
From the 97 patients evaluated, 53 were identified as oral Candida carriers: 81.1% were 
females (n=43), and 18.9% males (n=10) with ages ranging from 28 to 91 years old (mean=61, 
and median=62 years old). Prosthesis wearers accounted for 84.9% of the individuals (n=45).  
C. albicans was identified in 79% of the samples being the predominant Candida species. 
Additionally, C. parapsilosis comprised 6.5% of the isolates, followed by C. glabrata (4.8%), C. 
tropicalis (3.2%), and C. guilliermondii (1.6%). Five percent of the CHROMagar Candida positive 
samples (Table 2) were not identified. The distribution of Candida isolates within gender, and 
age groups is presented in Table 4-3. There was no association between C. albicans, and NCAC  
 
 
Table 4-2. Colour of colonies on CHROMagar Candida medium for species identified by PCR  
Species  
# Colony colour 
 Green Blue Pink 
C. albicans  48 - 1 
C. parapsilosis - - 4 
C. glabrata  - - 3 
C. tropicalis 1 2 - 
C. guilliermondii - - 1 
Unidentified 1 - 2 
C. albicans oral carriage Chapter 4 
 
 
151 
Table 4-3. Frequency of distribution of Candida species isolated and patients’ characteristics 
Patients 
characteristics 
Speciesa frequency, % (#) 
C. albicans 
NCAC species 
C. parapsilosis C. glabrata C. tropicalis C. guilliermondii Unidentified 
Gender       
Female 80 (40) 6 (3) 4 (2) 4 (2) 0 (0) 6 (3) 
Male 75 (9) 8.3 (1) 8.3 (1) 0 (0) 8.3 (1) 0 (0) 
Age (years)       
≤ 54 82.6 (19) 4.3 (1) 4.3 (1) 4.3 (1) 0 (0) 4.3 (1) 
55-79 75.9 (22) 6.9 (2) 3.4 (1) 3.4 (1) 3.4 (1) 6.9 (2) 
≥ 80 80 (8) 10 (1) 10 (1) 0 (0) 0 (0) 0 (0) 
a, PCR identification  
 
species carriage within (i) gender (P=0.7), (ii) the age groups defined (P=0.83) or (iii) prosthesis 
wearing (P=1). 
Seventeen percent of the individuals (n=9) presented more than one Candida species per 
sample (Table 4-4). These individuals (seven females, two males) had a mean age of 58 years 
old (range=38-88 years old). The percentage of patients wearing prostheses in this sub-
population (88.9%) was similar to the observed in the population studied. 
 
Table 4-4. Number of patients with more than one Candida species 
Speciesa 
#patients 
C. albicans–C. glabrata 3 
C. albicans–C. tropicalis 2 
C. albicans–C. parapsilosis 1 
C. albicans–unidentified 2 
C. parapsilosis–C. guilliermondii 1 
a, PCR identification 
 
DISCUSSION 
Motivation for microbiological tests in the field of oral medicine includes diagnosis, choice of 
therapy, treatment control, and risk evaluation [12]. This study focused on diagnostic, and risk 
evaluation.  
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The diagnosis approach used herein included a primary isolation on a chromogenic 
medium (CHROMagar Candida) followed by Candida species identification using a previously 
described PCR method [11]. The CHROMagar Candida phenotypic characteristics of the 
Candida species identified by PCR are specified in Table 4-2. In comparison with PCR, there 
was a lower sensitivity, and specificity of CHROMagar Candida in the identification of C. 
tropicalis, and of sensitivity regarding C. albicans, also described by other authors [13]. In fact, 
the low sensitivity shown by C. tropicalis to CHROMagar Candida (66.7%) is due to the fact that 
one isolate further identified as C. tropicalis presented green colour (Table 4-2), instead of the 
expected blue one. C. tropicalis isolates developing dark pink [14], lavender [13, 15], and white 
colour [13] on CHROMagar Candida have also been reported. Regarding C. albicans, two 
isolates that developed green colour on CHROMagar Candida were not identified as C. albicans 
(Table 4-2). In addition, one of the isolates, further identified as C. albicans, developed pink 
colour in CHROMagar Candida. In accordance, some literature reports show that C. albicans 
isolates can develop atypical colours in CHROMagar Candida which include pink [16], white 
[13], blue or lavender [15]. It should be noted that in the same plates containing these atypical 
strains, isolates of C. albicans, and C. tropicalis with the expected colour phenotype were 
identified. 
Additionally, three yeast isolates were not identified by the PCR method using specific 
primers for the most common species (Table 4-2). A comparison between literature reporting 
yeast species frequently isolated from the oral cavity [5], and colours developed by Candida 
species in CHROMagar Candida [10], suggests that the unidentified isolate developing green 
colour might be a Trichosporon species, and the pink isolates might be: Candida famata, 
Candida inconspicua, Candida lusitaniae, Candida norvegensis, Candida pelliculosa or S. 
cerevisiae. 
Results presented herein evidence that CHROMagar Candida medium failed to identify 
some yeast isolates, and that species identification should be supported by other methods, such 
as the molecular ones. Nevertheless, this medium facilitates the recognition of polymicrobial 
species in cultures, as exemplified in Table 4-4.  
The analysis of the epidemiological literature on the recovery of Candida species from the 
oral cavity is not clear concerning factors determining colonization. The reasons of such 
variability may include different patient selection criteria, collection data period, geographic 
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region in which the patients live, sampling collection methods, and methodology used for 
sample analysis. 
In the present study, the prevalence of yeasts isolated was 54.6%, and between 41% to 
67% in previous studies [3, 6, 17-19]. However, due to the irregular distribution of Candida in 
the oral cavity [20], it cannot be discarded that swab samples can yield false-negative results, 
and thus a misclassification of true carriers as non–carriers. The Candida carriage frequency 
observed herein was: C. albicans > C. parapsilosis > C. glabrata > C. tropicalis > C. 
guilliermondii (Table 4-3), with NCAC species standing for 21% of the total Candida species. The 
increased prevalence of C. parapsilosis within NCAC species was also observed in Portuguese 
patients with fungaemia [21], suggesting that C. parapsilosis might be an important fungal 
pathogen in Portugal. Nevertheless prevalence of C. tropicalis [18], C. parapsilosis [22], C. 
famata [4] or C. glabrata [6, 19] over other NCAC species in the oral cavity has been shown, 
and such variation may be due to patient age or underlying disease. 
The distribution of Candida isolates within gender, and age groups are presented in Table 
3. In the current study there was no association between C. albicans vs NCAC species carriage 
within gender or age, likewise the observed by other authors [23]. Nevertheless, NCAC species 
recovered from samples of patients with more than 80 years old were exclusively C. 
parapsilosis, and C. glabrata (Table 4-3), suggesting an association between this age group, and 
these Candida species. Even so, as only two NCAC species have been isolated in this age 
group, an increase in sample size would be necessary to establish a conclusive association. 
Earlier studies scarcely report the identification of mixed Candida cultures. However, in 
recent years, researchers became aware of it, and the refinement of identification procedures 
allowed the discrimination of multi-Candida species in culture. As observed in other studies [3, 
6, 19, 24-26], the most common association found herein was C. albicans plus C. glabrata 
(Table 4-4). Nevertheless, the epidemiological data available report the association between 
other Candida species [3, 4, 6, 19, 24-26]. It is interesting to note that in the current study C. 
parapsilosis was the only NCAC species identified that was not exclusively co–isolated with 
other Candida species (Tables 4-3, and 4-4). In fact, other authors have reported that the 
colonization with NCAC species, as the sole species, is lower when compared with its co–
colonization with other species [19]. This suggests that multi–species colonization may support 
the maintenance of the oral NCAC population contributing to increased interactions with 
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molecules, and surfaces in the oral cavity. In fact, it was shown that the intensity of colonization 
by more than one Candida species was higher than the observed with single species [19]. 
However, when host natural defences decay, the benign colonization can develop into oral 
candidiasis, and antifungal therapy may support NCAC species emergence as the sole 
detectable species from oral lesions. In line with this, results from the ARTEMIS DISK Global 
Antifungal Surveillance Program [27-29] show that Candida species resistance to fluconazole 
can be ranked as follow: C. glabrata, 16%, C. guilliermondii, 13%, C. tropicalis, 2.6%, C. 
parapsilosis, 2.4%, and C. albicans, 1.2%. These findings suggest that multi–species carriers 
might be at higher risk, than the mono–species carriers, of developing oral candidiasis, and of 
being resistant to antifungal therapy. 
According to the World Medical Association Declaration of Helsinki, purposes of research 
involving human individuals might be the advance in prophylactic, diagnostic, and therapeutic 
procedures as well as a better understanding of the aetiology of the disease. The present study 
fulfilled some of these issues. The diagnosis of oral Candida carriage before the presentation of 
clinical symptoms allowed the possibility of (i) dental hygiene education for routine oral care, (ii) 
control of the spread of the colonization through the monitoring of colonization, and (iii) use of 
therapeutic approaches when appropriated. Finally, the main observation that may contribute to 
a better understanding of Candida oral carriage arose from the high frequency of polymicrobial 
cultures, which may represent an increased risk of infection to patients, requiring careful 
surveillance. 
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CONCLUDING REMARKS AND FUTURE PERSPECTIVES 
Candida species live in complex and dynamic environments, being consequently exposed to 
external cues. In fact, to colonize so diverse niches such as the skin, gastrointestinal tract, or 
oral cavity, the cells need to adapt, for example, to different pH and oxygen levels, and microbial 
flora. This plasticity may involve the sensing and response to the multiple environmental inputs. 
It is currently accepted that one of the ways to coordinate the adaptation of the microbiological 
population is through cell to cell communication mediated by metabolites released by cells [1]. 
Therefore, one of the challenges in fundamental research is to identify the components that 
mediate cell to cell communication and to understand the nature, effect, and strength of the 
interactions on cell phenotype, to ultimately develop functional models (Fig.5-1) that may help to 
get a better understanding on pathogenesis [2].  
In the last decade it was observed an increase in the “omics” approaches (Fig.5-1) in the 
Candida field, crucial to the elucidation of the fungal physiological responses to its environment. 
The genomic era started with Candida albicans [3] and Candida glabrata [4] genomes 
sequence, but only recently Candida dubliniensis [5], Candida tropicalis, Candida parapsilosis, 
Candida guilliermondii, and Candida lusitaniae [6], but not Candida krusei genome sequence 
were published. Additionally, transcriptomic studies, based on the dynamic expression of 
messenger ribonucleic acid (mRNA), have been used to identify genes relevant in a given 
physiological process, as dimorphism [7] or in particular niches such as biofilms (reviewed by 
Coenye [8]). Moreover, the proteomic studies, through the analysis of global patterns of protein 
expression, have been applied to the identification of key proteins related for example with cell 
adhesion, drug resistance, and virulence factors (reviewed by Thomas et al. [11]). Overall, the  
 
 
Fig.5-1. Schematic diagram of the functional principles and dynamics of the cellular systems adapted from [2, 9, 
10].  
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combination of these approaches has been helpful to get a better understanding on C. albicans 
existence as a human commensal and pathogen. 
However, the cells adjust their metabolism, and consequently their metabolites, 
according to the different physiological states [12]. The whole group of metabolites– the 
metabolome - link DNA, mRNA, proteins, complex interactions, and cellular pathways with 
environmental stimuli (Fig.5-1), thus being considered functional entities of the cells [13, 14]. 
Metabolomic (the quantification of the metabolome) or metabolic profiling (the quantification of 
a set of pre-defined metabolites belonging to a class of compounds or to members of particular 
pathways [12]) are unexploited topics in the Candida field. This can be inferred by the number 
of publications on the field: a Pubmed search using the terms “Candida” and “metabolite 
profile” or “metabolome” returns three and two publications, respectively, 
[http://www.ncbi.nlm.nih.gov/sites/pubmed (on 2010-07-06)], and these are not always 
representative of the subject. However, increased awareness is arising in the scientific 
community, with the “Biochemical Pathways” feature being recently added as a tool at the 
Candida Genome Database (CGD, http://www.candidagenome.org/) [15].  
As pointed out in Chapter 1, one of the Candida extracellular metabolites that has been 
receiving particular attention in the last years is E,E-farnesol (farnesol). However, fungal 
extracellular compounds comprise so diverse molecules as volatiles, alcohol compounds, 
organic acids, extracellular enzymes, proteins [16], or DNA [17]. Due to the diversity of 
compounds and their dynamic regulation, the complete analysis of the metabolome is 
considered a difficult task [18]. Even though, it is possible to perform target analysis for the 
detection and quantification of a single or a small set of metabolites [12], thus achieving partial 
insights into the metabolome. In this thesis, to get insights into the extracellular milieu of 
Candida species, two different groups of extracellular molecules were evaluated: extracellular 
DNA (eDNA) (Chapter 2), and alcohol compounds (Chapter 3) (Fig.5-2 to Fig.5-5). 
 
The interest on the study of eDNA, the first target molecule selected, was raised by 
evidences showing that: (i) eDNA accumulates into the extracellular medium in vitro and in vivo 
[17], (ii) eDNA can regulate the host immune response [19-21], and (iii) DNase I reduces 
biofilm biomass [22] (Chapter 1, Table 1-1). In fact, this molecule has not received considerable  
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Fig.5-2. Overview of C. albicans extracellular compounds evaluated in this thesis and their effect in the organism’s 
biology. E,E-farnesol (FOH) and 2-phenylethanol (POH) biosynthetic pathways as previously described by Hornby et al. 
[23] and Ghosh et al. [24], respectively. The represented isoamyl alcohol (IAA), E-nerolidol (NOH), and 1-dodecanol 
(DOH) biosynthetic pathways are hypothetical pathways predicted from the Candida Genome Database [15] and Zea 
et al. [25] and Walker [26] works. These alcohols and DNA are released into the extracellular medium. The effect of 
the individual addition of these alcohols was analyzed in terms of planktonic cells filamentation (A) and biofilm 
development (B). For the determination of the in vivo effect of alcohols against hematogenously disseminated 
candidiasis (C) the indicated alcohols were administered in a Cocktail solution. The role of eDNA on biofilm 
development and drug resistance was also evaluated (B). Large down arrows denote decrease and large up arrows 
denote increase in the biological effect. 
 
considerable attention in the Candida biofilm field, and it has not been addressed, for example, 
whether it is a component of biofilm extracellular matrix (ECM) or not, or further exploited 
regarding its contribution to biofilm lifestyle. 
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Fig.5-3. Overview of C. dubliniensis extracellular compounds evaluated in this thesis and their effect in the 
organism’s biology. The represented isoamyl alcohol (IAA), 2-phenylethanol (POH), E-nerolidol (NOH), E,E-farnesol 
(FOH), and 1-dodecanol (DOH) biosynthetic pathways are hypothetical pathways predicted from the Candida Genome 
Database [15], Ghosh et al. [24], Zea et al. [25], Hornby et al. [23], and Walker [26] works. These alcohols are 
released into the extracellular medium. The effects of the individual addition of these alcohols was analyzed in terms 
of planktonic cells filamentation (A) and biofilm development (B). Large down arrows denote decrease and large up 
arrows denote increase in the biological effect. 
 
Using a fluorometric method to quantify DNA in the ECM, it was shown that C. albicans 
mature biofilms are a reservoir of eDNA (Chapter 2.1). In parallel, another group [27] reported 
the presence of eDNA in C. albicans biofilms from a different strain, reinforcing our observations 
that eDNA is a component of C. albicans biofilms. But one of the points that is raising more 
controversy in the Candida scientific community relates to the origin of C. albicans  
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Fig.5-4. Overview of C. parapsilosis extracellular compounds evaluated in this thesis and their effect in the 
organism’s biology. The represented isoamyl alcohol (IAA), 2-phenylethanol (POH), E,E-farnesol (FOH), and 1-
dodecanol (DOH) biosynthetic pathways are hypothetical pathways predicted from the Candida Genome Database 
[15], Ghosh et al. [24], Zea et al. [25], Hornby et al. [23], and Walker [26] works. The effect of the individually 
addition of FOH was analyzed in terms of planktonic cells growth (A). The effects of the individual addition of E-
nerolidol (NOH), IAA, POH, FOH, and DOH were analyzed in terms of biofilm development (B). Large down arrows 
denote decrease and large up arrows denote increase in the biological effect. 
 
eDNA. Accumulated evidences in the bacterial field suggest that eDNA may be released 
released through quorum sensing and specific secretion mechanisms, and cell lysis (reviewed 
in [28, 29]). The evaluation of eDNA content of biofilms formed by a C. albicans mutant strain, 
known to be non-responsive to farnesol [27], suggests that the release of eDNA is not 
dependent on quorum sensing mediated by farnesol. However, it may not be disregarded that 
other extracellular alcohols released by C. albicans (Chapter 3.2) may regulate eDNA release. 
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Fig.5-5. Overview of C. tropicalis extracellular compounds evaluated in this thesis and their effect in the 
organism’s biology. The represented isoamyl alcohol (IAA), 2-phenylethanol (POH), E,E-farnesol (FOH), and 1-
dodecanol (DOH) biosynthetic pathways are hypothetical pathways predicted from the Candida Genome Database 
[15], Ghosh et al. [24], Zea et al. [25], Hornby et al. [23], and Walker [26] works. These alcohols are released into the 
extracellular medium. The effect of the individual addition of FOH was analyzed in terms of planktonic cells growth (A). 
The effects of the individual addition of E-nerolidol (NOH), IAA, POH, FOH, and DOH were analyzed in terms of biofilm 
development (B). Large down arrows denote decrease, large up arrows denote increase in the biological effect. Large 
up and down arrow denote a different behavior in the different parameters evaluated concerning the same biological 
effect. 
 
In fact, in the Candida field, the most accepted hyphothesis is that eDNA is a by-product derived 
from cell lysis within the biofilm (personnal communications on internacional conferences). Our 
preliminary studies on the evaluation of the eDNA electrophoretic mobility in conventional 
agarose gels containing ethidium bromide showed that eDNA is not similar to genomic DNA, 
exhibiting a smear profile (ranging approximately from 5000 to 75 bp) (unpublished data). This 
suggests that C. albicans eDNA is derived from cell death [30]. However, research is still 
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needed: (i) to establish a possible correlation between cell death (necrosis and/or apoptosis), 
eDNA release and biofilm formation, and (ii) to exploit other origin(s) of eDNA. 
In addition, the role of eDNA was addressed in terms of biofilm development (Chapter 
2.1, Fig.5-2) and antifungal susceptibility (Chapter 2.2, Fig.5-2). Based on the degradation of 
eDNA and addition of exogenous DNA to biofilms at different stages of biofilm development, it 
was possible to define for the first time the relevance of eDNA during C. albicans biofilm 
development, showing that it contributes to the maintenance and stability of mature biofilms, 
but not to their establishment (Chapter 2.1).  
Although it is recognized that biofilm stability/dispersion is a crucial step in the biofilm 
lifecycle (Chapter 1, Fig.1-2), only recently the phenomenon of C. albicans biofilm dispersion 
began to be detailed. In a pioneer study, Uppuluri et al. [31] showed that the peak of cell 
dispersal occurs at the intermediate stage of biofilm development, being this process controlled 
by environmental and molecular factors. Additionally, the dispersed cells sum properties 
indicating that they are more virulent than the planktonic counterparts [31]. In light of these 
findings, it may be interesting to continue our studies by evaluating the phenotypic properties of 
the cells that are held together by DNA, and thus dispersed in the presence of DNase, in terms 
of morphology, adherence, ability to form biofilm, and in vivo virulence.  
One of the aspects not focused on our studies (Chapter 2.1) was the existence and/or 
role of eDNA derived from biofilm cells but not embedded within the ECM. In fact, it is possible 
that a portion of the eDNA released by biofilm cells is not trapped by the ECM, being released to 
the surrounding environment. It may be interesting to address: (i) how circulating eDNA derived 
from biofilm cells circulates, since it is known that proteins are able to bind DNA [32], and (ii) 
the role of biofilm-derived eDNA in the modulation of the host immune system. A step forward in 
the research on eDNA in Candida species, is the evaluation of the potential use of eDNA as a 
marker for the diagnostic and prognostic of Candida infections, similarly to the observed for β-
glucans [33].  
In addition, data presented in Chapter 2.2 suggest a novel role for eDNA in C. albicans 
biofilms, as a regulator of antifungal susceptibility (Fig.5-2). The studies performed show that 
DNase increases the effectiveness of amphotericin B and caspofungin against C. albicans 
biofilms (Chapter 2.2). Notably, in the last years the combined use of drugs [34] or drugs with 
other agents, such as enzymes [35], has received considerable attention. ECM degrading 
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enzymes present a broad spectrum activity, it is unlikely that they induce antimicrobial 
resistance, and their current use as therapeutic agents (e.g. DNase is already used for cystic 
fibrosis treatment), suggests their tolerance and activity in a clinical setting. However, it may not 
be ignored that enzyme-based therapies are expensive and may increase the risk of distal sites 
colonization due to biofilm cells dispersion [35]. Even though, our studies open the possibility of 
treating biofilm device related Candida infections, with lower antifungal levels, which may be 
beneficial considering the toxicity of polyene drugs [36] and the emergence of Candida 
echinocandin resistance [37]. Nevertheless, the potential relevance of these findings (Chapter 
2.2), requires further experiments in order: (i) to understand whether the reduced levels of 
mitochondrial cell activity represent an effective reduction in metabolism or are resultant of cell 
dispersion, (ii) to determine the fractional inhibitory concentration index as a measure of 
synergy between DNase and these antifungal agents, and (iii) to evaluate more drugs from each 
antifungal class. Furthermore, for the consideration of DNase as an anti-candidal enzyme, it is 
necessary to evaluate eDNA presence and function on an additional number of C. albicans 
strains and other Candida species, including clinical samples such as those identified in this 
thesis (Chapter 4).  
In fact, the potential therapeutic use of ECM degrading enzymes is not a new issue in the 
Candida field, since the enhanced efficacy of the combined use of β-1,3-glucanase and 
antifungal agents in the eradication of C. albicans biofilms has been previously shown by Nett el 
al. [38]. This corroborates our observations (Chapter 2) that agents that target processes 
affecting the biofilm structural integrity may have potential use as therapeutic adjuvants in 
biofilm treatment, at least as part of antifungal lock therapy of devices. 
Overall, the results of the set of experiments reported in Chapter 2 show that eDNA is a 
component of C. albicans biofilm ECM that contributes to biofilm integrity and antifungal 
resistance (Fig.5-2). Introducing a new line of research, these studies expanded the current 
knowledge on C. albicans biofilm ECM. 
 
The second set of molecules selected were extracellular alcohols (Chapter 3, summarized 
on Fig.5-2 to Fig.5-5). Extracellular alcohols were pointed as targets for our research due to: (i) 
the discovery of farnesol as a quorum sensing molecule in C. albicans, and (ii) sparse studies 
suggesting that yeast cells release autoregulatory molecules into the extracellular medium 
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(Chapter 1, Table 1-1). As observed in other Candida research areas, the investigation on Non-
Candida albicans Candida (NCAC) species is scarce, and for example not much is known on the 
role of farnesol on these species. In addition, the identification of extracellular molecules 
released by C. albicans, and consequently NCAC species, is dependent on appropriate 
analytical methods. Overcoming this constraint will open the possibility of exploiting the 
interaction of the identified molecules with virulence traits of Candida species.  
Previous investigations on the effect of farnesol on NCAC species planktonic cells 
suggested a species dependent response: (i) in C. dubliniensis, morphology control (Chapter 
3.2, Fig.5-3, [39]), and (ii) in C. parapsilosis growth regulation [40]. Having found in our 
experiments the same farnesol induced effect in C. parapsilosis we perused the effect of the 
addition of exogenous farnesol in other NCAC species planktonic cells (Chapter 3.1). Using a 
set of methodologies that allow morphology, growth, viability, and cell cycle monitoring, it was 
found that farnesol (≥ 50 µM) affects C. glabrata, C. krusei, and C. tropicalis (Fig.5-4) growth 
phase, with distinct effects in cell survival and cell cycle, without changes in cell morphology 
(Chapter 3.1). Notably, very recently, an independent group reported the growth inhibitory effect 
of farnesol on NCAC species [41], although the cytotoxic process was not assessed, contrarily 
to the evaluation performed in our study (Chapter 3.1). 
Despite the considerable insights into the role of farnesol in NCAC species two main 
questions remain unanswered. First, farnesol receptors or farnesol binding proteins have not 
been identified so far [42]. However, in some cell types, receptors regulated by farnesol and its 
derivates were identified, namely, farnesoid X receptor and peroxisome proliferator-activated 
receptors [43]. Due to the similarities shared between animals and fungi [44], the existence of 
these receptors in Candida species, as well as the hypothesis of these proteins being farnesol 
receptors should be addressed. Second, the potential farnesol targets inside NCAC species cells 
are not fully elucidated. From the studies performed in C. albicans there are evidences 
supporting the involvement of the cAMP signaling pathway in the farnesol mediated response 
[45]. In parallel, this pathway has been shown to regulate C. albicans cell growth, and cell cycle 
[46]. With these studies in the backdrop, dibutyryl-cyclic adenosine monophosphate (dibutyryl-
cAMP) (10 mM) was added into NCAC species culture medium following the addition of farnesol 
(150 µM), and cell growth and morphology were monitored. C. albicans was used as a positive 
control. Unfortunately, we were not successful in the validation of the assay, since C. albicans 
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farnesol mediated filamentation inhibition was not reversed by dibutyryl-cAMP, as previously 
described [45]. However, as noted in the beginning of this chapter, only recently the NCAC 
species genome sequences were released. From now on, it will be possible to develop for 
example oligonucleotide microarrays, tool required for the analysis of global pattern gene 
expression of NCAC species, for example, under the exposure to farnesol. In between, based on 
the insights given by Rossignol et al. [40] on the effect of farnesol in C. parapsilosis, other 
targets, such as lipid metabolism, ribosome biogenesis, and amino acid biosynthesis may be 
further evaluated in C. glabrata, C. krusei, and C. tropicalis. 
As shown in Chapters 3.2 and 3.3 farnesol production into the extracellular medium is a 
common feature of C. albicans, C. dubliniensis, C. parapsilosis, and C. tropicalis species 
planktonic cells. Moreover, we were also able to identify farnesol in C. krusei ATCC 6258 and C. 
glabrata ATCC 2001 supernatants (unpublished data). Although the regulation of farnesol 
production by Candida species is still under debate, the farnesol levels considered 
physiologically relevant are below 50 µM [42]. It should be noted that physiological farnesol 
levels do not affect C. glabrata, C. krusei, and C. tropicalis growth (Chapter 3.1), but they 
regulate C. albicans and C. dubliniensis morphology (Chapter 3.2). This suggests that farnesol 
acts more likely as a quorum sensing molecule in C. albicans and C. dubliniensis, regulating a 
specific virulence trait of these Candida species [47, 48], than in the other ones.  
In addition, ongoing research in our lab suggests that C. albicans releases into the 
extracellular medium other molecules that may interfere with NCAC species physiology. 
Specifically, C. albicans supernatant: (i) does not exhibit major effects on C. glabrata and C. 
dubliniensis growth, (ii) promotes C. krusei and C. parapsilosis cell growth, but (iii) has a growth 
inhibitory effect on C. tropicalis. It is interestingly to note that the identification of Candida 
species in the oral cavity of patients attending a dental clinic (Chapter 4) revealed that the most 
common polymicrobial association was between C. albicans and C. glabrata, although C. 
parapsilosis and C. tropicalis were also isolated in combination with C. albicans. In addition, C. 
albicans and C. dubliniensis supernatants are able to regulate their own morphology (Chapter 
3.2). These findings prompted our research to the characterization of the molecules present in 
the extracellular medium and the evaluation of their effect.  
A number of techniques have been employed for fungal metabolites profiling including 
paper chromatography, thin layer chromatography, capillary electrophoresis, and, the mainly 
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applied, high performance liquid chromatography (HPLC) and gas chromatography-mass 
spectrometry (GC–MS) [49]. Although chromatographic methods are very sensitive and 
selective their major disadvantage relates with the sample preparation methods, traditionally 
time consuming, expensive, and requiring a large volume of hazardous organic solvents [50]. 
However, in the beginning of the last decade solid-phase microextraction (SPME) technology 
was introduced to overcome some of these difficulties. SPME is a technique based in an 
equilibrium partition of the compounds between the sample matrix and the extracting phase, a 
polymer-coated fused fiber that can be directly coupled with HPLC or GC-MS [51]. One of the 
drawbacks of this technique for a full characterization of the metabolome is the fact that the 
compounds extracted are dependent on the SPME fiber coating and thickness [52]. In fact, the 
Cross-linked Carbowax-divinylbenzene coating fibre used in the studies presented in this thesis 
(Chapters 3.2 and 3.3) is recommended for small and polar molecules (molecular weight 
between 40 and 275), determining the target analysis of specific compounds. 
Using headspace-SPME (HS-SPME) coupled to GC-MS, it was established, for the first 
time, the profile of multiple extracellular alcohols produced during C. albicans (Chapter 3.2, 
Fig.5-2), C. dubliniensis (Chapter 3.2, Fig.5-3), C. parapsilosis (Chapter 3.3, Fig.5-4), and C. 
tropicalis (Chapter 3.3, Fig.5-5) in vitro growth. In an unified and detailed study along time (from 
24 to 96 h), a group of molecules sharing an alcohol group- isoamyl alcohol, 2-phenylethanol 
(phenylethanol), 1-dodecanol (dodecanol), E-nerolidol (nerolidol), and farnesol- were identified 
and quantified in planktonic and biofilm supernatants of C. albicans (Chapter 3.2, Fig.5-2) and 
C. dubliniensis (Chapter 3.2, Fig.5-3). Although alcohol secretion profiles were species, culture 
mode, and growth time specific, it was not possible to establish a biofilm fingerprint concerning 
these alcohols identity (Chapter 3.2. Therefore, as an initial approach to get insights into 
extracellular alcohols produced by other Candida species, only planktonic supernatants were 
analyzed. Specifically, C. parapsilosis (Chapter 3.3, Fig.5-4), C. tropicalis (Chapter 3.3, Fig.5-5), 
C. glabrata, and C. krusei (unpublished data) 24-h supernatants contained not only farnesol, as 
described earlier in this chapter, but also isoamyl alcohol, phenylethanol, and dodecanol. 
Nerolidol was only detected in C. glabrata and C. krusei supernatants. The continuous need of 
improvement of the analytical methods for the analysis of Candida extracellular alcohols is 
evidenced by a recent study describing the development of an ultra high performance liquid 
chromatography tandem mass spectrometry method for the analysis of extracellular alcohols 
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[53]. However, the method was only optimized for the identification and quantification of 
farnesol and tyrosol, in contrast to HS-SPME GC-MS methodology described in this thesis that 
allows the simultaneous analysis of several alcohols.  
It has been suggested that the majority of the molecules secreted by microorganisms are 
able to modulate physiological functions, although the observed effects are not always derived 
from a quorum sensing circuit but many times resultant from processes of compound 
metabolisation or detoxification [54]. It is interesting to note that the identified molecules 
(Chapters 3.2 and 3.3) have a volatile nature, which may help the signal diffusion, 
communication between cells, and consequently the regulation of virulence factors. In a recent 
publication, Diggle et al. [55] proposed a classification to distinguish the types of 
communication between cells. This classification differentiates signal, cue, and coercion 
depending on the consequences to the sender and the responder cell. Specifically, a molecule 
should be classified as a signal when it alters the behavior of a receiver cell and this response 
benefits the producer cell. This concept suggests that the signal evolved owing to the response 
it elicits. A molecule is considered as a cue if its effect is beneficial for the receiver but it does 
not benefit the sender cell, thus it has not evolved owing to its effect on the receiver cell. 
Additionally, a molecule may coerce a receiver cell into an action that does not benefit this cell, 
although it benefits the sender. So, one of the challenges is to determine the effect to the 
sender and to the receiver cells, and thus infer the costs and benefits of communication 
between cells. In this sense, to get insights into the interaction of the identified molecules 
(Chapters 3.2 and 3.3) with virulence traits of Candida species, the effect of the individual 
addition of commercial formulations of the identified alcohols, at physiological and/or 
supraphysiological concentrations (using as reference the C. albicans and C. dubliniensis 
produced levels – Chapter 3.2), was examined in terms of Candida species morphogenesis, 
growth regulation (Chapter 3.2, Fig.5-2 and Fig.5-3), biofilm formation (Chapter 3.3, Fig.5-2 to 
Fig.5-5), and in the progression of disseminated candidiasis (Chapter 3.4, Fig.5-2). 
First, from our studies on the effect of C. albicans and C. dubliniensis extracellular 
alcohols in their planktonic cells morphology, it was found that under filamentation inducing 
conditions, these compounds inhibit the yeast to filamentous form  conversion (Fig.5-2 and 
Fig.5-3) without significant growth constraints (Chapter 3.2). These findings added isoamyl 
alcohol, phenylethanol, dodecanol, and nerolidol as Candida species autoregulatory substances 
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involved in the morphogenesis regulation. However, in C. albicans the intracellular targets of 
isoamyl alcohol, phenylethanol, and nerolidol are not known, and in a first approach, the 
evaluation of the expression of genes involved in key pathways of morphogenesis [56] may be 
helpful. However, the knowledge on C. dubliniensis filamentation regulation by extracellular 
alcohols is even scarcer than in C. albicans. Thus, it may be particularly interesting to elucidate 
these pathways, since it has been suggested that the dimorphism regulation may differ between 
C. albicans and C. dubliniensis [47].  
In addition, morphogenesis regulation is not considered a virulence trait of other Candida 
species such as C. parapsilosis, C. glabrata, C. krusei, and C. tropicalis [57], and as suggested 
by data in Chapter 3.1, extracellular alcohols may not interfere with it. Although the effect of the 
exogenous addition of isoamyl alcohol, phenylethanol, dodecanol, and nerolidol has not been 
tested in these NCAC species in terms of morphology, our preliminary studies suggest that 
these compounds do not interfere with their growth (unpublished data).  
Second, by screening the effect of exogenously added isoamyl alcohol, phenylethanol, 
dodecanol, nerolidol, and farnesol on biofilms (Chapter 3.3) it was shown, for the first time, that 
other alcohol compounds, besides farnesol, regulate C. albicans (Fig.5-2), C. dubliniensis (Fig.5-
3), C. parapsilosis (Fig.5-4), and C. tropicalis (Fig.5-5) biofilm development. Specifically, (i) 
isoamyl alcohol elicited anti-biofilm activity against C. albicans and C. dubliniensis, and a 
heterogeneous activity against C. tropicalis biofilm cells, (ii) phenylethanol showed anti-biofilm 
activity against C. tropicalis, (iii) dodecanol elicited a pro-biofilm activity in C. parapsilosis but 
anti-biofilm activity in C. tropicalis, (iv) nerolidol showed an anti-biofilm activity against C. 
parapsilosis and C. tropicalis, and (v) farnesol reduced C. albicans and C. dubliniensis biofilm 
(Chapter 3.3, Fig.5-2 to Fig.5-5). It should be noted that we attempted to test the effect of these 
alcohols in C. glabrata and C. krusei biofilm development. However, the standard methods used 
to study biofilm cells mitochondrial activity ([2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-
tetrazolium-5-carboxanilide]- XTT) and biofilm biomass (crystal violet assay) (Chapter 3.3), 
exhibited poor sensitivity and reproducibility for C. glabrata and C. krusei. In fact, other authors 
warned for these difficulties, specifically with the use of XTT on NCAC species [58], pointing out 
to the need for optimization of the existing methods or the development of new robust methods 
to study C. glabrata and C. krusei biofilms. Concerning the effect of the evaluated alcohols on 
biofilm development (Chapter 3.3), further studies are still required to evaluate: (i) the 
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production of the different extracellular alcohols by the NCAC species biofilm cells, (ii) the 
impact of increasing the range of concentrations tested when these alcohols showed an effect, 
and (iii) other parameters such as biofilm cells morphology, and ECM composition, including 
eDNA. In addition, it would be interesting to elucidate how the cells in different regions of the 
biofilm respond to the addition of the alcohols. This can now be accomplished by cryosectioning 
the biofilms and using capture microdissection microscopy coupled with multiplex quantitative 
real-time reverse transcriptase polymerase chain reaction [59]. 
Third, as these alcohols were not individually identified in the culture supernatants 
(Chapters 3.2 and 3.3), they may not act isolate but rather as part of a network. To clarify the 
biological relevance of these alcohols, C. albicans and C. dubliniensis 96 h planktonic and 
biofilm supernatants were mimicked using Cocktail solutions containing commercial 
formulations of isoamyl alcohol, phenylethanol, nerolidol, and farnesol at the concentrations 
determined (Chapter 3.2). In general, the in vitro effect of the Cocktail mixtures, on C. albicans 
and C. dubliniensis filamentation inhibition, was similar to that of the corresponding 
supernatants (Chapter 3.2). The exception was the Cocktail solution mimicking C. dubliniensis 
planktonic supernatant (Chapter 3.2), suggesting that other morpho-regulatory molecules may 
be present in these fractions. Following this line, on one of our ongoing studies, the complete 
profile of compounds secreted by C. albicans and C. dubliniensis is being determined and the 
effect of the molecules unraveled (unpublished data). For example, it was found that menthol is 
present in both C. albicans and C. dubliniensis planktonic and biofilm supernatants. The 
addition of the corresponding commercial standard to the culture medium at physiological levels 
(< 1 µg/l) inhibits these Candida species growth.  
Fourth, an indication of the in vivo relevance of these alcohols (Chapter 3.2) was shown 
during infection in a mouse model of disseminated C. albicans candidiasis (Chapter 3.4, Fig.5-
2). The exogenous administration of the C. albicans Cocktail solution displayed the capacity to 
modify the course of the infection and decrease its severity, by increasing mice survival, 
decreasing organ fungal burden, and inhibiting filamentation. It is still to explore how the 
Cocktail solution interferes with the host immune system, thus modulating the disease 
progression. This could be achieved by profiling cytokines with systems such as the Bio-Plex®, 
that allow the simultaneously quantification of up to 23 mouse cytokines. In addition, it would 
be interesting to elucidate the contribution of each individual alcohol in the progression of the 
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disseminated disease. Moreover, evidences in literature suggest that the role of farnesol in vivo 
depends on the disease model [60, 61]. In light of our findings (Chapter 3) it would be of 
interest: (i) to test the effect of the Cocktail solution in the recently developed animal biofilm 
models [62, 63], and (ii) to ascertain the in vivo distribution and metabolism of these 
compounds, which can be achieved by the use of emerging imaging techniques such as mass 
spectrometry imaging [64]. 
Although these studies (Chapter 3) began to dissect the regulation of Candida species 
biology through autoregulatory molecules, there are additional points that could be addressed 
throughout, such as: (i) the elucidation of the metabolic pathways underlying the production of 
these compounds, for example by the use of 13C nuclear magnetic resonance spectroscopy, as 
previously performed for Saccharomyces cerevisiae [65], (ii) the study of the physiological 
conditions that regulate the production of the these alcohols in the planktonic and biofilm 
lifestyle, (iii) the assessment of the externally added compounds metabolization by the cells, (iv) 
the evaluation of the effect of the alcohols on other virulence attributes, such as adhesins, 
proteolytic and hydrolytic enzymes secretion [47, 48, 66, 67], and (v) the increase in the 
number of strains of each Candida species evaluated. 
The results of this set of experiments (Chapter 3) report that other alcohol molecules, 
besides farnesol are produced by Candida species, and that these molecules are able to 
modulate filamentation, biofilm development, and disease pathogenesis, depending on the 
alcohol and on the Candida species. In short term, these findings increased the current 
understanding on the regulation of physiology and virulence traits of Candida species through 
autoregulatory molecules.  
Remarkably, it may be noted that it is difficult to establish costs and benefits of 
communication between cells when several parameters are being evaluated (Chapters 3.2 and 
3.3). In addition, studies such as those presented in Chapter 4, shed some light into the 
complexity of the natural environments that may influence the role of the molecules in the 
regulation of Candida phenotype. Actually, in a natural environment, the signal molecules may 
be washed out being the concentration of the compounds a balance between their production, 
degradation or half-life time [68]. In addition, in these systems, such as the oral cavity 
(evaluated in Chapter 4), other components may interfere with the balance of extracellular 
molecules, such as host components and oral bacteria, that make part of oral C. albicans 
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biofilms [69]. Curiously, it was recently found that the oral bacterium Streptococcus mutans 
produces a molecule similar to farnesol, E-2-decenoic acid, that inhibits C. albicans 
filamentation. So, one of the major challenges in the future is to be able to distinguish the 
differential production of molecules by the different species in different environments, in order 
to establish the comprehensive and accurate dynamic changes of molecules within a cell, which 
can only be achieved by the use of modeling tools (Fig.5-1) [13]. 
 
In summary, the information resulting from this thesis contributes to a better 
understanding of the extracellular milieu, not only of C. albicans but also of NCAC species. In 
short term, we increased our knowledge on specific components of Candida species 
extracellular medium- eDNA and alcohol compounds- and on their interaction with Candida 
species phenotype. In long term, the insights achieved can open the doors to other 
investigations that can lead to the development of treatment and/ or diagnostic strategies to 
combat disseminated candidiasis. 
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